(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | ||||
(Address of principal executive offices) | (Zip Code) | ||||
( | |||||
(Registrant's telephone number, including area code) | |||||
Not Applicable | |||||
(Former name, former address and former fiscal year, if changed since last report) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
x | Accelerated filer | ☐ | ||||||||||||
Non-accelerated filer | ¨ | Smaller reporting company | ||||||||||||
Emerging growth company | ||||||||||||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | ☐ | |||||||||||||
Page | |||||||||||
September 30 | December 31 | ||||||||||
2022 | 2021 | ||||||||||
(in millions of dollars) | |||||||||||
(Unaudited) | |||||||||||
Assets | |||||||||||
Investments | |||||||||||
Fixed Maturity Securities - at fair value (amortized cost of $ | $ | $ | |||||||||
Mortgage Loans (net of allowance for credit losses of $ | |||||||||||
Policy Loans | |||||||||||
Other Long-term Investments | |||||||||||
Short-term Investments | |||||||||||
Total Investments | |||||||||||
Other Assets | |||||||||||
Cash and Bank Deposits | |||||||||||
Accounts and Premiums Receivable (net of allowance for credit losses of $ | |||||||||||
Reinsurance Recoverable (net of allowance for credit losses of $ | |||||||||||
Accrued Investment Income | |||||||||||
Deferred Acquisition Costs | |||||||||||
Goodwill | |||||||||||
Property and Equipment | |||||||||||
Deferred Income Tax | |||||||||||
Other Assets | |||||||||||
Total Assets | $ | $ |
September 30 | December 31 | ||||||||||
2022 | 2021 | ||||||||||
(in millions of dollars) | |||||||||||
(Unaudited) | |||||||||||
Liabilities and Stockholders' Equity | |||||||||||
Liabilities | |||||||||||
Policy and Contract Benefits | $ | $ | |||||||||
Reserves for Future Policy and Contract Benefits | |||||||||||
Unearned Premiums | |||||||||||
Other Policyholders’ Funds | |||||||||||
Income Tax Payable | |||||||||||
Deferred Income Tax | |||||||||||
Long-term Debt | |||||||||||
Other Liabilities | |||||||||||
Total Liabilities | |||||||||||
Commitments and Contingent Liabilities - Note 11 | |||||||||||
Stockholders' Equity | |||||||||||
Common Stock, $ | |||||||||||
Authorized: | |||||||||||
Issued: | |||||||||||
Additional Paid-in Capital | |||||||||||
Accumulated Other Comprehensive Income (Loss) | ( | ||||||||||
Retained Earnings | |||||||||||
Treasury Stock - at cost: | ( | ( | |||||||||
Total Stockholders' Equity | |||||||||||
Total Liabilities and Stockholders' Equity | $ | $ |
Three Months Ended September 30 | Nine Months Ended September 30 | ||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||
(in millions of dollars, except share data) | |||||||||||||||||||||||
Revenue | |||||||||||||||||||||||
Premium Income | $ | $ | $ | $ | |||||||||||||||||||
Net Investment Income | |||||||||||||||||||||||
Net Investment Gain (Loss) | ( | ( | ( | ||||||||||||||||||||
Other Income | |||||||||||||||||||||||
Total Revenue | |||||||||||||||||||||||
Benefits and Expenses | |||||||||||||||||||||||
Benefits and Change in Reserves for Future Benefits | |||||||||||||||||||||||
Commissions | |||||||||||||||||||||||
Interest and Debt Expense | |||||||||||||||||||||||
Cost Related to Early Retirement of Debt | |||||||||||||||||||||||
Deferral of Acquisition Costs | ( | ( | ( | ( | |||||||||||||||||||
Amortization of Deferred Acquisition Costs | |||||||||||||||||||||||
Compensation Expense | |||||||||||||||||||||||
Other Expenses | |||||||||||||||||||||||
Total Benefits and Expenses | |||||||||||||||||||||||
Income Before Income Tax | |||||||||||||||||||||||
Income Tax Expense (Benefit) | |||||||||||||||||||||||
Current | |||||||||||||||||||||||
Deferred | ( | ( | |||||||||||||||||||||
Total Income Tax Expense | |||||||||||||||||||||||
Net Income | $ | $ | $ | $ | |||||||||||||||||||
Net Income Per Common Share | |||||||||||||||||||||||
Basic | $ | $ | $ | $ | |||||||||||||||||||
Assuming Dilution | $ | $ | $ | $ |
Three Months Ended September 30 | Nine Months Ended September 30 | ||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||
(in millions of dollars) | |||||||||||||||||||||||
Net Income | $ | $ | $ | $ | |||||||||||||||||||
Other Comprehensive Loss | |||||||||||||||||||||||
Change in Net Unrealized Gain (Loss) on Securities Before Adjustment (net of tax benefit of $( | ( | ( | ( | ( | |||||||||||||||||||
Change in Adjustment to Deferred Acquisition Costs and Reserves for Future Policy and Contract Benefits, Net of Reinsurance (net of tax expense of $ | |||||||||||||||||||||||
Change in Net Gain on Hedges (net of tax benefit of $ | ( | ( | ( | ( | |||||||||||||||||||
Change in Foreign Currency Translation Adjustment (net of tax expense of $ | ( | ( | ( | ( | |||||||||||||||||||
Change in Unrecognized Pension and Postretirement Benefit Costs (net of tax expense of $ | |||||||||||||||||||||||
Total Other Comprehensive Loss | ( | ( | ( | ( | |||||||||||||||||||
Comprehensive Income (Loss) | $ | ( | $ | $ | ( | $ |
Three Months Ended September 30 | Nine Months Ended September 30 | ||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||
(in millions of dollars) | |||||||||||||||||||||||
Common Stock | |||||||||||||||||||||||
Balance at Beginning of Period | $ | $ | $ | $ | |||||||||||||||||||
Common Stock Activity | |||||||||||||||||||||||
Balance at End of Period | |||||||||||||||||||||||
Additional Paid-in Capital | |||||||||||||||||||||||
Balance at Beginning of Period | |||||||||||||||||||||||
Common Stock Activity | |||||||||||||||||||||||
Balance at End of Period | |||||||||||||||||||||||
Accumulated Other Comprehensive Income (Loss) | |||||||||||||||||||||||
Balance at Beginning of Period | ( | ||||||||||||||||||||||
Other Comprehensive Loss | ( | ( | ( | ( | |||||||||||||||||||
Balance at End of Period | ( | ( | |||||||||||||||||||||
Retained Earnings | |||||||||||||||||||||||
Balance at Beginning of Period | |||||||||||||||||||||||
Net Income | |||||||||||||||||||||||
Dividends to Stockholders (per common share: $ | ( | ( | ( | ( | |||||||||||||||||||
Balance at End of Period | |||||||||||||||||||||||
Treasury Stock | |||||||||||||||||||||||
Balance at Beginning of Period | ( | ( | ( | ( | |||||||||||||||||||
Repurchases of Treasury Stock | ( | ( | |||||||||||||||||||||
Balance at End of Period | ( | ( | ( | ( | |||||||||||||||||||
Total Stockholders' Equity at End of Period | $ | $ | $ | $ |
Nine Months Ended September 30 | |||||||||||
2022 | 2021 | ||||||||||
(in millions of dollars) | |||||||||||
Cash Flows from Operating Activities | |||||||||||
Net Income | $ | $ | |||||||||
Adjustments to Reconcile Net Income to Net Cash Provided by Operating Activities | |||||||||||
Change in Receivables | |||||||||||
Change in Deferred Acquisition Costs | |||||||||||
Change in Insurance Reserves and Liabilities | ( | ||||||||||
Change in Income Taxes | ( | ||||||||||
Change in Other Accrued Liabilities | ( | ( | |||||||||
Non-cash Components of Net Investment Income | ( | ( | |||||||||
Net Investment (Gain) Loss | ( | ||||||||||
Depreciation | |||||||||||
Cash Related to Reinsurance Transaction | ( | ||||||||||
Amortization of the Cost of Reinsurance | |||||||||||
Other, Net | ( | ||||||||||
Net Cash Provided by Operating Activities | |||||||||||
Cash Flows from Investing Activities | |||||||||||
Proceeds from Sales of Fixed Maturity Securities | |||||||||||
Proceeds from Maturities of Fixed Maturity Securities | |||||||||||
Proceeds from Sales and Maturities of Other Investments | |||||||||||
Purchases of Fixed Maturity Securities | ( | ( | |||||||||
Purchases of Other Investments | ( | ( | |||||||||
Net Sales of Short-term Investments | |||||||||||
Net Increase in Payables for Collateral on Investments | |||||||||||
Net Purchases of Property and Equipment | ( | ( | |||||||||
Other, Net | ( | ||||||||||
Net Cash Used by Investing Activities | ( | ( | |||||||||
Cash Flows from Financing Activities | |||||||||||
Issuance of Long-term Debt | |||||||||||
Long-term Debt Repayment | ( | ( | |||||||||
Cost Related to Early Retirement of Debt | ( | ( | |||||||||
Issuance of Common Stock | |||||||||||
Repurchase of Common Stock | ( | ||||||||||
Dividends Paid to Stockholders | ( | ( | |||||||||
Proceeds from Policyholder Account Deposits | |||||||||||
Payments for Policyholder Account Withdrawals | ( | ( | |||||||||
Cash Received Related to Active Life Volatility Cover Agreement | |||||||||||
Other, Net | ( | ( | |||||||||
Net Cash Used by Financing Activities | ( | ( | |||||||||
Net Increase (Decrease) in Cash and Bank Deposits | ( | ||||||||||
Cash and Bank Deposits at Beginning of Year | |||||||||||
Cash and Bank Deposits at End of Period | $ | $ |
Standard | Description | Date of Adoption | Effect on Financial Statements | |||||||||||||||||
Accounting Standards Update (ASU) 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity | The amendments in this update simplified the accounting for convertible instruments by removing certain separation models in the guidance related to convertible instruments and expanded related disclosure requirements. The amendments also revised the requirements for a contract or embedded derivative that is potentially settled in an entity's own stock to be classified as equity and also amended certain guidance related to the computations of earnings per share for convertible instruments and contracts in an entity's own stock. This guidance was applied in the period of adoption. | January 1, 2022 | The adoption of this update did not have an effect on our financial position or results of operations, and did not expand our disclosures. | |||||||||||||||||
Level 2 | Level 3 | ||||||||||||||||
Instrument | Observable Inputs | Unobservable Inputs | |||||||||||||||
United States Government and Government Agencies and Authorities | |||||||||||||||||
Valuation Method | Principally the market approach | Not applicable | |||||||||||||||
Valuation Techniques / Inputs | Prices obtained from external pricing services | ||||||||||||||||
States, Municipalities, and Political Subdivisions | |||||||||||||||||
Valuation Method | Principally the market approach | Principally the market approach | |||||||||||||||
Valuation Techniques / Inputs | Prices obtained from external pricing services | Analysis of similar bonds, adjusted for comparability | |||||||||||||||
Relevant reports issued by analysts and rating agencies | |||||||||||||||||
Audited financial statements | |||||||||||||||||
Foreign Governments | |||||||||||||||||
Valuation Method | Principally the market approach | Principally the market approach | |||||||||||||||
Valuation Techniques / Inputs | Prices obtained from external pricing services | Analysis of similar bonds, adjusted for comparability | |||||||||||||||
Non-binding broker quotes | |||||||||||||||||
Call provisions | |||||||||||||||||
Public Utilities | |||||||||||||||||
Valuation Method | Principally the market and income approaches | Principally the market and income approaches | |||||||||||||||
Valuation Techniques / Inputs | Prices obtained from external pricing services | Change in benchmark reference | |||||||||||||||
Level 2 | Level 3 | ||||||||||||||||
Instrument | Observable Inputs | Unobservable Inputs | |||||||||||||||
Public Utilities - Continued | |||||||||||||||||
Non-binding broker quotes | Analysis of similar bonds, adjusted for comparability | ||||||||||||||||
Benchmark yields | Discount for size - illiquidity | ||||||||||||||||
Transactional data for new issuances and secondary trades | Volatility of credit | ||||||||||||||||
Security cash flows and structures | Lack of marketability | ||||||||||||||||
Recent issuance / supply | |||||||||||||||||
Audited financial statements | |||||||||||||||||
Security and issuer level spreads | |||||||||||||||||
Security creditor ratings/maturity/capital structure/optionality | |||||||||||||||||
Public covenants | |||||||||||||||||
Comparative bond analysis | |||||||||||||||||
Relevant reports issued by analysts and rating agencies | |||||||||||||||||
Mortgage/Asset-Backed Securities | |||||||||||||||||
Valuation Method | Principally the market and income approaches | Principally the market approach | |||||||||||||||
Valuation Techniques / Inputs | Prices obtained from external pricing services | Analysis of similar bonds, adjusted for comparability | |||||||||||||||
Non-binding broker quotes | Prices obtained from external pricing services | ||||||||||||||||
Security cash flows and structures | |||||||||||||||||
Underlying collateral | |||||||||||||||||
Prepayment speeds/loan performance/delinquencies | |||||||||||||||||
Relevant reports issued by analysts and rating agencies | |||||||||||||||||
Audited financial statements | |||||||||||||||||
All Other Corporate Bonds | |||||||||||||||||
Valuation Method | Principally the market and income approaches | Principally the market and income approaches | |||||||||||||||
Valuation Techniques / Inputs | Prices obtained from external pricing services | Change in benchmark reference | |||||||||||||||
Non-binding broker quotes | Discount for size - illiquidity | ||||||||||||||||
Benchmark yields | Volatility of credit | ||||||||||||||||
Transactional data for new issuances and secondary trades | Lack of marketability | ||||||||||||||||
Security cash flows and structures | Prices obtained from external pricing services | ||||||||||||||||
Recent issuance / supply | |||||||||||||||||
Security and issuer level spreads | |||||||||||||||||
Security creditor ratings/maturity/capital structure/optionality | |||||||||||||||||
Level 2 | Level 3 | ||||||||||||||||
Instrument | Observable Inputs | Unobservable Inputs | |||||||||||||||
All Other Corporate Bonds - Continued | |||||||||||||||||
Public covenants | |||||||||||||||||
Comparative bond analysis | |||||||||||||||||
Relevant reports issued by analysts and rating agencies | |||||||||||||||||
Audited financial statements | |||||||||||||||||
Redeemable Preferred Stocks | |||||||||||||||||
Valuation Method | Principally the market approach | Principally the market approach | |||||||||||||||
Valuation Techniques / Inputs | Non-binding broker quotes | Financial statement analysis | |||||||||||||||
Benchmark yields | |||||||||||||||||
Comparative bond analysis | |||||||||||||||||
Call provisions | |||||||||||||||||
Relevant reports issued by analysts and rating agencies | |||||||||||||||||
Audited financial statements | |||||||||||||||||
Perpetual Preferred and Equity Securities | |||||||||||||||||
Valuation Method | Principally the market approach | Principally the market and income approaches | |||||||||||||||
Valuation Techniques / Inputs | Prices obtained from external pricing services | Financial statement analysis | |||||||||||||||
Non-binding broker quotes |
September 30, 2022 | ||||||||||||||||||||
Investment Category | Fair Value | Redemption Term / Redemption Notice | Unfunded Commitments | |||||||||||||||||
(in millions of dollars) | (in millions of dollars) | |||||||||||||||||||
Private Credit | (a) | $ | Not redeemable | $ | ||||||||||||||||
Initial 2 year lock on each new investment / Quarterly after 2 year lock with 90 days notice | ||||||||||||||||||||
Total Private Credit | ||||||||||||||||||||
Private Equity | (b) | Not redeemable | ||||||||||||||||||
Initial 5.5 year lock on each new investment / Quarterly after 5.5 year lock with 90 days notice | ||||||||||||||||||||
Total Private Equity | ||||||||||||||||||||
Real Assets | (c) | Not redeemable | ||||||||||||||||||
Quarterly / 90 days notice | ||||||||||||||||||||
Total Real Assets | ||||||||||||||||||||
Total Partnerships | $ | $ |
December 31, 2021 | ||||||||||||||||||||
Investment Category | Fair Value | Redemption Term / Redemption Notice | Unfunded Commitments | |||||||||||||||||
(in millions of dollars) | (in millions of dollars) | |||||||||||||||||||
Private Credit | (a) | $ | Not redeemable | $ | ||||||||||||||||
Initial 2 year lock on each new investment / Quarterly after 2 year lock with 90 days notice | ||||||||||||||||||||
Total Private Credit | ||||||||||||||||||||
Private Equity | (b) | Not redeemable | ||||||||||||||||||
Initial 5.5 year lock on each new investment / Quarterly after 5.5 year lock with 90 days notice | ||||||||||||||||||||
Total Private Equity | ||||||||||||||||||||
Real Assets | (c) | Not redeemable | ||||||||||||||||||
Quarterly / 90 days notice | ||||||||||||||||||||
Total Real Assets | ||||||||||||||||||||
Total Partnerships | $ | $ |
September 30, 2022 | |||||||||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | NAV | Total | |||||||||||||||||||||||||
(in millions of dollars) | |||||||||||||||||||||||||||||
Assets | |||||||||||||||||||||||||||||
Fixed Maturity Securities | |||||||||||||||||||||||||||||
United States Government and Government Agencies and Authorities | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
States, Municipalities, and Political Subdivisions | |||||||||||||||||||||||||||||
Foreign Governments | |||||||||||||||||||||||||||||
Public Utilities | |||||||||||||||||||||||||||||
Mortgage/Asset-Backed Securities | |||||||||||||||||||||||||||||
All Other Corporate Bonds | |||||||||||||||||||||||||||||
Redeemable Preferred Stocks | |||||||||||||||||||||||||||||
Total Fixed Maturity Securities | |||||||||||||||||||||||||||||
Other Long-term Investments | |||||||||||||||||||||||||||||
Derivatives | |||||||||||||||||||||||||||||
Forwards | |||||||||||||||||||||||||||||
Foreign Exchange Contracts | |||||||||||||||||||||||||||||
Total Derivatives | |||||||||||||||||||||||||||||
Perpetual Preferred and Equity Securities | |||||||||||||||||||||||||||||
Private Equity Partnerships | |||||||||||||||||||||||||||||
Total Other Long-term Investments | |||||||||||||||||||||||||||||
Total Financial Instrument Assets Carried at Fair Value | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Liabilities | |||||||||||||||||||||||||||||
Other Liabilities | |||||||||||||||||||||||||||||
Derivatives | |||||||||||||||||||||||||||||
Forwards | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Foreign Exchange Contracts | |||||||||||||||||||||||||||||
Embedded Derivative in Modified Coinsurance Arrangement | |||||||||||||||||||||||||||||
Total Derivatives | |||||||||||||||||||||||||||||
Total Financial Instrument Liabilities Carried at Fair Value | $ | $ | $ | $ | $ |
December 31, 2021 | |||||||||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | NAV | Total | |||||||||||||||||||||||||
(in millions of dollars) | |||||||||||||||||||||||||||||
Assets | |||||||||||||||||||||||||||||
Fixed Maturity Securities | |||||||||||||||||||||||||||||
United States Government and Government Agencies and Authorities | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
States, Municipalities, and Political Subdivisions | |||||||||||||||||||||||||||||
Foreign Governments | |||||||||||||||||||||||||||||
Public Utilities | |||||||||||||||||||||||||||||
Mortgage/Asset-Backed Securities | |||||||||||||||||||||||||||||
All Other Corporate Bonds | |||||||||||||||||||||||||||||
Redeemable Preferred Stocks | |||||||||||||||||||||||||||||
Total Fixed Maturity Securities | |||||||||||||||||||||||||||||
Other Long-term Investments | |||||||||||||||||||||||||||||
Derivatives | |||||||||||||||||||||||||||||
Foreign Exchange Contracts | |||||||||||||||||||||||||||||
Total Derivatives | |||||||||||||||||||||||||||||
Perpetual Preferred and Equity Securities | |||||||||||||||||||||||||||||
Private Equity Partnerships | |||||||||||||||||||||||||||||
Total Other Long-term Investments | |||||||||||||||||||||||||||||
Total Financial Instrument Assets Carried at Fair Value | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Liabilities | |||||||||||||||||||||||||||||
Other Liabilities | |||||||||||||||||||||||||||||
Derivatives | |||||||||||||||||||||||||||||
Foreign Exchange Contracts | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Embedded Derivative in Modified Coinsurance Arrangement | |||||||||||||||||||||||||||||
Total Derivatives | |||||||||||||||||||||||||||||
Total Financial Instrument Liabilities Carried at Fair Value | $ | $ | $ | $ | $ |
Three Months Ended September 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Beginning of Period | Total Realized and Unrealized Investment Gains (Losses) in | Level 3 Transfers | Fair Value End of Period | Change in Unrealized Gain (Loss) on Securities Held at the End of Period included in | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings | OCI | Purchases | Sales/Maturities | Into | Out of | OCI | Earnings | ||||||||||||||||||||||||||||||||||||||||||||||||||||
(in millions of dollars) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fixed Maturity Securities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
States, Municipalities, and Political Subdivisions | $ | $ | $ | ( | $ | $ | $ | $ | $ | $ | ( | $ | |||||||||||||||||||||||||||||||||||||||||||||||
Foreign Governments | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Public Utilities | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mortgage/Asset-Backed Securities | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
All Other Corporate Bonds | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total Fixed Maturity Securities | ( | ( | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Perpetual Preferred and Equity Securities | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Embedded Derivative in Modified Coinsurance Arrangement | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Three Months Ended September 30, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Beginning of Period | Total Realized and Unrealized Investment Gains (Losses) in | Level 3 Transfers | Fair Value End of Period | Change in Unrealized Gain (Loss) on Securities Held at the End of Period included in | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings | OCI | Purchases | Sales/Maturities | Into | Out of | OCI | Earnings | ||||||||||||||||||||||||||||||||||||||||||||||||||||
(in millions of dollars) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fixed Maturity Securities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Foreign Governments | $ | $ | $ | ( | $ | $ | $ | $ | $ | $ | ( | $ | |||||||||||||||||||||||||||||||||||||||||||||||
Public Utilities | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mortgage/Asset-Backed Securities | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
All Other Corporate Bonds | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total Fixed Maturity Securities | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Perpetual Preferred and Equity Securities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Embedded Derivative in Modified Coinsurance Arrangement | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nine Months Ended September 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Beginning of Year | Total Realized and Unrealized Investment Gains (Losses) in | Level 3 Transfers | Fair Value End of Period | Change in Unrealized Gain (Loss) on Securities Held at the End of Period included in | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings | OCI | Purchases | Sales/Maturities | Into | Out of | OCI | Earnings | ||||||||||||||||||||||||||||||||||||||||||||||||||||
(in millions of dollars) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fixed Maturity Securities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
States, Municipalities, and Political Subdivisions | $ | $ | $ | ( | $ | $ | $ | $ | ( | $ | $ | ( | $ | ||||||||||||||||||||||||||||||||||||||||||||||
Foreign Governments | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Public Utilities | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mortgage/Asset-Backed Securities | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
All Other Corporate Bonds | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total Fixed Maturity Securities | ( | ( | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Perpetual Preferred and Equity Securities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Embedded Derivative in Modified Coinsurance Arrangement | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nine Months Ended September 30, 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Beginning of Year | Total Realized and Unrealized Investment Gains (Losses) in | Level 3 Transfers | Fair Value End of Period | Change in Unrealized Gain (Loss) on Securities Held at the End of Period included in | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings | OCI | Purchases | Sales/Maturities | Into | Out of | OCI | Earnings | |||||||||||||||||||||||||||||||||||||||||||||||||
(in millions of dollars) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fixed Maturity Securities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
States, Municipalities, and Political Subdivisions | $ | $ | $ | $ | $ | $ | $ | ( | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||||||||
Foreign Governments | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Public Utilities | ( | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Mortgage/Asset-Backed Securities | ( | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||
All Other Corporate Bonds | ( | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Total Fixed Maturity Securities | ( | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Perpetual Preferred and Equity Securities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Embedded Derivative in Modified Coinsurance Arrangement | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
September 30, 2022 | |||||||||||||||||||||||
Fair Value | Valuation Method | Unobservable Input | Range/Weighted Average | ||||||||||||||||||||
(in millions of dollars) | |||||||||||||||||||||||
Fixed Maturity Securities | |||||||||||||||||||||||
Public Utilities | $ | Discounted Cash Flows | Projected Liability Cash Flows | (a) | Investment Analyst Assumptions | ||||||||||||||||||
Mortgage/Asset-Backed Securities - Private | Market Approach | Market Convention | (b) | Comparability Approach | |||||||||||||||||||
All Other Corporate Bonds - Private | Market Approach | Volatility of Credit Market Convention | (d) (e) | Priced at Par Value | |||||||||||||||||||
Perpetual Preferred and Equity Securities | Market Approach | Market Convention | (e) | Priced at Cost, Owner's Equity, or Most Recent Round | |||||||||||||||||||
Embedded Derivative in Modified Coinsurance Arrangement | ( | Discounted Cash Flows | Projected Liability Cash Flows Weighted Spread of Swap Curve | (f) | Actuarial Assumptions |
December 31, 2021 | |||||||||||||||||||||||
Fair Value | Valuation Method | Unobservable Input | Range/Weighted Average | ||||||||||||||||||||
(in millions of dollars) | |||||||||||||||||||||||
Fixed Maturity Securities | |||||||||||||||||||||||
All Other Corporate Bonds - Private | $ | Market Approach | Lack of Marketability Volatility of Credit | (c) (d) | |||||||||||||||||||
Perpetual Preferred and Equity Securities | Market Approach | Market Convention | (e) | Priced at Cost or Owner's Equity | |||||||||||||||||||
Embedded Derivative in Modified Coinsurance Arrangement | ( | Discounted Cash Flows | Projected Liability Cash Flows Weighted Spread of Swap Curve | (f) | Actuarial Assumptions |
September 30, 2022 | |||||||||||||||||||||||||||||
Estimated Fair Value | |||||||||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | Carrying Value | |||||||||||||||||||||||||
(in millions of dollars) | |||||||||||||||||||||||||||||
Assets | |||||||||||||||||||||||||||||
Mortgage Loans | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Policy Loans | |||||||||||||||||||||||||||||
Other Long-term Investments | |||||||||||||||||||||||||||||
Miscellaneous Long-term Investments | |||||||||||||||||||||||||||||
Total Financial Instrument Assets Not Carried at Fair Value | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Liabilities | |||||||||||||||||||||||||||||
Long-term Debt | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Other Liabilities | |||||||||||||||||||||||||||||
Unfunded Commitments | |||||||||||||||||||||||||||||
Payable for Collateral on FHLB Funding Agreements | |||||||||||||||||||||||||||||
Total Financial Instrument Liabilities Not Carried at Fair Value | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
December 31, 2021 | |||||||||||||||||||||||||||||
Estimated Fair Value | |||||||||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | Carrying Value | |||||||||||||||||||||||||
(in millions of dollars) | |||||||||||||||||||||||||||||
Assets | |||||||||||||||||||||||||||||
Mortgage Loans | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Policy Loans | |||||||||||||||||||||||||||||
Other Long-term Investments | |||||||||||||||||||||||||||||
Miscellaneous Long-term Investments | |||||||||||||||||||||||||||||
Total Financial Instrument Assets Not Carried at Fair Value | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Liabilities | |||||||||||||||||||||||||||||
Long-term Debt | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Other Liabilities | |||||||||||||||||||||||||||||
Unfunded Commitments | |||||||||||||||||||||||||||||
Payable for Collateral on FHLB Funding Agreements | |||||||||||||||||||||||||||||
Total Financial Instrument Liabilities Not Carried at Fair Value | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
September 30, 2022 | |||||||||||||||||||||||||||||
Amortized Cost, Gross of ACL(1) | ACL(1) | Gross Unrealized Gain | Gross Unrealized Loss | Fair Value | |||||||||||||||||||||||||
(in millions of dollars) | |||||||||||||||||||||||||||||
United States Government and Government Agencies and Authorities | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
States, Municipalities, and Political Subdivisions | |||||||||||||||||||||||||||||
Foreign Governments | |||||||||||||||||||||||||||||
Public Utilities | |||||||||||||||||||||||||||||
Mortgage/Asset-Backed Securities | |||||||||||||||||||||||||||||
All Other Corporate Bonds | |||||||||||||||||||||||||||||
Redeemable Preferred Stocks | |||||||||||||||||||||||||||||
Total Fixed Maturity Securities | $ | $ | $ | $ | $ |
December 31, 2021 | |||||||||||||||||||||||||||||
Amortized Cost, Gross of ACL(1) | ACL(1) | Gross Unrealized Gain | Gross Unrealized Loss | Fair Value | |||||||||||||||||||||||||
(in millions of dollars) | |||||||||||||||||||||||||||||
United States Government and Government Agencies and Authorities | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
States, Municipalities, and Political Subdivisions | |||||||||||||||||||||||||||||
Foreign Governments | |||||||||||||||||||||||||||||
Public Utilities | |||||||||||||||||||||||||||||
Mortgage/Asset-Backed Securities | |||||||||||||||||||||||||||||
All Other Corporate Bonds | |||||||||||||||||||||||||||||
Redeemable Preferred Stocks | |||||||||||||||||||||||||||||
Total Fixed Maturity Securities | $ | $ | $ | $ | $ |
September 30, 2022 | |||||||||||||||||||||||
Less Than 12 Months | 12 Months or Greater | ||||||||||||||||||||||
Fair Value | Gross Unrealized Loss | Fair Value | Gross Unrealized Loss | ||||||||||||||||||||
(in millions of dollars) | |||||||||||||||||||||||
United States Government and Government Agencies and Authorities | $ | $ | $ | $ | |||||||||||||||||||
States, Municipalities, and Political Subdivisions | |||||||||||||||||||||||
Foreign Governments | |||||||||||||||||||||||
Public Utilities | |||||||||||||||||||||||
Mortgage/Asset-Backed Securities | |||||||||||||||||||||||
All Other Corporate Bonds | |||||||||||||||||||||||
Redeemable Preferred Stocks | |||||||||||||||||||||||
Total Fixed Maturity Securities | $ | $ | $ | $ |
December 31, 2021 | |||||||||||||||||||||||
Less Than 12 Months | 12 Months or Greater | ||||||||||||||||||||||
Fair Value | Gross Unrealized Loss | Fair Value | Gross Unrealized Loss | ||||||||||||||||||||
(in millions of dollars) | |||||||||||||||||||||||
United States Government and Government Agencies and Authorities | $ | $ | $ | $ | |||||||||||||||||||
States, Municipalities, and Political Subdivisions | |||||||||||||||||||||||
Foreign Governments | |||||||||||||||||||||||
Public Utilities | |||||||||||||||||||||||
Mortgage/Asset-Backed Securities | |||||||||||||||||||||||
All Other Corporate Bonds | |||||||||||||||||||||||
Total Fixed Maturity Securities | $ | $ | $ | $ |
September 30, 2022 | |||||||||||||||||||||||||||||
Amortized Cost, Net of ACL | Unrealized Gain Position | Unrealized Loss Position | |||||||||||||||||||||||||||
Gross Gain | Fair Value | Gross Loss | Fair Value | ||||||||||||||||||||||||||
(in millions of dollars) | |||||||||||||||||||||||||||||
1 year or less | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Over 1 year through 5 years | |||||||||||||||||||||||||||||
Over 5 years through 10 years | |||||||||||||||||||||||||||||
Over 10 years | |||||||||||||||||||||||||||||
Mortgage/Asset-Backed Securities | |||||||||||||||||||||||||||||
Total Fixed Maturity Securities | $ | $ | $ | $ | $ |
December 31, 2021 | |||||||||||||||||||||||||||||
Amortized Cost, Net of ACL | Unrealized Gain Position | Unrealized Loss Position | |||||||||||||||||||||||||||
Gross Gain | Fair Value | Gross Loss | Fair Value | ||||||||||||||||||||||||||
(in millions of dollars) | |||||||||||||||||||||||||||||
1 year or less | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Over 1 year through 5 years | |||||||||||||||||||||||||||||
Over 5 years through 10 years | |||||||||||||||||||||||||||||
Over 10 years | |||||||||||||||||||||||||||||
Mortgage/Asset-Backed Securities | |||||||||||||||||||||||||||||
Total Fixed Maturity Securities | $ | $ | $ | $ | $ |
Gross Unrealized Loss | |||||||||||||||||||||||
Fair Value | Gross Unrealized Gain | Amount | Percent of Total Gross Unrealized Loss | ||||||||||||||||||||
(in millions of dollars) | |||||||||||||||||||||||
Investment-Grade | $ | $ | $ | % | |||||||||||||||||||
Below-Investment-Grade | |||||||||||||||||||||||
Total Fixed Maturity Securities | $ | $ | $ | % |
Three Months Ended September 30 | |||||||||||
2022 | 2021 | ||||||||||
(in millions of dollars) | |||||||||||
Balance, beginning of period | $ | $ | |||||||||
Change in allowance on securities with allowance recorded in previous period | |||||||||||
Balance, end of period | $ | $ |
Nine Months Ended September 30 | |||||||||||
2022 | 2021 | ||||||||||
(in millions of dollars) | |||||||||||
Balance, beginning of period | $ | $ | |||||||||
Credit losses on securities for which credit losses were not previously recorded | |||||||||||
Change in allowance on securities with allowance recorded in previous period | |||||||||||
Change in allowance on securities sold during the period | ( | ||||||||||
Balance, end of period | $ | $ |
Three Months Ended September 30 | Nine Months Ended September 30 | ||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||
(in millions of dollars) | |||||||||||||||||||||||
Income Tax Credits | $ | $ | $ | $ | |||||||||||||||||||
Amortization, Net of Tax | ( | ( | ( | ( | |||||||||||||||||||
Income Tax Benefit | $ | $ | $ | $ |
September 30, 2022 | December 31, 2021 | ||||||||||||||||||||||
(in millions of dollars) | |||||||||||||||||||||||
Carrying Amount | Percent of Total | Carrying Amount | Percent of Total | ||||||||||||||||||||
Property Type | |||||||||||||||||||||||
Apartment | $ | % | $ | % | |||||||||||||||||||
Industrial | |||||||||||||||||||||||
Office | |||||||||||||||||||||||
Retail | |||||||||||||||||||||||
Other | |||||||||||||||||||||||
Total | $ | % | $ | % | |||||||||||||||||||
Region | |||||||||||||||||||||||
New England | $ | % | $ | % | |||||||||||||||||||
Mid-Atlantic | |||||||||||||||||||||||
East North Central | |||||||||||||||||||||||
West North Central | |||||||||||||||||||||||
South Atlantic | |||||||||||||||||||||||
East South Central | |||||||||||||||||||||||
West South Central | |||||||||||||||||||||||
Mountain | |||||||||||||||||||||||
Pacific | |||||||||||||||||||||||
Total | $ | % | $ | % |
September 30, 2022 | December 31, 2021 | ||||||||||||||||||||||
(in millions of dollars) | |||||||||||||||||||||||
Carrying Amount | Percent of Total | Carrying Amount | Percent of Total | ||||||||||||||||||||
Internal Mortgage Rating | |||||||||||||||||||||||
AA | $ | % | $ | % | |||||||||||||||||||
A | |||||||||||||||||||||||
BBB | |||||||||||||||||||||||
BB | |||||||||||||||||||||||
Total | $ | % | $ | % | |||||||||||||||||||
Loan-to-Value Ratio(1) | |||||||||||||||||||||||
<= 65% | $ | % | $ | % | |||||||||||||||||||
> 65% <= 75% | |||||||||||||||||||||||
> 75% <= 85% | |||||||||||||||||||||||
> 85% | |||||||||||||||||||||||
Total | $ | % | $ | % |
September 30, 2022 | |||||||||||||||||||||||||||||||||||||||||
Prior to 2018 | 2018 | 2019 | 2020 | 2021 | 2022 | Total | |||||||||||||||||||||||||||||||||||
(in millions of dollars) | |||||||||||||||||||||||||||||||||||||||||
Internal Mortgage Rating | |||||||||||||||||||||||||||||||||||||||||
AA | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
A | |||||||||||||||||||||||||||||||||||||||||
BBB | |||||||||||||||||||||||||||||||||||||||||
BB | |||||||||||||||||||||||||||||||||||||||||
Total Amortized Cost | |||||||||||||||||||||||||||||||||||||||||
Allowance for credit losses | ( | ( | ( | ( | ( | ( | ( | ||||||||||||||||||||||||||||||||||
Carrying Amount | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
Loan-to-Value Ratio(1) | |||||||||||||||||||||||||||||||||||||||||
<=65% | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
>65<=75% | |||||||||||||||||||||||||||||||||||||||||
>75%<=85% | |||||||||||||||||||||||||||||||||||||||||
>85% | |||||||||||||||||||||||||||||||||||||||||
Total Amortized Cost | |||||||||||||||||||||||||||||||||||||||||
Allowance for credit losses | ( | ( | ( | ( | ( | ( | ( | ||||||||||||||||||||||||||||||||||
Carrying Amount | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
December 31, 2021 | |||||||||||||||||||||||||||||||||||||||||
Prior to 2017 | 2017 | 2018 | 2019 | 2020 | 2021 | Total | |||||||||||||||||||||||||||||||||||
(in millions of dollars) | |||||||||||||||||||||||||||||||||||||||||
Internal Mortgage Rating | |||||||||||||||||||||||||||||||||||||||||
AA | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
A | |||||||||||||||||||||||||||||||||||||||||
BBB | |||||||||||||||||||||||||||||||||||||||||
BB | |||||||||||||||||||||||||||||||||||||||||
Total Amortized Cost | |||||||||||||||||||||||||||||||||||||||||
Allowance for credit losses | ( | ( | ( | ( | ( | ( | ( | ||||||||||||||||||||||||||||||||||
Carrying Amount | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
Loan-to-Value Ratio(1) | |||||||||||||||||||||||||||||||||||||||||
<=65% | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
>65<=75% | |||||||||||||||||||||||||||||||||||||||||
>75%<=85% | |||||||||||||||||||||||||||||||||||||||||
>85% | |||||||||||||||||||||||||||||||||||||||||
Total Amortized Cost | |||||||||||||||||||||||||||||||||||||||||
Allowance for credit losses | ( | ( | ( | ( | ( | ( | ( | ||||||||||||||||||||||||||||||||||
Carrying Amount | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
Three Months Ended September 30, 2022 | |||||||||||||||||||||||||||||
Beginning of Period | Current Period Provisions | Write-Offs | Recoveries | End of Period | |||||||||||||||||||||||||
(in millions of dollars) | |||||||||||||||||||||||||||||
Loan-to-Value Ratio(1) | |||||||||||||||||||||||||||||
<=65% | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
>65<=75% | |||||||||||||||||||||||||||||
>75%<=85% | ( | ||||||||||||||||||||||||||||
>85% | ( | ||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ |
Three Months Ended September 30, 2021 | |||||||||||||||||||||||||||||
Beginning of Period | Current Period Provisions | Write-Offs | Recoveries | End of Period | |||||||||||||||||||||||||
(in millions of dollars) | |||||||||||||||||||||||||||||
Loan-to-Value Ratio(1) | |||||||||||||||||||||||||||||
<=65% | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
>65<=75% | |||||||||||||||||||||||||||||
>75%<=85% | ( | ||||||||||||||||||||||||||||
>85% | |||||||||||||||||||||||||||||
Total | $ | $ | ( | $ | $ | $ |
Nine Months Ended September 30, 2022 | |||||||||||||||||||||||||||||
Beginning of Year | Current Period Provisions | Write-Offs | Recoveries | End of Period | |||||||||||||||||||||||||
(in millions of dollars) | |||||||||||||||||||||||||||||
Loan-to-Value Ratio(1) | |||||||||||||||||||||||||||||
<=65% | $ | $ | ( | $ | $ | $ | |||||||||||||||||||||||
>65<=75% | |||||||||||||||||||||||||||||
>75%<=85% | |||||||||||||||||||||||||||||
>85% | |||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ |
Nine Months Ended September 30, 2021 | |||||||||||||||||||||||||||||
Beginning of Year | Current Period Provisions | Write-Offs | Recoveries | End of Period | |||||||||||||||||||||||||
(in millions of dollars) | |||||||||||||||||||||||||||||
Loan-to-Value Ratio(1) | |||||||||||||||||||||||||||||
<=65% | $ | $ | ( | $ | $ | $ | |||||||||||||||||||||||
>65<=75% | ( | ||||||||||||||||||||||||||||
>75%<=85% | |||||||||||||||||||||||||||||
>85% | ( | ||||||||||||||||||||||||||||
Total | $ | $ | ( | $ | $ | $ |
September 30, 2022 | December 31, 2021 | ||||||||||
Overnight and Continuous | |||||||||||
(in millions of dollars) | |||||||||||
Borrowings | |||||||||||
United States Government and Government Agencies and Authorities | $ | $ | |||||||||
States, Municipalities, and Political Subdivisions | |||||||||||
Public Utilities | |||||||||||
All Other Corporate Bonds | |||||||||||
Total Borrowings | $ | $ | |||||||||
Gross Amount of Recognized Liability for Securities Lending Transactions | |||||||||||
Amounts Related to Agreements Not Included in Offsetting Disclosure Contained Herein | $ | $ |
September 30, 2022 | December 31, 2021 | |||||||||||||
(in millions of dollars) | ||||||||||||||
Carrying Value of FHLB Common Stock | $ | $ | ||||||||||||
Advances from FHLB | ||||||||||||||
Carrying Value of Collateral Posted to FHLB | ||||||||||||||
Fixed Maturity Securities | $ | $ | ||||||||||||
Commercial Mortgage Loans | ||||||||||||||
Total Carrying Value of Collateral Posted to FHLB | $ | $ |
September 30, 2022 | ||||||||||||||||||||||||||||||||||||||
Gross Amount | Gross Amount Not | |||||||||||||||||||||||||||||||||||||
of Recognized | Gross Amount | Net Amount | Offset in Balance Sheet | |||||||||||||||||||||||||||||||||||
Financial | Offset in | Presented in | Financial | Cash | Net | |||||||||||||||||||||||||||||||||
Instruments | Balance Sheet | Balance Sheet | Instruments | Collateral | Amount | |||||||||||||||||||||||||||||||||
(in millions of dollars) | ||||||||||||||||||||||||||||||||||||||
Financial Assets: | ||||||||||||||||||||||||||||||||||||||
Derivatives | $ | $ | $ | $ | ( | $ | ( | $ | ||||||||||||||||||||||||||||||
Securities Lending | ( | ( | ||||||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | ( | $ | ( | $ | ||||||||||||||||||||||||||||||
Financial Liabilities: | ||||||||||||||||||||||||||||||||||||||
Derivatives | $ | $ | $ | $ | ( | $ | $ | |||||||||||||||||||||||||||||||
Securities Lending | ( | |||||||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | ( | $ | $ |
December 31, 2021 | ||||||||||||||||||||||||||||||||||||||
Gross Amount | Gross Amount Not | |||||||||||||||||||||||||||||||||||||
of Recognized | Gross Amount | Net Amount | Offset in Balance Sheet | |||||||||||||||||||||||||||||||||||
Financial | Offset in | Presented in | Financial | Cash | Net | |||||||||||||||||||||||||||||||||
Instruments | Balance Sheet | Balance Sheet | Instruments | Collateral | Amount | |||||||||||||||||||||||||||||||||
(in millions of dollars) | ||||||||||||||||||||||||||||||||||||||
Financial Assets: | ||||||||||||||||||||||||||||||||||||||
Derivatives | $ | $ | $ | $ | ( | $ | ( | $ | ||||||||||||||||||||||||||||||
Securities Lending | ( | ( | ||||||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | ( | $ | ( | $ | ||||||||||||||||||||||||||||||
Financial Liabilities: | ||||||||||||||||||||||||||||||||||||||
Derivatives | $ | $ | $ | $ | ( | $ | $ | |||||||||||||||||||||||||||||||
Securities Lending | ( | |||||||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | ( | $ | $ |
Three Months Ended September 30 | Nine Months Ended September 30 | ||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||
(in millions of dollars) | |||||||||||||||||||||||
Fixed Maturity Securities | $ | $ | $ | $ | |||||||||||||||||||
Derivatives | |||||||||||||||||||||||
Mortgage Loans | |||||||||||||||||||||||
Policy Loans | |||||||||||||||||||||||
Other Long-term Investments | |||||||||||||||||||||||
Perpetual Preferred Securities1 | |||||||||||||||||||||||
Private Equity Partnerships | |||||||||||||||||||||||
Other | |||||||||||||||||||||||
Short-term Investments | |||||||||||||||||||||||
Gross Investment Income | |||||||||||||||||||||||
Less Investment Expenses | |||||||||||||||||||||||
Less Investment Income on Participation Fund Account Assets | |||||||||||||||||||||||
Net Investment Income | $ | $ | $ | $ |
Three Months Ended September 30 | Nine Months Ended September 30 | ||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||
(in millions of dollars) | |||||||||||||||||||||||
Fixed Maturity Securities | |||||||||||||||||||||||
Gross Gains on Sales1 | $ | $ | $ | $ | |||||||||||||||||||
Gross Losses on Sales | ( | ( | ( | ( | |||||||||||||||||||
Credit Losses | ( | ( | ( | ||||||||||||||||||||
Mortgage Loans and Other Invested Assets | |||||||||||||||||||||||
Gross Gains on Sales | |||||||||||||||||||||||
Change in Allowance for Credit Losses | ( | ( | |||||||||||||||||||||
Embedded Derivative in Modified Coinsurance Arrangement | |||||||||||||||||||||||
All Other Derivatives | ( | ||||||||||||||||||||||
Foreign Currency Transactions | ( | ( | ( | ( | |||||||||||||||||||
Net Investment Gain (Loss) | $ | ( | $ | ( | $ | ( | $ |
September 30, 2022 | December 31, 2021 | |||||||||||||
(in millions of dollars) | ||||||||||||||
Carrying Value of Collateral Received from Counterparties | ||||||||||||||
Cash | $ | $ | ||||||||||||
Fixed Maturity Securities | ||||||||||||||
$ | $ | |||||||||||||
Carrying Value of Collateral Posted to Counterparties | ||||||||||||||
Cash | $ | $ | ||||||||||||
Fixed Maturity Securities | ||||||||||||||
$ | $ |
Carrying Amount of Hedged Assets | Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of the Hedged Assets | ||||||||||||||||||||||
September 30, 2022 | December 31, 2021 | September 30, 2022 | December 31, 2021 | ||||||||||||||||||||
(in millions of dollars) | |||||||||||||||||||||||
Fixed maturity securities: | |||||||||||||||||||||||
Receive fixed functional currency interest, pay fixed foreign currency interest | $ | $ | $ | ( | $ |
September 30, 2022 | |||||||||||||||||
Derivative Assets | Derivative Liabilities | ||||||||||||||||
Notional Amount | Fair Value | Fair Value | |||||||||||||||
(in millions of dollars) | |||||||||||||||||
Designated as Hedging Instruments | |||||||||||||||||
Cash Flow Hedges | |||||||||||||||||
Forward Benchmark Interest Rate Locks | $ | $ | $ | ||||||||||||||
Foreign Currency Interest Rate Swaps | |||||||||||||||||
Total Cash Flow Hedges | |||||||||||||||||
Fair Value Hedges | |||||||||||||||||
Foreign Currency Interest Rate Swaps | |||||||||||||||||
Total Designated as Hedging Instruments | $ | $ | $ | ||||||||||||||
Not Designated as Hedging Instruments | |||||||||||||||||
Foreign Currency Forwards | $ | $ | $ | ||||||||||||||
Foreign Currency Interest Rate Swaps | |||||||||||||||||
Total Return Swaps | |||||||||||||||||
Embedded Derivative in Modified Coinsurance Arrangement | |||||||||||||||||
Total Not Designated as Hedging Instruments | $ | $ | $ | ||||||||||||||
Total Derivatives | $ | $ | $ |
December 31, 2021 | |||||||||||||||||
Derivative Assets | Derivative Liabilities | ||||||||||||||||
Notional Amount | Fair Value | Fair Value | |||||||||||||||
(in millions of dollars) | |||||||||||||||||
Designated as Hedging Instruments | |||||||||||||||||
Cash Flow Hedges | |||||||||||||||||
Foreign Currency Interest Rate Swaps | $ | $ | $ | ||||||||||||||
Fair Value Hedges | |||||||||||||||||
Foreign Currency Interest Rate Swaps | |||||||||||||||||
Total Designated as Hedging Instruments | $ | $ | $ | ||||||||||||||
Not Designated as Hedging Instruments | |||||||||||||||||
Credit Default Swaps | $ | $ | $ | ||||||||||||||
Foreign Currency Forwards | |||||||||||||||||
Foreign Currency Interest Rate Swaps | |||||||||||||||||
Total Return Swaps | |||||||||||||||||
Embedded Derivative in Modified Coinsurance Arrangement | |||||||||||||||||
Total Not Designated as Hedging Instruments | $ | $ | $ | ||||||||||||||
Total Derivatives | $ | $ | $ |
Three Months Ended September 30 | |||||||||||||||||||||||||||||||||||
2022 | 2021 | ||||||||||||||||||||||||||||||||||
Net Investment Income | Net Investment Gain (Loss) | Interest and Debt Expense | Net Investment Income | Net Investment Gain (Loss) | Interest and Debt Expense | ||||||||||||||||||||||||||||||
(in millions of dollars) | |||||||||||||||||||||||||||||||||||
Total Income and Expense Presented in the Consolidated Statements of Income of Which Hedged Items are Recorded | $ | $ | ( | $ | $ | $ | ( | $ | |||||||||||||||||||||||||||
Gain (Loss) on Cash Flow Hedging Relationships | |||||||||||||||||||||||||||||||||||
Interest Rate Swaps: | |||||||||||||||||||||||||||||||||||
Hedged items | |||||||||||||||||||||||||||||||||||
Derivatives Designated as Hedging Instruments | |||||||||||||||||||||||||||||||||||
Foreign Exchange Contracts: | — | ||||||||||||||||||||||||||||||||||
Hedged items | ( | ||||||||||||||||||||||||||||||||||
Derivatives Designated as Hedging Instruments | ( | ( | |||||||||||||||||||||||||||||||||
Forward Benchmark Interest Rate Locks: | |||||||||||||||||||||||||||||||||||
Hedged items | |||||||||||||||||||||||||||||||||||
Derivatives Designated as Hedging Instruments | |||||||||||||||||||||||||||||||||||
Gain (Loss) on Fair Value Hedging Relationships | |||||||||||||||||||||||||||||||||||
Foreign Exchange Contracts | |||||||||||||||||||||||||||||||||||
Hedged items | ( | ( | |||||||||||||||||||||||||||||||||
Derivatives Designated as Hedging Instruments | |||||||||||||||||||||||||||||||||||
Nine Months Ended September 30 | |||||||||||||||||||||||||||||||||||
2022 | 2021 | ||||||||||||||||||||||||||||||||||
Net Investment Income | Net Investment Gain (Loss) | Interest and Debt Expense | Net Investment Income | Net Investment Gain (Loss) | Interest and Debt Expense | ||||||||||||||||||||||||||||||
(in millions of dollars) | |||||||||||||||||||||||||||||||||||
Total Income and Expense Presented in the Consolidated Statements of Income of Which Hedged Items are Recorded | $ | $ | ( | $ | $ | $ | $ | ||||||||||||||||||||||||||||
Gain (Loss) on Cash Flow Hedging Relationships | |||||||||||||||||||||||||||||||||||
Interest Rate Swaps: | |||||||||||||||||||||||||||||||||||
Hedged items | |||||||||||||||||||||||||||||||||||
Derivatives Designated as Hedging Instruments | |||||||||||||||||||||||||||||||||||
Foreign Exchange Contracts: | |||||||||||||||||||||||||||||||||||
Hedged items | ( | ||||||||||||||||||||||||||||||||||
Derivatives Designated as Hedging Instruments | ( | ( | |||||||||||||||||||||||||||||||||
Forward Benchmark Interest Rate Locks: | |||||||||||||||||||||||||||||||||||
Hedged items | |||||||||||||||||||||||||||||||||||
Derivatives Designated as Hedging Instruments | |||||||||||||||||||||||||||||||||||
Gain (Loss) on Fair Value Hedging Relationships | |||||||||||||||||||||||||||||||||||
Foreign Exchange Contracts | |||||||||||||||||||||||||||||||||||
Hedged items | ( | ( | |||||||||||||||||||||||||||||||||
Derivatives Designated as Hedging Instruments | |||||||||||||||||||||||||||||||||||
Three Months Ended September 30 | Nine Months Ended September 30 | |||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
(in millions of dollars) | ||||||||||||||||||||||||||
Gain (Loss) Recognized in Other Comprehensive Income (Loss) on Derivatives | ||||||||||||||||||||||||||
Forwards | $ | ( | $ | ( | $ | ( | $ | ( | ||||||||||||||||||
Foreign Exchange Contracts | ||||||||||||||||||||||||||
Total | $ | ( | $ | $ | ( | $ | ||||||||||||||||||||
Three Months Ended September 30 | Nine Months Ended September 30 | ||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||
(in millions of dollars) | |||||||||||||||||||||||
Net Investment Gain (Loss) | |||||||||||||||||||||||
Credit Default Swaps | $ | $ | ( | $ | $ | ( | |||||||||||||||||
Foreign Exchange Contracts | ( | ||||||||||||||||||||||
Embedded Derivative in Modified Coinsurance Arrangement | |||||||||||||||||||||||
Total | $ | $ | $ | $ | |||||||||||||||||||
Other Expenses | |||||||||||||||||||||||
(Gain) Loss on Total Return Swaps | $ | $ | $ | $ | ( |
Net Unrealized Gain (Loss) on Securities | Net Gain on Hedges | Foreign Currency Translation Adjustment | Unrecognized Pension and Postretirement Benefit Costs | Total | ||||||||||||||||||||||||||||
(in millions of dollars) | ||||||||||||||||||||||||||||||||
Balance at June 30, 2022 | $ | ( | $ | $ | ( | $ | ( | $ | ( | |||||||||||||||||||||||
Other Comprehensive Income (Loss) Before Reclassifications | ( | ( | ( | ( | ||||||||||||||||||||||||||||
Amounts Reclassified from Accumulated Other Comprehensive Income or Loss | ( | |||||||||||||||||||||||||||||||
Net Other Comprehensive Income (Loss) | ( | ( | ( | ( | ||||||||||||||||||||||||||||
Balance at September 30, 2022 | $ | ( | $ | $ | ( | $ | ( | $ | ( | |||||||||||||||||||||||
Balance at June 30, 2021 | $ | $ | $ | ( | $ | ( | $ | |||||||||||||||||||||||||
Other Comprehensive Income (Loss) Before Reclassifications | ( | ( | ( | |||||||||||||||||||||||||||||
Amounts Reclassified from Accumulated Other Comprehensive Income or Loss | ( | ( | ||||||||||||||||||||||||||||||
Net Other Comprehensive Income (Loss) | ( | ( | ( | ( | ||||||||||||||||||||||||||||
Balance at September 30, 2021 | $ | $ | $ | ( | $ | ( | $ | |||||||||||||||||||||||||
Balance at December 31, 2021 | $ | $ | $ | ( | $ | ( | $ | |||||||||||||||||||||||||
Other Comprehensive Income (Loss) Before Reclassifications | ( | ( | ( | ( | ||||||||||||||||||||||||||||
Amounts Reclassified from Accumulated Other Comprehensive Income or Loss | ( | |||||||||||||||||||||||||||||||
Net Other Comprehensive Income (Loss) | ( | ( | ( | ( | ||||||||||||||||||||||||||||
Balance at September 30, 2022 | $ | ( | $ | $ | ( | $ | ( | $ | ( | |||||||||||||||||||||||
Balance at December 31, 2020 | $ | $ | $ | ( | $ | ( | $ | |||||||||||||||||||||||||
Other Comprehensive Income (Loss) Before Reclassifications | ( | ( | ( | |||||||||||||||||||||||||||||
Amounts Reclassified from Accumulated Other Comprehensive Income or Loss | ( | |||||||||||||||||||||||||||||||
Net Other Comprehensive Income (Loss) | ( | ( | ( | ( | ||||||||||||||||||||||||||||
Balance at September 30, 2021 | $ | $ | $ | ( | $ | ( | $ |
Change at September 30, 2022 | ||||||||||||||||||||||||||||||||
September 30 | June 30 | December 31 | Three Months | Nine Months | ||||||||||||||||||||||||||||
2022 | 2022 | 2021 | Ended | Ended | ||||||||||||||||||||||||||||
(in millions of dollars) | ||||||||||||||||||||||||||||||||
Fixed Maturity Securities | $ | ( | $ | ( | $ | $ | ( | $ | ( | |||||||||||||||||||||||
Deferred Acquisition Costs | ( | ( | ||||||||||||||||||||||||||||||
Reserves for Future Policy and Contract Benefits | ( | ( | ||||||||||||||||||||||||||||||
Reinsurance Recoverable | ( | ( | ( | |||||||||||||||||||||||||||||
Income Tax | ( | |||||||||||||||||||||||||||||||
Total | $ | ( | $ | ( | $ | $ | ( | $ | ( |
Change at September 30, 2021 | ||||||||||||||||||||||||||||||||
September 30 | June 30 | December 31 | Three Months | Nine Months | ||||||||||||||||||||||||||||
2021 | 2021 | 2020 | Ended | Ended | ||||||||||||||||||||||||||||
(in millions of dollars) | ||||||||||||||||||||||||||||||||
Fixed Maturity Securities | $ | $ | $ | $ | ( | $ | ( | |||||||||||||||||||||||||
Deferred Acquisition Costs | ( | ( | ( | |||||||||||||||||||||||||||||
Reserves for Future Policy and Contract Benefits | ( | ( | ( | |||||||||||||||||||||||||||||
Reinsurance Recoverable | ( | ( | ||||||||||||||||||||||||||||||
Income Tax | ( | ( | ( | |||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | ( | $ | ( |
Three Months Ended September 30 | Nine Months Ended September 30 | |||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
(in millions of dollars) | ||||||||||||||||||||||||||
Net Unrealized Loss on Securities | ||||||||||||||||||||||||||
Net Investment Gain (Loss) | ||||||||||||||||||||||||||
Gain (Loss) on Sales of Securities | $ | ( | $ | ( | $ | ( | $ | |||||||||||||||||||
Credit Losses on Fixed Maturity Securities | ( | ( | ( | |||||||||||||||||||||||
Loss on Benefits and Change in Reserves for Future Benefits | ( | |||||||||||||||||||||||||
( | ( | ( | ( | |||||||||||||||||||||||
Income Tax Benefit | ( | ( | ( | ( | ||||||||||||||||||||||
Total | $ | ( | $ | ( | $ | ( | $ | ( | ||||||||||||||||||
Net Gain on Hedges | ||||||||||||||||||||||||||
Net Investment Income | ||||||||||||||||||||||||||
Gain on Interest Rate Swaps and Forwards | $ | $ | $ | $ | ||||||||||||||||||||||
Gain (Loss) on Foreign Exchange Contracts | ( | ( | ||||||||||||||||||||||||
Net Investment Gain | ||||||||||||||||||||||||||
Gain on Interest Rate Swaps | ||||||||||||||||||||||||||
Gain on Foreign Exchange Contracts | ||||||||||||||||||||||||||
Income Tax Expense | ||||||||||||||||||||||||||
Total | $ | $ | $ | $ | ||||||||||||||||||||||
Unrecognized Pension and Postretirement Benefit Costs | ||||||||||||||||||||||||||
Other Expenses | ||||||||||||||||||||||||||
Amortization of Net Actuarial Loss | $ | ( | $ | ( | $ | ( | $ | ( | ||||||||||||||||||
Amortization of Prior Service Credit | ||||||||||||||||||||||||||
( | ( | ( | ( | |||||||||||||||||||||||
Income Tax Benefit | ( | ( | ( | ( | ||||||||||||||||||||||
Total | $ | ( | $ | ( | $ | ( | $ | ( |
2022 | 2021 | ||||||||||
(in millions of dollars) | |||||||||||
Balance at January 1 | $ | $ | |||||||||
Less Reinsurance Recoverable | |||||||||||
Net Balance at January 1 | |||||||||||
Incurred Related to | |||||||||||
Current Year | |||||||||||
Prior Years | |||||||||||
Interest | |||||||||||
All Other Incurred | ( | ( | |||||||||
Foreign Currency | ( | ( | |||||||||
Total Incurred | |||||||||||
Paid Related to | |||||||||||
Current Year | ( | ( | |||||||||
Prior Years | ( | ( | |||||||||
Total Paid | ( | ( | |||||||||
Reserves Ceded Pursuant to Reinsurance Transaction | ( | ||||||||||
Net Balance at September 30 | |||||||||||
Plus Reinsurance Recoverable | |||||||||||
Balance at September 30 | $ | $ |
September 30 | |||||||||||
2022 | 2021 | ||||||||||
(in millions of dollars) | |||||||||||
Policy and Contract Benefits | $ | $ | |||||||||
Reserves for Future Policy and Contract Benefits | |||||||||||
Total | |||||||||||
Less: | |||||||||||
Life Reserves for Future Policy and Contract Benefits | |||||||||||
Accident and Health Active Life Reserves | |||||||||||
Adjustment Related to Unrealized Investment Gains and Losses | ( | ||||||||||
Liability for Unpaid Claims and Claim Adjustment Expenses | $ | $ |
Three Months Ended September 30 | Nine Months Ended September 30 | ||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||
(in millions of dollars) | |||||||||||||||||||||||
Premium Income | |||||||||||||||||||||||
Unum US | |||||||||||||||||||||||
Group Disability | |||||||||||||||||||||||
Group Long-term Disability | $ | $ | $ | $ | |||||||||||||||||||
Group Short-term Disability | |||||||||||||||||||||||
Group Life and Accidental Death & Dismemberment | |||||||||||||||||||||||
Group Life | |||||||||||||||||||||||
Accidental Death & Dismemberment | |||||||||||||||||||||||
Supplemental and Voluntary | |||||||||||||||||||||||
Voluntary Benefits | |||||||||||||||||||||||
Individual Disability | |||||||||||||||||||||||
Dental and Vision | |||||||||||||||||||||||
Unum International | |||||||||||||||||||||||
Unum UK | |||||||||||||||||||||||
Group Long-term Disability | |||||||||||||||||||||||
Group Life | |||||||||||||||||||||||
Supplemental | |||||||||||||||||||||||
Unum Poland | |||||||||||||||||||||||
Colonial Life | |||||||||||||||||||||||
Accident, Sickness, and Disability | |||||||||||||||||||||||
Life | |||||||||||||||||||||||
Cancer and Critical Illness | |||||||||||||||||||||||
Closed Block | |||||||||||||||||||||||
Long-term Care | |||||||||||||||||||||||
Individual Disability | |||||||||||||||||||||||
All Other | |||||||||||||||||||||||
Total Premium Income | $ | $ | $ | $ |
Unum US | Unum International | Colonial Life | Closed Block | Corporate | Total | ||||||||||||||||||||||||||||||
(in millions of dollars) | |||||||||||||||||||||||||||||||||||
Three Months Ended September 30, 2022 | |||||||||||||||||||||||||||||||||||
Premium Income | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
Net Investment Income | |||||||||||||||||||||||||||||||||||
Other Income | |||||||||||||||||||||||||||||||||||
Adjusted Operating Revenue | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
Adjusted Operating Income (Loss) | $ | $ | $ | $ | $ | ( | $ | ||||||||||||||||||||||||||||
Three Months Ended September 30, 2021 | |||||||||||||||||||||||||||||||||||
Premium Income | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
Net Investment Income | |||||||||||||||||||||||||||||||||||
Other Income | |||||||||||||||||||||||||||||||||||
Adjusted Operating Revenue | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
Adjusted Operating Income (Loss) | $ | $ | $ | $ | $ | ( | $ | ||||||||||||||||||||||||||||
Unum US | Unum International | Colonial Life | Closed Block | Corporate | Total | ||||||||||||||||||||||||||||||
(in millions of dollars) | |||||||||||||||||||||||||||||||||||
Nine Months Ended September 30, 2022 | |||||||||||||||||||||||||||||||||||
Premium Income | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
Net Investment Income | |||||||||||||||||||||||||||||||||||
Other Income | |||||||||||||||||||||||||||||||||||
Adjusted Operating Revenue | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
Adjusted Operating Income (Loss) | $ | $ | $ | $ | $ | ( | $ | ||||||||||||||||||||||||||||
Nine Months Ended September 30, 2021 | |||||||||||||||||||||||||||||||||||
Premium Income | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
Net Investment Income | |||||||||||||||||||||||||||||||||||
Other Income | |||||||||||||||||||||||||||||||||||
Adjusted Operating Revenue | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
Adjusted Operating Income (Loss) | $ | $ | $ | $ | $ | ( | $ | ||||||||||||||||||||||||||||
September 30 | December 31 | ||||||||||
2022 | 2021 | ||||||||||
(in millions of dollars) | |||||||||||
Assets | |||||||||||
Unum US | $ | $ | |||||||||
Unum International | |||||||||||
Colonial Life | |||||||||||
Closed Block | |||||||||||
Corporate | |||||||||||
Total Assets | $ | $ |
Three Months Ended September 30 | Nine Months Ended September 30 | ||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||
(in millions of dollars) | |||||||||||||||||||||||
Total Revenue | $ | $ | $ | $ | |||||||||||||||||||
Excluding: | |||||||||||||||||||||||
Net Investment Gain (Loss) | ( | ( | ( | ||||||||||||||||||||
Adjusted Operating Revenue | $ | $ | $ | $ | |||||||||||||||||||
Income Before Income Tax | $ | $ | $ | $ | |||||||||||||||||||
Excluding: | |||||||||||||||||||||||
Net Investment Gains and Losses | |||||||||||||||||||||||
Net Realized Investment Gain Related to Reinsurance Transaction | |||||||||||||||||||||||
Net Investment Gain (Loss), Other | ( | ( | ( | ||||||||||||||||||||
Total Net Investment Gain (Loss) | ( | ( | ( | ||||||||||||||||||||
Items Related to Closed Block Individual Disability Reinsurance Transaction | |||||||||||||||||||||||
Change in Benefit Reserves and Transaction Costs | ( | ||||||||||||||||||||||
Amortization of the Cost of Reinsurance | ( | ( | ( | ( | |||||||||||||||||||
Total Items Related to Closed Block Individual Disability Reinsurance Transaction | (15.2) | (19.7) | (48.5) | (198.7) | |||||||||||||||||||
Net Reserve Decrease Related to Reserve Assumption Updates | |||||||||||||||||||||||
Impairment Loss on Internal-Use Software | ( | ( | |||||||||||||||||||||
Cost Related to Early Retirement of Debt | ( | ||||||||||||||||||||||
Impairment Loss on ROU Asset | ( | ||||||||||||||||||||||
Adjusted Operating Income | $ | $ | $ | $ |
Three Months Ended September 30 | |||||||||||||||||||||||||||||||||||
Pension Benefits | |||||||||||||||||||||||||||||||||||
U.S. Plans | U.K. Plan | OPEB | |||||||||||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||||||||||||
(in millions of dollars) | |||||||||||||||||||||||||||||||||||
Service Cost | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
Interest Cost | |||||||||||||||||||||||||||||||||||
Expected Return on Plan Assets | ( | ( | ( | ( | ( | ( | |||||||||||||||||||||||||||||
Amortization of: | |||||||||||||||||||||||||||||||||||
Net Actuarial (Gain) Loss | ( | ||||||||||||||||||||||||||||||||||
Prior Service Credit | ( | ( | |||||||||||||||||||||||||||||||||
Total Net Periodic Benefit Cost (Credit) | $ | ( | $ | ( | $ | ( | $ | ( | $ | $ |
Nine Months Ended September 30 | |||||||||||||||||||||||||||||||||||
Pension Benefits | |||||||||||||||||||||||||||||||||||
U.S. Plans | U.K. Plan | OPEB | |||||||||||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||||||||||||
(in millions of dollars) | |||||||||||||||||||||||||||||||||||
Service Cost | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
Interest Cost | |||||||||||||||||||||||||||||||||||
Expected Return on Plan Assets | ( | ( | ( | ( | ( | ( | |||||||||||||||||||||||||||||
Amortization of: | |||||||||||||||||||||||||||||||||||
Net Actuarial (Gain) Loss | ( | ||||||||||||||||||||||||||||||||||
Prior Service Credit | ( | ( | |||||||||||||||||||||||||||||||||
Total Net Periodic Benefit Cost (Credit) | $ | ( | $ | ( | $ | ( | $ | ( | $ | $ |
Three Months Ended September 30 | Nine Months Ended September 30 | ||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||
(in millions of dollars, except share data) | |||||||||||||||||||||||
Numerator | |||||||||||||||||||||||
Net Income | $ | $ | $ | $ | |||||||||||||||||||
Denominator (000s) | |||||||||||||||||||||||
Weighted Average Common Shares - Basic | |||||||||||||||||||||||
Dilution for Assumed Exercises of Stock Options and Nonvested Stock Awards | |||||||||||||||||||||||
Weighted Average Common Shares - Assuming Dilution | |||||||||||||||||||||||
Net Income Per Common Share | |||||||||||||||||||||||
Basic | $ | $ | $ | $ | |||||||||||||||||||
Assuming Dilution | $ | $ | $ | $ |
Three Months Ended September 30 | Nine Months Ended September 30 | ||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||
(in millions of dollars, except share data) | |||||||||||||||||||||||
Shares Repurchased (000s) | |||||||||||||||||||||||
Cost of Shares Repurchased1 | $ | $ | $ | $ |
Three Months Ended September 30 | |||||||||||||||||||||||
2022 | 2021 | ||||||||||||||||||||||
(in millions) | per share * | (in millions) | per share * | ||||||||||||||||||||
Net Income | $ | 410.7 | $ | 2.04 | $ | 328.6 | $ | 1.60 | |||||||||||||||
Excluding: | |||||||||||||||||||||||
Net Investment Loss (net of tax benefit of $1.0; $—) | (3.4) | (0.02) | (0.1) | — | |||||||||||||||||||
Amortization of the Cost of Reinsurance (net of tax benefit of $3.1; $4.2) | (12.1) | (0.06) | (15.5) | (0.08) | |||||||||||||||||||
Net Reserve Decrease Related to Reserve Assumption Updates (net of tax expense of $32.5; $38.1) | 122.5 | 0.61 | 143.3 | 0.70 | |||||||||||||||||||
Impairment Loss on Internal-Use Software (net of tax benefit of $—; $2.5) | — | — | (9.6) | (0.05) | |||||||||||||||||||
After-tax Adjusted Operating Income | $ | 303.7 | $ | 1.51 | $ | 210.5 | $ | 1.03 | |||||||||||||||
* Assuming Dilution |
Nine Months Ended September 30 | |||||||||||||||||||||||
2022 | 2021 | ||||||||||||||||||||||
(in millions) | per share * | (in millions) | per share * | ||||||||||||||||||||
Net Income | $ | 1,034.6 | $ | 5.11 | $ | 664.5 | $ | 3.24 | |||||||||||||||
Excluding: | |||||||||||||||||||||||
Net Investment Gains and Losses | |||||||||||||||||||||||
Net Realized Investment Gain Related to Reinsurance Transaction (net of tax expense of $—; $14.2) | — | — | 53.4 | 0.26 | |||||||||||||||||||
Net Investment Gain (Loss), Other (net of tax expense (benefit) of $(5.2); $3.8) | (17.1) | (0.09) | 14.0 | 0.07 | |||||||||||||||||||
Total Net Investment Gain (Loss) | (17.1) | (0.09) | 67.4 | 0.33 | |||||||||||||||||||
Items Related to Closed Block Individual Disability Reinsurance Transaction | |||||||||||||||||||||||
Change in Benefit Reserves and Transaction Costs (net of tax benefit of $—; $29.2) | — | — | (110.1) | (0.53) | |||||||||||||||||||
Amortization of the Cost of Reinsurance (net of tax benefit of $10.1; $12.6) | (38.4) | (0.19) | (46.8) | (0.24) | |||||||||||||||||||
Total Items Related to Closed Block Individual Disability Reinsurance Transaction | (38.4) | (0.19) | (156.9) | (0.77) | |||||||||||||||||||
Net Reserve Decrease Related to Reserve Assumption Updates (net of tax expense of $32.5; $38.1) | 122.5 | 0.61 | 143.3 | 0.70 | |||||||||||||||||||
Impairment Loss on Internal-Use Software (net of tax benefit of $—; $2.5) | — | — | (9.6) | (0.05) | |||||||||||||||||||
Cost Related to Early Retirement of Debt (net of tax benefit of $—; $14.1) | — | — | (53.2) | (0.26) | |||||||||||||||||||
Impairment Loss on ROU Asset (net of tax benefit of $—; $2.9) | — | — | (11.0) | (0.05) | |||||||||||||||||||
Impact of U.K. Tax Rate Increase | — | — | (24.2) | (0.12) | |||||||||||||||||||
After-tax Adjusted Operating Income | $ | 967.6 | $ | 4.78 | $ | 708.7 | $ | 3.46 | |||||||||||||||
* Assuming Dilution |
Three Months Ended September 30 | Nine Months Ended September 30 | ||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||
(in millions of dollars) | |||||||||||||||||||||||
Total Revenue | $ | 2,961.9 | $ | 2,969.7 | $ | 8,985.3 | $ | 9,034.7 | |||||||||||||||
Excluding: | |||||||||||||||||||||||
Net Investment Gain (Loss) | (4.4) | (0.1) | (22.3) | 85.4 | |||||||||||||||||||
Adjusted Operating Revenue | $ | 2,966.3 | $ | 2,969.8 | $ | 9,007.6 | $ | 8,949.3 | |||||||||||||||
Income Before Income Tax | $ | 515.3 | $ | 409.9 | $ | 1,270.5 | $ | 871.3 | |||||||||||||||
Excluding: | |||||||||||||||||||||||
Net Investment Gains and Losses | |||||||||||||||||||||||
Net Realized Investment Gain Related to Reinsurance Transaction | — | — | — | 67.6 | |||||||||||||||||||
Net Investment Gain (Loss), Other | (4.4) | (0.1) | (22.3) | 17.8 | |||||||||||||||||||
Total Net Investment Gain (Loss) | (4.4) | (0.1) | (22.3) | 85.4 | |||||||||||||||||||
Items Related to Closed Block Individual Disability Reinsurance Transaction | |||||||||||||||||||||||
Change in Benefit Reserves and Transaction Costs | — | — | — | (139.3) | |||||||||||||||||||
Amortization of the Cost of Reinsurance | (15.2) | (19.7) | (48.5) | (59.4) | |||||||||||||||||||
Total Items Related to Closed Block Individual Disability Reinsurance Transaction | (15.2) | (19.7) | (48.5) | (198.7) | |||||||||||||||||||
Net Reserve Decrease Related to Reserve Assumption Updates | 155.0 | 181.4 | 155.0 | 181.4 | |||||||||||||||||||
Impairment Loss on Internal-Use Software | — | (12.1) | — | (12.1) | |||||||||||||||||||
Cost Related to Early Retirement of Debt | — | — | — | (67.3) | |||||||||||||||||||
Impairment Loss on ROU Asset | — | — | — | (13.9) | |||||||||||||||||||
Adjusted Operating Income | $ | 379.9 | $ | 260.4 | $ | 1,186.3 | $ | 896.5 |
(in millions of dollars) | |||||||||||||||||||||||||||||||||||
Three Months Ended September 30 | Nine Months Ended September 30 | ||||||||||||||||||||||||||||||||||
2022 | % Change | 2021 | 2022 | % Change | 2021 | ||||||||||||||||||||||||||||||
Revenue | |||||||||||||||||||||||||||||||||||
Premium Income | $ | 2,391.7 | 1.6 | % | $ | 2,353.7 | $ | 7,212.3 | 1.5 | % | $ | 7,106.4 | |||||||||||||||||||||||
Net Investment Income | 511.6 | (7.0) | 550.2 | 1,597.8 | (3.9) | 1,662.4 | |||||||||||||||||||||||||||||
Net Investment Gain (Loss) | (4.4) | N.M. | (0.1) | (22.3) | N.M. | 85.4 | |||||||||||||||||||||||||||||
Other Income | 63.0 | (4.4) | 65.9 | 197.5 | 9.4 | 180.5 | |||||||||||||||||||||||||||||
Total Revenue | 2,961.9 | (0.3) | 2,969.7 | 8,985.3 | (0.5) | 9,034.7 | |||||||||||||||||||||||||||||
Benefits and Expenses | |||||||||||||||||||||||||||||||||||
Benefits and Change in Reserves for Future Benefits | 1,579.3 | (10.0) | 1,753.9 | 5,181.3 | (8.4) | 5,659.2 | |||||||||||||||||||||||||||||
Commissions | 271.5 | 5.1 | 258.3 | 819.1 | 5.3 | 777.9 | |||||||||||||||||||||||||||||
Interest and Debt Expense | 47.0 | 5.1 | 44.7 | 141.3 | 5.1 | 134.4 | |||||||||||||||||||||||||||||
Cost Related to Early Retirement of Debt | 4.2 | N.M. | — | 4.2 | (93.8) | 67.3 | |||||||||||||||||||||||||||||
Deferral of Acquisition Costs | (139.4) | 8.4 | (128.6) | (419.1) | 7.8 | (388.9) | |||||||||||||||||||||||||||||
Amortization of Deferred Acquisition Costs | 150.8 | 9.0 | 138.4 | 449.5 | 2.0 | 440.8 | |||||||||||||||||||||||||||||
Compensation Expense | 285.9 | 18.3 | 241.6 | 794.1 | 9.4 | 725.9 | |||||||||||||||||||||||||||||
Other Expenses | 247.3 | (1.7) | 251.5 | 744.4 | (0.3) | 746.8 | |||||||||||||||||||||||||||||
Total Benefits and Expenses | 2,446.6 | (4.4) | 2,559.8 | 7,714.8 | (5.5) | 8,163.4 | |||||||||||||||||||||||||||||
Income Before Income Tax | 515.3 | 25.7 | 409.9 | 1,270.5 | 45.8 | 871.3 | |||||||||||||||||||||||||||||
Income Tax Expense | 104.6 | 28.7 | 81.3 | 235.9 | 14.1 | 206.8 | |||||||||||||||||||||||||||||
Net Income | $ | 410.7 | 25.0 | $ | 328.6 | $ | 1,034.6 | 55.7 | $ | 664.5 | |||||||||||||||||||||||||
N.M. = not a meaningful percentage |
(in millions) | |||||||||||||||||||||||||||||||||||
Three Months Ended September 30 | Nine Months Ended September 30 | ||||||||||||||||||||||||||||||||||
2022 | % Change | 2021 | 2022 | % Change | 2021 | ||||||||||||||||||||||||||||||
Unum US | $ | 157.5 | 11.0 | % | $ | 141.9 | $ | 645.4 | 14.9 | % | $ | 561.9 | |||||||||||||||||||||||
Unum International | $ | 40.1 | 66.4 | % | $ | 24.1 | $ | 110.1 | 36.9 | % | $ | 80.4 | |||||||||||||||||||||||
Colonial Life | $ | 115.9 | 3.2 | % | $ | 112.3 | $ | 338.1 | 7.8 | % | $ | 313.6 |
(in millions of dollars, except ratios) | |||||||||||||||||||||||||||||||||||
Three Months Ended September 30 | Nine Months Ended September 30 | ||||||||||||||||||||||||||||||||||
2022 | % Change | 2021 | 2022 | % Change | 2021 | ||||||||||||||||||||||||||||||
Adjusted Operating Revenue | |||||||||||||||||||||||||||||||||||
Premium Income | $ | 1,559.6 | 3.9 | % | $ | 1,500.8 | $ | 4,676.8 | 2.8 | % | $ | 4,548.7 | |||||||||||||||||||||||
Net Investment Income | 170.6 | (3.2) | 176.2 | 509.4 | (5.6) | 539.5 | |||||||||||||||||||||||||||||
Other Income | 49.0 | 12.6 | 43.5 | 146.8 | 17.3 | 125.2 | |||||||||||||||||||||||||||||
Total | 1,779.2 | 3.4 | 1,720.5 | 5,333.0 | 2.3 | 5,213.4 | |||||||||||||||||||||||||||||
Benefits and Expenses | |||||||||||||||||||||||||||||||||||
Benefits and Change in Reserves for Future Benefits | 834.1 | (12.2) | 950.2 | 2,912.4 | (8.3) | 3,175.6 | |||||||||||||||||||||||||||||
Commissions | 151.3 | 5.4 | 143.5 | 458.6 | 4.5 | 439.0 | |||||||||||||||||||||||||||||
Deferral of Acquisition Costs | (66.2) | 8.3 | (61.1) | (199.4) | 3.1 | (193.4) | |||||||||||||||||||||||||||||
Amortization of Deferred Acquisition Costs | 75.3 | 5.9 | 71.1 | 228.0 | (6.4) | 243.7 | |||||||||||||||||||||||||||||
Other Expenses | 354.7 | 13.2 | 313.3 | 1,036.4 | 9.1 | 950.0 | |||||||||||||||||||||||||||||
Total | 1,349.2 | (4.8) | 1,417.0 | 4,436.0 | (3.9) | 4,614.9 | |||||||||||||||||||||||||||||
Income Before Income Tax and Net Investment Gains and Losses | 430.0 | 41.7 | 303.5 | 897.0 | 49.9 | 598.5 | |||||||||||||||||||||||||||||
Reserve Assumption Updates | (155.0) | 27.9 | (215.0) | (155.0) | 27.9 | (215.0) | |||||||||||||||||||||||||||||
Adjusted Operating Income | $ | 275.0 | N.M. | $ | 88.5 | $ | 742.0 | 93.5 | $ | 383.5 | |||||||||||||||||||||||||
Operating Ratios (% of Premium Income): | |||||||||||||||||||||||||||||||||||
Benefit Ratio1 | 63.4 | % | 77.6 | % | 65.6 | % | 74.5 | % | |||||||||||||||||||||||||||
Other Expense Ratio | 22.7 | % | 20.9 | % | 22.2 | % | 20.9 | % | |||||||||||||||||||||||||||
Adjusted Operating Income Ratio | 17.6 | % | 5.9 | % | 15.9 | % | 8.4 | % | |||||||||||||||||||||||||||
1Excludes the $155.0 million and $215.0 million reserve decreases from the third quarters and first nine months of 2022 and 2021, respectively, related to the assumption updates that occurred during the third quarters of each year. | |||||||||||||||||||||||||||||||||||
N.M. = not a meaningful percentage |
(in millions of dollars, except ratios) | |||||||||||||||||||||||||||||||||||
Three Months Ended September 30 | Nine Months Ended September 30 | ||||||||||||||||||||||||||||||||||
2022 | % Change | 2021 | 2022 | % Change | 2021 | ||||||||||||||||||||||||||||||
Adjusted Operating Revenue | |||||||||||||||||||||||||||||||||||
Premium Income | |||||||||||||||||||||||||||||||||||
Group Long-term Disability | $ | 480.9 | 6.5 | % | $ | 451.4 | $ | 1,419.2 | 3.8 | % | $ | 1,367.7 | |||||||||||||||||||||||
Group Short-term Disability | 232.2 | 9.3 | 212.4 | 685.9 | 7.0 | 641.2 | |||||||||||||||||||||||||||||
Total Premium Income | 713.1 | 7.4 | 663.8 | 2,105.1 | 4.8 | 2,008.9 | |||||||||||||||||||||||||||||
Net Investment Income | 84.8 | (9.1) | 93.3 | 262.6 | (7.8) | 284.7 | |||||||||||||||||||||||||||||
Other Income | 48.4 | 15.0 | 42.1 | 143.5 | 18.2 | 121.4 | |||||||||||||||||||||||||||||
Total | 846.3 | 5.9 | 799.2 | 2,511.2 | 4.0 | 2,415.0 | |||||||||||||||||||||||||||||
Benefits and Expenses | |||||||||||||||||||||||||||||||||||
Benefits and Change in Reserves for Future Benefits | 326.0 | 5.6 | 308.6 | 1,301.3 | (1.0) | 1,314.3 | |||||||||||||||||||||||||||||
Commissions | 52.1 | 6.1 | 49.1 | 158.0 | 4.5 | 151.2 | |||||||||||||||||||||||||||||
Deferral of Acquisition Costs | (12.9) | 4.9 | (12.3) | (38.1) | 1.9 | (37.4) | |||||||||||||||||||||||||||||
Amortization of Deferred Acquisition Costs | 13.1 | 1.6 | 12.9 | 38.6 | — | 38.6 | |||||||||||||||||||||||||||||
Other Expenses | 217.2 | 16.5 | 186.4 | 630.5 | 10.7 | 569.8 | |||||||||||||||||||||||||||||
Total | 595.5 | 9.3 | 544.7 | 2,090.3 | 2.6 | 2,036.5 | |||||||||||||||||||||||||||||
Income Before Income Tax and Net Investment Gains and Losses | 250.8 | (1.5) | 254.5 | 420.9 | 11.2 | 378.5 | |||||||||||||||||||||||||||||
Reserve Assumption Updates | (121.0) | 43.7 | (215.0) | (121.0) | 43.7 | (215.0) | |||||||||||||||||||||||||||||
Adjusted Operating Income | $ | 129.8 | N.M. | $ | 39.5 | $ | 299.9 | 83.4 | $ | 163.5 | |||||||||||||||||||||||||
Operating Ratios (% of Premium Income): | |||||||||||||||||||||||||||||||||||
Benefit Ratio1 | 62.7 | % | 78.9 | % | 67.6 | % | 76.1 | % | |||||||||||||||||||||||||||
Other Expense Ratio | 30.5 | % | 28.1 | % | 30.0 | % | 28.4 | % | |||||||||||||||||||||||||||
Adjusted Operating Income Ratio | 18.2 | % | 6.0 | % | 14.2 | % | 8.1 | % | |||||||||||||||||||||||||||
Persistency: | |||||||||||||||||||||||||||||||||||
Group Long-term Disability | 90.7 | % | 89.8 | % | |||||||||||||||||||||||||||||||
Group Short-term Disability | 89.2 | % | 87.1 | % | |||||||||||||||||||||||||||||||
1Excludes the $121.0 million and $215.0 million reserve decreases from the third quarters and first nine months of 2022 and 2021, respectively, related to the assumption updates that occurred during the third quarters of each year. | |||||||||||||||||||||||||||||||||||
N.M. = not a meaningful percentage |
(in millions of dollars, except ratios) | |||||||||||||||||||||||||||||||||||
Three Months Ended September 30 | Nine Months Ended September 30 | ||||||||||||||||||||||||||||||||||
2022 | % Change | 2021 | 2022 | % Change | 2021 | ||||||||||||||||||||||||||||||
Adjusted Operating Revenue | |||||||||||||||||||||||||||||||||||
Premium Income | |||||||||||||||||||||||||||||||||||
Group Life | $ | 417.7 | 3.3 | % | $ | 404.2 | $ | 1,249.9 | 1.7 | % | $ | 1,228.8 | |||||||||||||||||||||||
Accidental Death & Dismemberment | 43.8 | 10.6 | 39.6 | 129.7 | 5.4 | 123.0 | |||||||||||||||||||||||||||||
Total Premium Income | 461.5 | 4.0 | 443.8 | 1,379.6 | 2.1 | 1,351.8 | |||||||||||||||||||||||||||||
Net Investment Income | 25.3 | 4.1 | 24.3 | 75.1 | (1.3) | 76.1 | |||||||||||||||||||||||||||||
Other Income | 0.4 | (20.0) | 0.5 | 1.2 | (7.7) | 1.3 | |||||||||||||||||||||||||||||
Total | 487.2 | 4.0 | 468.6 | 1,455.9 | 1.9 | 1,429.2 | |||||||||||||||||||||||||||||
Benefits and Expenses | |||||||||||||||||||||||||||||||||||
Benefits and Change in Reserves for Future Benefits | 325.8 | (27.0) | 446.6 | 1,052.8 | (17.8) | 1,281.2 | |||||||||||||||||||||||||||||
Commissions | 38.8 | 6.6 | 36.4 | 113.7 | 4.2 | 109.1 | |||||||||||||||||||||||||||||
Deferral of Acquisition Costs | (9.0) | 1.1 | (8.9) | (26.9) | (1.5) | (27.3) | |||||||||||||||||||||||||||||
Amortization of Deferred Acquisition Costs | 8.3 | (12.6) | 9.5 | 24.8 | (13.6) | 28.7 | |||||||||||||||||||||||||||||
Other Expenses | 58.4 | 12.1 | 52.1 | 168.7 | 7.0 | 157.7 | |||||||||||||||||||||||||||||
Total | 422.3 | (21.2) | 535.7 | 1,333.1 | (14.0) | 1,549.4 | |||||||||||||||||||||||||||||
Income (Loss) Before Income Tax and Net Investment Gains and Losses | 64.9 | 196.7 | (67.1) | 122.8 | N.M. | (120.2) | |||||||||||||||||||||||||||||
Reserve Assumption Update | (34.0) | N.M. | — | (34.0) | N.M. | — | |||||||||||||||||||||||||||||
Adjusted Operating Income (Loss) | $ | 30.9 | 146.1 | $ | (67.1) | $ | 88.8 | 173.9 | $ | (120.2) | |||||||||||||||||||||||||
Operating Ratios (% of Premium Income): | |||||||||||||||||||||||||||||||||||
Benefit Ratio1 | 78.0 | % | 100.6 | % | 78.8 | % | 94.8 | % | |||||||||||||||||||||||||||
Other Expense Ratio | 12.7 | % | 11.7 | % | 12.2 | % | 11.7 | % | |||||||||||||||||||||||||||
Adjusted Operating Income (Loss) Ratio | 6.7 | % | (15.1) | % | 6.4 | % | (8.9) | % | |||||||||||||||||||||||||||
Persistency: | |||||||||||||||||||||||||||||||||||
Group Life | 89.2 | % | 89.9 | % | |||||||||||||||||||||||||||||||
Accidental Death & Dismemberment | 88.1 | % | 89.3 | % | |||||||||||||||||||||||||||||||
1Excludes the $34.0 million reserve decrease from the third quarter and first nine months of 2022 related to the assumption update that occurred during the third quarter of 2022. | |||||||||||||||||||||||||||||||||||
N.M. = not a meaningful percentage |
(in millions of dollars, except ratios) | |||||||||||||||||||||||||||||||||||
Three Months Ended September 30 | Nine Months Ended September 30 | ||||||||||||||||||||||||||||||||||
2022 | % Change | 2021 | 2022 | % Change | 2021 | ||||||||||||||||||||||||||||||
Adjusted Operating Revenue | |||||||||||||||||||||||||||||||||||
Premium Income | |||||||||||||||||||||||||||||||||||
Voluntary Benefits | $ | 199.0 | (5.1) | % | $ | 209.6 | $ | 635.2 | (0.8) | % | $ | 640.4 | |||||||||||||||||||||||
Individual Disability | 118.9 | 2.8 | 115.7 | 350.3 | 1.5 | 345.0 | |||||||||||||||||||||||||||||
Dental and Vision | 67.1 | (1.2) | 67.9 | 206.6 | 2.0 | 202.6 | |||||||||||||||||||||||||||||
Total Premium Income | 385.0 | (2.1) | 393.2 | 1,192.1 | 0.3 | 1,188.0 | |||||||||||||||||||||||||||||
Net Investment Income | 60.5 | 3.2 | 58.6 | 171.7 | (3.9) | 178.7 | |||||||||||||||||||||||||||||
Other Income | 0.2 | (77.8) | 0.9 | 2.1 | (16.0) | 2.5 | |||||||||||||||||||||||||||||
Total | 445.7 | (1.5) | 452.7 | 1,365.9 | (0.2) | 1,369.2 | |||||||||||||||||||||||||||||
Benefits and Expenses | |||||||||||||||||||||||||||||||||||
Benefits and Change in Reserves for Future Benefits | 182.3 | (6.5) | 195.0 | 558.3 | (3.8) | 580.1 | |||||||||||||||||||||||||||||
Commissions | 60.4 | 4.1 | 58.0 | 186.9 | 4.6 | 178.7 | |||||||||||||||||||||||||||||
Deferral of Acquisition Costs | (44.3) | 11.0 | (39.9) | (134.4) | 4.4 | (128.7) | |||||||||||||||||||||||||||||
Amortization of Deferred Acquisition Costs | 53.9 | 10.7 | 48.7 | 164.6 | (6.7) | 176.4 | |||||||||||||||||||||||||||||
Other Expenses | 79.1 | 5.7 | 74.8 | 237.2 | 6.6 | 222.5 | |||||||||||||||||||||||||||||
Total | 331.4 | (1.5) | 336.6 | 1,012.6 | (1.6) | 1,029.0 | |||||||||||||||||||||||||||||
Adjusted Operating Income | $ | 114.3 | (1.6) | $ | 116.1 | $ | 353.3 | 3.9 | $ | 340.2 | |||||||||||||||||||||||||
Operating Ratios (% of Premium Income): | |||||||||||||||||||||||||||||||||||
Benefit Ratios: | |||||||||||||||||||||||||||||||||||
Voluntary Benefits | 42.6 | % | 46.6 | % | 41.2 | % | 43.3 | % | |||||||||||||||||||||||||||
Individual Disability | 40.0 | % | 40.1 | % | 41.3 | % | 43.6 | % | |||||||||||||||||||||||||||
Dental and Vision | 74.5 | % | 75.0 | % | 73.6 | % | 75.1 | % | |||||||||||||||||||||||||||
Other Expense Ratio | 20.5 | % | 19.0 | % | 19.9 | % | 18.7 | % | |||||||||||||||||||||||||||
Adjusted Operating Income Ratio | 29.7 | % | 29.5 | % | 29.6 | % | 28.6 | % | |||||||||||||||||||||||||||
Persistency: | |||||||||||||||||||||||||||||||||||
Voluntary Benefits | 75.1 | % | 75.4 | % | |||||||||||||||||||||||||||||||
Individual Disability | 89.2 | % | 88.4 | % | |||||||||||||||||||||||||||||||
Dental and Vision | 81.4 | % | 86.3 | % | |||||||||||||||||||||||||||||||
(in millions of dollars) | |||||||||||||||||||||||||||||||||||
Three Months Ended September 30 | Nine Months Ended September 30 | ||||||||||||||||||||||||||||||||||
2022 | % Change | 2021 | 2022 | % Change | 2021 | ||||||||||||||||||||||||||||||
Sales by Product | |||||||||||||||||||||||||||||||||||
Group Disability and Group Life and AD&D | |||||||||||||||||||||||||||||||||||
Group Long-term Disability | $ | 35.4 | 35.1 | % | $ | 26.2 | $ | 139.2 | 40.2 | % | $ | 99.3 | |||||||||||||||||||||||
Group Short-term Disability | 18.3 | (15.3) | 21.6 | 82.4 | 7.2 | 76.9 | |||||||||||||||||||||||||||||
Group Life and AD&D | 26.9 | 1.1 | 26.6 | 137.5 | 14.0 | 120.6 | |||||||||||||||||||||||||||||
Subtotal | 80.6 | 8.3 | 74.4 | 359.1 | 21.0 | 296.8 | |||||||||||||||||||||||||||||
Supplemental and Voluntary | |||||||||||||||||||||||||||||||||||
Voluntary Benefits | 40.5 | 19.1 | 34.0 | 188.8 | 5.7 | 178.7 | |||||||||||||||||||||||||||||
Individual Disability | 25.9 | 23.9 | 20.9 | 64.9 | 22.9 | 52.8 | |||||||||||||||||||||||||||||
Dental and Vision | 10.5 | (16.7) | 12.6 | 32.6 | (3.0) | 33.6 | |||||||||||||||||||||||||||||
Subtotal | 76.9 | 13.9 | 67.5 | 286.3 | 8.0 | 265.1 | |||||||||||||||||||||||||||||
Total Sales | $ | 157.5 | 11.0 | $ | 141.9 | $ | 645.4 | 14.9 | $ | 561.9 | |||||||||||||||||||||||||
Sales by Market Sector | |||||||||||||||||||||||||||||||||||
Group Disability and Group Life and AD&D | |||||||||||||||||||||||||||||||||||
Core Market (< 2,000 employees) | $ | 58.7 | 27.9 | % | $ | 45.9 | $ | 228.5 | 21.9 | % | $ | 187.5 | |||||||||||||||||||||||
Large Case Market | 21.9 | (23.2) | 28.5 | 130.6 | 19.5 | 109.3 | |||||||||||||||||||||||||||||
Subtotal | 80.6 | 8.3 | 74.4 | 359.1 | 21.0 | 296.8 | |||||||||||||||||||||||||||||
Supplemental and Voluntary | 76.9 | 13.9 | 67.5 | 286.3 | 8.0 | 265.1 | |||||||||||||||||||||||||||||
Total Sales | $ | 157.5 | 11.0 | $ | 141.9 | $ | 645.4 | 14.9 | $ | 561.9 | |||||||||||||||||||||||||
(in millions of dollars, except ratios) | |||||||||||||||||||||||||||||||||||
Three Months Ended September 30 | Nine Months Ended September 30 | ||||||||||||||||||||||||||||||||||
2022 | % Change | 2021 | 2022 | % Change | 2021 | ||||||||||||||||||||||||||||||
Adjusted Operating Revenue | |||||||||||||||||||||||||||||||||||
Premium Income | |||||||||||||||||||||||||||||||||||
Unum UK | |||||||||||||||||||||||||||||||||||
Group Long-term Disability | $ | 89.8 | (11.6) | % | $ | 101.6 | $ | 287.5 | (5.4) | % | $ | 303.8 | |||||||||||||||||||||||
Group Life | 35.0 | 20.3 | 29.1 | 100.5 | 19.1 | 84.4 | |||||||||||||||||||||||||||||
Supplemental | 27.4 | (3.2) | 28.3 | 85.8 | 1.9 | 84.2 | |||||||||||||||||||||||||||||
Unum Poland | 21.1 | (6.6) | 22.6 | 66.7 | (0.6) | 67.1 | |||||||||||||||||||||||||||||
Total Premium Income | 173.3 | (4.6) | 181.6 | 540.5 | 0.2 | 539.5 | |||||||||||||||||||||||||||||
Net Investment Income | 37.0 | 11.8 | 33.1 | 122.3 | 29.0 | 94.8 | |||||||||||||||||||||||||||||
Other Income | 0.2 | (50.0) | 0.4 | 0.7 | 16.7 | 0.6 | |||||||||||||||||||||||||||||
Total | 210.5 | (2.1) | 215.1 | 663.5 | 4.5 | 634.9 | |||||||||||||||||||||||||||||
Benefits and Expenses | |||||||||||||||||||||||||||||||||||
Benefits and Change in Reserves for Future Benefits | 131.1 | (6.1) | 139.6 | 432.8 | 3.9 | 416.6 | |||||||||||||||||||||||||||||
Commissions | 15.0 | 7.9 | 13.9 | 44.9 | 10.3 | 40.7 | |||||||||||||||||||||||||||||
Deferral of Acquisition Costs | (2.9) | (12.1) | (3.3) | (9.3) | (3.1) | (9.6) | |||||||||||||||||||||||||||||
Amortization of Deferred Acquisition Costs | 1.2 | (40.0) | 2.0 | 5.8 | (4.9) | 6.1 | |||||||||||||||||||||||||||||
Other Expenses | 36.2 | 2.0 | 35.5 | 107.3 | 4.7 | 102.5 | |||||||||||||||||||||||||||||
Total | 180.6 | (3.8) | 187.7 | 581.5 | 4.5 | 556.3 | |||||||||||||||||||||||||||||
Adjusted Operating Income | $ | 29.9 | 9.1 | $ | 27.4 | $ | 82.0 | 4.3 | $ | 78.6 | |||||||||||||||||||||||||
(in millions of pounds, except ratios) | |||||||||||||||||||||||||||||||||||
Three Months Ended September 30 | Nine Months Ended September 30 | ||||||||||||||||||||||||||||||||||
2022 | % Change | 2021 | 2022 | % Change | 2021 | ||||||||||||||||||||||||||||||
Adjusted Operating Revenue | |||||||||||||||||||||||||||||||||||
Premium Income | |||||||||||||||||||||||||||||||||||
Group Long-term Disability | £ | 76.2 | 3.4 | % | £ | 73.7 | £ | 228.4 | 4.1 | % | £ | 219.3 | |||||||||||||||||||||||
Group Life | 29.8 | 41.2 | 21.1 | 80.3 | 31.9 | 60.9 | |||||||||||||||||||||||||||||
Supplemental | 23.4 | 13.6 | 20.6 | 68.4 | 12.5 | 60.8 | |||||||||||||||||||||||||||||
Total Premium Income | 129.4 | 12.1 | 115.4 | 377.1 | 10.6 | 341.0 | |||||||||||||||||||||||||||||
Net Investment Income | 29.9 | 32.9 | 22.5 | 93.3 | 45.3 | 64.2 | |||||||||||||||||||||||||||||
Other Income | — | N.M. | 0.2 | 0.1 | (50.0) | 0.2 | |||||||||||||||||||||||||||||
Total | 159.3 | 15.4 | 138.1 | 470.5 | 16.1 | 405.4 | |||||||||||||||||||||||||||||
Benefits and Expenses | |||||||||||||||||||||||||||||||||||
Benefits and Change in Reserves for Future Benefits | 101.7 | 11.3 | 91.4 | 312.8 | 16.0 | 269.6 | |||||||||||||||||||||||||||||
Commissions | 9.1 | 21.3 | 7.5 | 26.0 | 20.4 | 21.6 | |||||||||||||||||||||||||||||
Deferral of Acquisition Costs | (1.0) | (16.7) | (1.2) | (3.3) | 3.1 | (3.2) | |||||||||||||||||||||||||||||
Amortization of Deferred Acquisition Costs | 0.6 | (50.0) | 1.2 | 3.7 | (2.6) | 3.8 | |||||||||||||||||||||||||||||
Other Expenses | 25.3 | 21.6 | 20.8 | 69.2 | 15.7 | 59.8 | |||||||||||||||||||||||||||||
Total | 135.7 | 13.4 | 119.7 | 408.4 | 16.2 | 351.6 | |||||||||||||||||||||||||||||
Adjusted Operating Income | £ | 23.6 | 28.3 | £ | 18.4 | £ | 62.1 | 15.4 | £ | 53.8 | |||||||||||||||||||||||||
Weighted Average Pound/Dollar Exchange Rate | 1.169 | 1.380 | 1.246 | 1.385 | |||||||||||||||||||||||||||||||
Operating Ratios (% of Premium Income): | |||||||||||||||||||||||||||||||||||
Benefit Ratio | 78.6 | % | 79.2 | % | 82.9 | % | 79.1 | % | |||||||||||||||||||||||||||
Other Expense Ratio | 19.6 | % | 18.0 | % | 18.4 | % | 17.5 | % | |||||||||||||||||||||||||||
Adjusted Operating Income Ratio | 18.2 | % | 15.9 | % | 16.5 | % | 15.8 | % | |||||||||||||||||||||||||||
Persistency: | |||||||||||||||||||||||||||||||||||
Group Long-term Disability | 84.9 | % | 88.9 | % | |||||||||||||||||||||||||||||||
Group Life | 88.2 | % | 86.0 | % | |||||||||||||||||||||||||||||||
Supplemental | 92.3 | % | 89.9 | % | |||||||||||||||||||||||||||||||
N.M. = not a meaningful percentage |
(in millions of dollars and pounds) | |||||||||||||||||||||||||||||||||||
Three Months Ended September 30 | Nine Months Ended September 30 | ||||||||||||||||||||||||||||||||||
2022 | % Change | 2021 | 2022 | % Change | 2021 | ||||||||||||||||||||||||||||||
Unum International Sales by Product | |||||||||||||||||||||||||||||||||||
Unum UK | |||||||||||||||||||||||||||||||||||
Group Long-term Disability | $ | 6.4 | (36.6) | % | $ | 10.1 | $ | 35.2 | 5.4 | % | $ | 33.4 | |||||||||||||||||||||||
Group Life | 28.1 | N.M. | 6.8 | 49.0 | 114.0 | 22.9 | |||||||||||||||||||||||||||||
Supplemental | 2.2 | (40.5) | 3.7 | 14.5 | 6.6 | 13.6 | |||||||||||||||||||||||||||||
Unum Poland | 3.4 | (2.9) | 3.5 | 11.4 | 8.6 | 10.5 | |||||||||||||||||||||||||||||
Total Sales | $ | 40.1 | 66.4 | $ | 24.1 | $ | 110.1 | 36.9 | $ | 80.4 | |||||||||||||||||||||||||
Unum International Sales by Market Sector | |||||||||||||||||||||||||||||||||||
Unum UK | |||||||||||||||||||||||||||||||||||
Group Long-term Disability and Group Life | |||||||||||||||||||||||||||||||||||
Core Market (< 500 employees) | $ | 9.3 | — | % | $ | 9.3 | $ | 32.8 | 7.5 | % | $ | 30.5 | |||||||||||||||||||||||
Large Case Market | 25.2 | N.M. | 7.6 | 51.4 | 99.2 | 25.8 | |||||||||||||||||||||||||||||
Subtotal | 34.5 | 104.1 | 16.9 | 84.2 | 49.6 | 56.3 | |||||||||||||||||||||||||||||
Supplemental | 2.2 | (40.5) | 3.7 | 14.5 | 6.6 | 13.6 | |||||||||||||||||||||||||||||
Unum Poland | 3.4 | (2.9) | 3.5 | 11.4 | 8.6 | 10.5 | |||||||||||||||||||||||||||||
Total Sales | $ | 40.1 | 66.4 | $ | 24.1 | $ | 110.1 | 36.9 | $ | 80.4 | |||||||||||||||||||||||||
Unum UK Sales by Product | |||||||||||||||||||||||||||||||||||
Group Long-term Disability | £ | 5.5 | (25.7) | % | £ | 7.4 | £ | 27.6 | 14.5 | % | £ | 24.1 | |||||||||||||||||||||||
Group Life | 23.5 | N.M. | 4.9 | 39.7 | 140.6 | 16.5 | |||||||||||||||||||||||||||||
Supplemental | 1.9 | (29.6) | 2.7 | 11.3 | 14.1 | 9.9 | |||||||||||||||||||||||||||||
Total Sales | £ | 30.9 | 106.0 | £ | 15.0 | £ | 78.6 | 55.6 | £ | 50.5 | |||||||||||||||||||||||||
Unum UK Sales by Market Sector | |||||||||||||||||||||||||||||||||||
Group Long-term Disability and Group Life | |||||||||||||||||||||||||||||||||||
Core Market (< 500 employees) | £ | 7.9 | 17.9 | % | £ | 6.7 | £ | 25.9 | 17.7 | % | £ | 22.0 | |||||||||||||||||||||||
Large Case Market | 21.1 | N.M. | 5.6 | 41.4 | 122.6 | 18.6 | |||||||||||||||||||||||||||||
Subtotal | 29.0 | 135.8 | 12.3 | 67.3 | 65.8 | 40.6 | |||||||||||||||||||||||||||||
Supplemental | 1.9 | (29.6) | 2.7 | 11.3 | 14.1 | 9.9 | |||||||||||||||||||||||||||||
Total Sales | £ | 30.9 | 106.0 | £ | 15.0 | £ | 78.6 | 55.6 | £ | 50.5 | |||||||||||||||||||||||||
N.M. = not a meaningful percentage |
(in millions of dollars, except ratios) | |||||||||||||||||||||||||||||||||||
Three Months Ended September 30 | Nine Months Ended September 30 | ||||||||||||||||||||||||||||||||||
2022 | % Change | 2021 | 2022 | % Change | 2021 | ||||||||||||||||||||||||||||||
Adjusted Operating Revenue | |||||||||||||||||||||||||||||||||||
Premium Income | |||||||||||||||||||||||||||||||||||
Accident, Sickness, and Disability | $ | 236.1 | (0.8) | % | $ | 238.0 | $ | 714.0 | (0.2) | % | $ | 715.1 | |||||||||||||||||||||||
Life | 100.2 | 5.9 | 94.6 | 303.2 | 5.5 | 287.3 | |||||||||||||||||||||||||||||
Cancer and Critical Illness | 87.0 | (1.4) | 88.2 | 264.4 | — | 264.5 | |||||||||||||||||||||||||||||
Total Premium Income | 423.3 | 0.6 | 420.8 | 1,281.6 | 1.2 | 1,266.9 | |||||||||||||||||||||||||||||
Net Investment Income | 38.6 | (25.5) | 51.8 | 115.4 | (12.0) | 131.1 | |||||||||||||||||||||||||||||
Other Income | 0.3 | — | 0.3 | 0.8 | — | 0.8 | |||||||||||||||||||||||||||||
Total | 462.2 | (2.3) | 472.9 | 1,397.8 | (0.1) | 1,398.8 | |||||||||||||||||||||||||||||
Benefits and Expenses | |||||||||||||||||||||||||||||||||||
Benefits and Change in Reserves for Future Benefits | 198.0 | (15.8) | 235.2 | 613.8 | (10.8) | 688.2 | |||||||||||||||||||||||||||||
Commissions | 86.0 | 6.8 | 80.5 | 258.0 | 8.9 | 236.9 | |||||||||||||||||||||||||||||
Deferral of Acquisition Costs | (70.3) | 9.5 | (64.2) | (210.4) | 13.2 | (185.9) | |||||||||||||||||||||||||||||
Amortization of Deferred Acquisition Costs | 74.3 | 13.8 | 65.3 | 215.7 | 12.9 | 191.0 | |||||||||||||||||||||||||||||
Other Expenses | 83.8 | 10.3 | 76.0 | 239.1 | 9.0 | 219.4 | |||||||||||||||||||||||||||||
Total | 371.8 | (5.3) | 392.8 | 1,116.2 | (2.9) | 1,149.6 | |||||||||||||||||||||||||||||
Adjusted Operating Income | $ | 90.4 | 12.9 | $ | 80.1 | $ | 281.6 | 13.0 | $ | 249.2 | |||||||||||||||||||||||||
Operating Ratios (% of Premium Income): | |||||||||||||||||||||||||||||||||||
Benefit Ratio | 46.8 | % | 55.9 | % | 47.9 | % | 54.3 | % | |||||||||||||||||||||||||||
Other Expense Ratio | 19.8 | % | 18.1 | % | 18.7 | % | 17.3 | % | |||||||||||||||||||||||||||
Adjusted Operating Income Ratio | 21.4 | % | 19.0 | % | 22.0 | % | 19.7 | % | |||||||||||||||||||||||||||
Persistency: | |||||||||||||||||||||||||||||||||||
Accident, Sickness, and Disability | 73.8 | % | 75.6 | % | |||||||||||||||||||||||||||||||
Life | 85.1 | % | 84.9 | % | |||||||||||||||||||||||||||||||
Cancer and Critical Illness | 82.3 | % | 82.1 | % | |||||||||||||||||||||||||||||||
(in millions of dollars) | |||||||||||||||||||||||||||||||||||
Three Months Ended September 30 | Nine Months Ended September 30 | ||||||||||||||||||||||||||||||||||
2022 | % Change | 2021 | 2022 | % Change | 2021 | ||||||||||||||||||||||||||||||
Sales by Product | |||||||||||||||||||||||||||||||||||
Accident, Sickness, and Disability | $ | 71.4 | 2.3 | % | $ | 69.8 | $ | 210.0 | 6.9 | % | $ | 196.4 | |||||||||||||||||||||||
Life | 27.9 | 5.7 | 26.4 | 80.4 | 9.8 | 73.2 | |||||||||||||||||||||||||||||
Cancer and Critical Illness | 16.6 | 3.1 | 16.1 | 47.7 | 8.4 | 44.0 | |||||||||||||||||||||||||||||
Total Sales | $ | 115.9 | 3.2 | $ | 112.3 | $ | 338.1 | 7.8 | $ | 313.6 | |||||||||||||||||||||||||
Sales by Market Sector | |||||||||||||||||||||||||||||||||||
Commercial | |||||||||||||||||||||||||||||||||||
Core Market (< 1,000 employees) | $ | 73.4 | 1.5 | % | $ | 72.3 | $ | 225.4 | 8.8 | % | $ | 207.2 | |||||||||||||||||||||||
Large Case Market | 10.7 | (25.2) | 14.3 | 36.3 | (16.4) | 43.4 | |||||||||||||||||||||||||||||
Subtotal | 84.1 | (2.9) | 86.6 | 261.7 | 4.4 | 250.6 | |||||||||||||||||||||||||||||
Public Sector | 31.8 | 23.7 | 25.7 | 76.4 | 21.3 | 63.0 | |||||||||||||||||||||||||||||
Total Sales | $ | 115.9 | 3.2 | $ | 112.3 | $ | 338.1 | 7.8 | $ | 313.6 | |||||||||||||||||||||||||
(in millions of dollars, except ratios) | |||||||||||||||||||||||||||||||||||
Three Months Ended September 30 | Nine Months Ended September 30 | ||||||||||||||||||||||||||||||||||
2022 | % Change | 2021 | 2022 | % Change | 2021 | ||||||||||||||||||||||||||||||
Adjusted Operating Revenue | |||||||||||||||||||||||||||||||||||
Premium Income | |||||||||||||||||||||||||||||||||||
Long-term Care | $ | 174.5 | (0.9) | % | $ | 176.1 | $ | 523.0 | (1.0) | % | $ | 528.4 | |||||||||||||||||||||||
Individual Disability | 59.5 | (17.7) | 72.3 | 185.3 | (14.5) | 216.8 | |||||||||||||||||||||||||||||
All Other | 1.5 | (28.6) | 2.1 | 5.1 | (16.4) | 6.1 | |||||||||||||||||||||||||||||
Total Premium Income | 235.5 | (6.0) | 250.5 | 713.4 | (5.0) | 751.3 | |||||||||||||||||||||||||||||
Net Investment Income | 251.4 | (11.7) | 284.6 | 817.7 | (6.7) | 876.5 | |||||||||||||||||||||||||||||
Other Income | 13.1 | (32.1) | 19.3 | 45.6 | (8.4) | 49.8 | |||||||||||||||||||||||||||||
Total | 500.0 | (9.8) | 554.4 | 1,576.7 | (6.0) | 1,677.6 | |||||||||||||||||||||||||||||
Benefits and Expenses | |||||||||||||||||||||||||||||||||||
Benefits and Change in Reserves for Future Benefits | 416.1 | (3.0) | 428.9 | 1,222.3 | (11.4) | 1,378.8 | |||||||||||||||||||||||||||||
Commissions | 19.2 | (5.9) | 20.4 | 57.6 | (6.0) | 61.3 | |||||||||||||||||||||||||||||
Other Expenses | 45.8 | (5.8) | 48.6 | 137.8 | (9.2) | 151.8 | |||||||||||||||||||||||||||||
Total | 481.1 | (3.4) | 497.9 | 1,417.7 | (10.9) | 1,591.9 | |||||||||||||||||||||||||||||
Income Before Income Tax and Net Investment Gains and Losses | 18.9 | (66.5) | 56.5 | 159.0 | 85.5 | 85.7 | |||||||||||||||||||||||||||||
Long-term Care Reserve Increase | — | N.M. | 2.1 | — | N.M. | 2.1 | |||||||||||||||||||||||||||||
Individual Disability Reserve Increase | — | N.M. | 6.4 | — | N.M. | 6.4 | |||||||||||||||||||||||||||||
Group Pension Reserve Increase | — | N.M. | 25.1 | — | N.M. | 25.1 | |||||||||||||||||||||||||||||
Impacts from Closed Block Individual Disability Reinsurance Transaction | — | — | — | — | N.M. | 139.3 | |||||||||||||||||||||||||||||
Amortization of the Cost of Reinsurance | 15.2 | (22.8) | 19.7 | 48.5 | (18.4) | 59.4 | |||||||||||||||||||||||||||||
Adjusted Operating Income | $ | 34.1 | (68.9) | $ | 109.8 | $ | 207.5 | (34.7) | $ | 318.0 | |||||||||||||||||||||||||
Interest Adjusted Loss Ratios: | |||||||||||||||||||||||||||||||||||
Long-term Care1 | 85.7 | % | 74.8 | % | 80.6 | % | 75.7 | % | |||||||||||||||||||||||||||
Individual Disability2 | 77.5 | % | 58.2 | % | 78.6 | % | 65.6 | % | |||||||||||||||||||||||||||
Operating Ratios (% of Premium Income): | |||||||||||||||||||||||||||||||||||
Other Expense Ratio3 | 13.0 | % | 11.5 | % | 12.5 | % | 11.5 | % | |||||||||||||||||||||||||||
Income Ratio | 8.0 | % | 22.6 | % | 22.3 | % | 11.4 | % | |||||||||||||||||||||||||||
Adjusted Operating Income Ratio | 14.5 | % | 43.8 | % | 29.1 | % | 42.3 | % | |||||||||||||||||||||||||||
Persistency: | |||||||||||||||||||||||||||||||||||
Long-term Care | 95.4 | % | 95.5 | % | |||||||||||||||||||||||||||||||
Individual Disability | 86.4 | % | 86.5 | % | |||||||||||||||||||||||||||||||
1Excludes the $2.1 million reserve increase from the third quarter and first nine months of 2021 related to the assumption update that occurred during the third quarter of 2021. | |||||||||||||||||||||||||||||||||||
2Excludes the $133.1 million reserve recognition from the first nine months of 2021 related to the second phase of the reinsurance transaction that occurred during the first quarter of 2021. Also excludes the $6.4 million reserve increase from the third quarter and first nine months of 2021 related to the assumption update that occurred during the third quarter of 2021. | |||||||||||||||||||||||||||||||||||
3Excludes amortization of the cost of reinsurance from the third quarter and first nine months of 2022 and 2021. Also excludes $6.2 million of transaction costs from the first nine months of 2021 related to the reinsurance transaction that occurred during the first quarter of 2021. | |||||||||||||||||||||||||||||||||||
N.M. = not a meaningful percentage |
(in millions of dollars) | |||||||||||||||||||||||||||||||||||
Three Months Ended September 30 | Nine Months Ended September 30 | ||||||||||||||||||||||||||||||||||
2022 | % Change | 2021 | 2022 | % Change | 2021 | ||||||||||||||||||||||||||||||
Adjusted Operating Revenue | |||||||||||||||||||||||||||||||||||
Net Investment Income | $ | 14.0 | N.M. | $ | 4.5 | $ | 33.0 | 61.0 | % | $ | 20.5 | ||||||||||||||||||||||||
Other Income | 0.4 | (83.3) | 2.4 | 3.6 | (12.2) | 4.1 | |||||||||||||||||||||||||||||
Total | 14.4 | 108.7 | 6.9 | 36.6 | 48.8 | 24.6 | |||||||||||||||||||||||||||||
Interest, Debt, and Other Expenses | 63.9 | (0.8) | 64.4 | 163.4 | (34.8) | 250.7 | |||||||||||||||||||||||||||||
Loss Before Income Tax and Net Investment Gains and Losses | (49.5) | 13.9 | (57.5) | (126.8) | 43.9 | (226.1) | |||||||||||||||||||||||||||||
Impairment Loss on Internal-Use Software | — | N.M. | 12.1 | — | N.M. | 12.1 | |||||||||||||||||||||||||||||
Cost Related to Early Retirement of Debt | — | — | — | — | N.M. | 67.3 | |||||||||||||||||||||||||||||
Impairment Loss on ROU Asset | — | — | — | — | N.M. | 13.9 | |||||||||||||||||||||||||||||
Adjusted Operating Loss | $ | (49.5) | (9.0) | $ | (45.4) | $ | (126.8) | 4.5 | $ | (132.8) | |||||||||||||||||||||||||
N.M. = not a meaningful percentage |
(in millions of dollars) | ||||||||||||||||||||||||||||||||||||||
Classification | Fair Value | Net Unrealized Gain (Loss) | Fair Value with Gross Unrealized Loss | Gross Unrealized Loss | Fair Value with Gross Unrealized Gain | Gross Unrealized Gain | ||||||||||||||||||||||||||||||||
Basic Industry | $ | 2,528.8 | $ | (267.4) | $ | 2,030.1 | $ | 294.3 | $ | 498.7 | $ | 26.9 | ||||||||||||||||||||||||||
Capital Goods | 3,192.3 | (296.2) | 2,306.7 | 356.3 | 885.6 | 60.1 | ||||||||||||||||||||||||||||||||
Communications | 2,134.2 | (193.6) | 1,452.3 | 262.2 | 681.9 | 68.6 | ||||||||||||||||||||||||||||||||
Consumer Cyclical | 1,350.3 | (148.1) | 1,093.9 | 164.5 | 256.4 | 16.4 | ||||||||||||||||||||||||||||||||
Consumer Non-Cyclical | 5,448.3 | (590.1) | 3,953.3 | 683.1 | 1,495.0 | 93.0 | ||||||||||||||||||||||||||||||||
Energy | 2,736.3 | (131.2) | 1,583.0 | 194.2 | 1,153.3 | 63.0 | ||||||||||||||||||||||||||||||||
Financial Institutions | 3,305.3 | (527.4) | 3,013.4 | 541.3 | 291.9 | 13.9 | ||||||||||||||||||||||||||||||||
Mortgage/Asset-Backed | 530.3 | (24.7) | 399.6 | 32.1 | 130.7 | 7.4 | ||||||||||||||||||||||||||||||||
Sovereigns | 809.1 | (63.5) | 263.8 | 99.8 | 545.3 | 36.3 | ||||||||||||||||||||||||||||||||
Technology | 1,554.8 | (217.0) | 1,428.6 | 223.7 | 126.2 | 6.7 | ||||||||||||||||||||||||||||||||
Transportation | 1,545.8 | (198.2) | 1,233.4 | 214.2 | 312.4 | 16.0 | ||||||||||||||||||||||||||||||||
U.S. Government Agencies and Municipalities | 4,101.8 | (651.3) | 2,665.0 | 754.8 | 1,436.8 | 103.5 | ||||||||||||||||||||||||||||||||
Public Utilities | 4,910.9 | (259.9) | 2,744.6 | 386.6 | 2,166.3 | 126.7 | ||||||||||||||||||||||||||||||||
Total | $ | 34,148.2 | $ | (3,568.6) | $ | 24,167.7 | $ | 4,207.1 | $ | 9,980.5 | $ | 638.5 |
(in millions of dollars) | ||||||||||||||||||||||||||||||||
2022 | 2021 | |||||||||||||||||||||||||||||||
September 30 | June 30 | March 31 | December 31 | September 30 | ||||||||||||||||||||||||||||
Fair Value < 100% >= 70% of Amortized Cost | ||||||||||||||||||||||||||||||||
<= 90 days | $ | 523.7 | $ | 514.7 | $ | 491.6 | $ | 29.9 | $ | 42.8 | ||||||||||||||||||||||
> 90 <= 180 days | 879.0 | 1,177.1 | 199.5 | 29.4 | 0.2 | |||||||||||||||||||||||||||
> 180 <= 270 days | 945.4 | 268.9 | 109.1 | 0.7 | 26.3 | |||||||||||||||||||||||||||
> 270 days <= 1 year | 218.6 | 147.1 | 1.1 | 21.8 | 1.4 | |||||||||||||||||||||||||||
> 1 year <= 2 years | 195.0 | 66.5 | 67.2 | 5.1 | 3.9 | |||||||||||||||||||||||||||
> 2 years <= 3 years | 2.9 | 6.5 | 1.7 | — | — | |||||||||||||||||||||||||||
Sub-total | 2,764.6 | 2,180.8 | 870.2 | 86.9 | 74.6 | |||||||||||||||||||||||||||
Fair Value < 70% >= 40% of Amortized Cost | ||||||||||||||||||||||||||||||||
<= 90 days | — | 10.3 | — | — | — | |||||||||||||||||||||||||||
> 90 <= 180 days | 22.3 | 37.8 | 3.1 | — | — | |||||||||||||||||||||||||||
> 180 <= 270 days | 564.2 | 80.6 | 3.7 | — | — | |||||||||||||||||||||||||||
> 270 days <= 1 year | 427.4 | 39.4 | — | 1.5 | — | |||||||||||||||||||||||||||
> 1 year <= 2 years | 176.5 | 39.8 | 1.9 | — | — | |||||||||||||||||||||||||||
> 2 years <= 3 years | 18.5 | — | — | — | — | |||||||||||||||||||||||||||
Sub-total | 1,208.9 | 207.9 | 8.7 | 1.5 | — | |||||||||||||||||||||||||||
Total | $ | 3,973.5 | $ | 2,388.7 | $ | 878.9 | $ | 88.4 | $ | 74.6 |
(in millions of dollars) | ||||||||||||||||||||||||||||||||
2022 | 2021 | |||||||||||||||||||||||||||||||
September 30 | June 30 | March 31 | December 31 | September 30 | ||||||||||||||||||||||||||||
Fair Value < 100% >= 70% of Amortized Cost | ||||||||||||||||||||||||||||||||
<= 90 days | $ | 27.1 | $ | 73.4 | $ | 24.8 | $ | 0.8 | $ | 0.4 | ||||||||||||||||||||||
> 90 <= 180 days | 58.5 | 92.8 | 5.9 | 0.3 | — | |||||||||||||||||||||||||||
> 180 <= 270 days | 103.8 | 13.5 | 1.9 | — | 2.0 | |||||||||||||||||||||||||||
> 270 days <= 1 year | 15.2 | 3.3 | — | 2.2 | 2.1 | |||||||||||||||||||||||||||
> 1 year <= 2 years | 3.8 | 0.2 | 1.8 | 2.5 | 2.6 | |||||||||||||||||||||||||||
> 2 years <= 3 years | 0.7 | 1.4 | 3.7 | 0.3 | 0.2 | |||||||||||||||||||||||||||
> 3 years | 3.4 | 2.9 | 7.9 | 5.6 | 4.8 | |||||||||||||||||||||||||||
Sub-total | 212.5 | 187.5 | 46.0 | 11.7 | 12.1 | |||||||||||||||||||||||||||
Fair Value < 70% >= 40% of Amortized Cost | ||||||||||||||||||||||||||||||||
> 90 <= 180 days | — | 6.1 | — | — | — | |||||||||||||||||||||||||||
> 180 <= 270 days | 5.0 | 3.4 | — | — | — | |||||||||||||||||||||||||||
> 270 days <= 1 year | — | 1.4 | — | — | — | |||||||||||||||||||||||||||
> 2 years <= 3 years | 6.2 | 5.4 | — | — | — | |||||||||||||||||||||||||||
> 3 years | 9.9 | 9.1 | — | — | — | |||||||||||||||||||||||||||
Sub-total | 21.1 | 25.4 | — | — | — | |||||||||||||||||||||||||||
Total | $ | 233.6 | $ | 212.9 | $ | 46.0 | $ | 11.7 | $ | 12.1 |
Gross Unrealized Losses $10 Million or Greater on Investment-Grade Fixed Maturity Securities | |||||||||||||||||
As of September 30, 2022 | |||||||||||||||||
(in millions of dollars) | |||||||||||||||||
Classification | Fair Value | Gross Unrealized Loss | Numbers of Issuers | ||||||||||||||
Basic Industry | $ | 291.7 | $ | (69.6) | 5 | ||||||||||||
Capital Goods | 332.5 | (93.8) | 7 | ||||||||||||||
Communications | 409.7 | (104.4) | 7 | ||||||||||||||
Consumer Cyclical | 281.0 | (76.5) | 5 | ||||||||||||||
Consumer Non-Cyclical | 1,090.4 | (237.8) | 17 | ||||||||||||||
Energy | 213.0 | (43.6) | 3 | ||||||||||||||
Financial Institutions | 1,091.4 | (230.4) | 15 | ||||||||||||||
Mortgage/Asset-Backed | 363.6 | (31.5) | 1 | ||||||||||||||
Sovereigns | 239.5 | (84.9) | 2 | ||||||||||||||
Technology | 417.7 | (110.7) | 8 | ||||||||||||||
Transportation | 293.4 | (92.2) | 7 | ||||||||||||||
U.S. Government Agencies and Municipalities | 161.5 | (32.1) | 3 | ||||||||||||||
Public Utilities | 415.2 | (100.1) | 6 | ||||||||||||||
Total | $ | 5,600.6 | $ | (1,307.6) | 86 |
(in millions of dollars) | ||||||||||||||
Nine Months Ended September 30 | ||||||||||||||
2022 | 2021 | |||||||||||||
Net Cash Provided by Operating Activities | $ | 1,061.8 | $ | 907.4 | ||||||||||
Net Cash Used by Investing Activities | (691.2) | (905.8) | ||||||||||||
Net Cash Used by Financing Activities | (302.3) | (76.9) | ||||||||||||
Net Change in Cash and Bank Deposits | $ | 68.3 | $ | (75.3) |
AM Best | Fitch | Moody's | S&P | ||||||||||||||||||||
Issuer Credit Ratings | bbb | BBB- | Baa3 | BBB | |||||||||||||||||||
Financial Strength Ratings | |||||||||||||||||||||||
Provident Life and Accident Insurance Company | A | A- | A3 | A | |||||||||||||||||||
Provident Life and Casualty Insurance Company | A | A- | NR | NR | |||||||||||||||||||
Unum Life Insurance Company of America | A | A- | A3 | A | |||||||||||||||||||
First Unum Life Insurance Company | A | A- | A3 | A | |||||||||||||||||||
Colonial Life & Accident Insurance Company | A | A- | A3 | A | |||||||||||||||||||
The Paul Revere Life Insurance Company | A | A- | A3 | A | |||||||||||||||||||
Starmount Life Insurance Company | A | NR | NR | NR | |||||||||||||||||||
Unum Insurance Company | A | A- | A3 | NR | |||||||||||||||||||
Unum Limited | NR | NR | NR | A- | |||||||||||||||||||
Outlooks | |||||||||||||||||||||||
Issuer Credit Rating | Positive | Stable | Stable | Stable | |||||||||||||||||||
Financial Strength Rating | Stable | Stable | Stable | Stable |
(a) Total Number of Shares Purchased | (b) Average Price Paid per Share (1) | (c) Total Number of Shares Purchased as Part of Publicly Announced Program (2) | (d) Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program (2) | ||||||||||||||||||||
July 1 - July 31, 2022 | 330,042 | $ | 32.46 | 330,042 | $ | 94,344,567 | |||||||||||||||||
August 1 - August 31, 2022 | 451,793 | 37.35 | 451,793 | 77,469,976 | |||||||||||||||||||
September 1 - September 30, 2022 | 382,990 | 39.16 | 382,990 | 62,470,410 | |||||||||||||||||||
Total | 1,164,825 | 1,164,825 | |||||||||||||||||||||
Index to Exhibits | ||||||||
(31.1) | ||||||||
(31.2) | ||||||||
(32.1) | ||||||||
(32.2) | ||||||||
(101) | The instance document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document. | |||||||
(104) | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). | |||||||
Unum Group | ||||||||
(Registrant) | ||||||||
Date: November 2, 2022 | By: | /s/ Steven A. Zabel | ||||||
Steven A. Zabel | ||||||||
Executive Vice President, Chief Financial Officer | ||||||||
Date: November 2, 2022 | By: | /s/ Walter L. Rice, Jr. | ||||||
Walter L. Rice, Jr. | ||||||||
Senior Vice President, Chief Accounting Officer |
Date: November 2, 2022 | /s/ Richard P. McKenney | ||||
Richard P. McKenney | |||||
President and Chief Executive Officer |
Date: November 2, 2022 | /s/ Steven A. Zabel | ||||
Steven A. Zabel | |||||
Executive Vice President, Chief Financial Officer |
Date: November 2, 2022 | /s/ Richard P. McKenney | ||||
Richard P. McKenney | |||||
President and Chief Executive Officer |
Date: November 2, 2022 | /s/ Steven A. Zabel | ||||
Steven A. Zabel | |||||
Executive Vice President, Chief Financial Officer |
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Millions |
Sep. 30, 2022 |
Dec. 31, 2021 |
---|---|---|
Investments | ||
Amortized Cost of Fixed Maturity Securities | $ 37,721.4 | $ 37,386.7 |
Debt Securities, Available-for-sale, Allowance for credit losses for Fixed Maturity Securities | 4.6 | 0.0 |
Allowance for credit losses for Mortgage Loans | 8.7 | |
Other Assets | ||
Accounts and Premiums Receivable (net of allowance for credit losses of $31.4; $34.2) | 1,475.4 | 1,519.9 |
Reinsurance Recoverable, Allowance for Credit Loss | $ 2.3 | $ 2.3 |
Stockholders' Equity | ||
Common Stock, Par Value (in dollars per share) | $ 0.10 | $ 0.10 |
Common Stock, Shares Authorized | 725,000,000 | 725,000,000 |
Common Stock, Shares Issued | 308,189,371 | 307,334,853 |
Treasury Stock, Shares at Cost | 109,064,105 | 104,820,670 |
Premium Receivable, Allowance for Credit Loss | $ 31.4 | $ 34.2 |
CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
|
Revenue | ||||
Premium Income | $ 2,391.7 | $ 2,353.7 | $ 7,212.3 | $ 7,106.4 |
Net Investment Income | 511.6 | 550.2 | 1,597.8 | 1,662.4 |
Net Investment Gain (Loss) | (4.4) | (0.1) | (22.3) | 85.4 |
Other Income | 63.0 | 65.9 | 197.5 | 180.5 |
Total Revenue | 2,961.9 | 2,969.7 | 8,985.3 | 9,034.7 |
Benefits and Expenses | ||||
Benefits and Change in Reserves for Future Benefits | 1,579.3 | 1,753.9 | 5,181.3 | 5,659.2 |
Commissions | 271.5 | 258.3 | 819.1 | 777.9 |
Interest and Debt Expense | 47.0 | 44.7 | 141.3 | 134.4 |
Cost Related to Early Retirement of Debt | 4.2 | 0.0 | 4.2 | 67.3 |
Deferral of Acquisition Costs | (139.4) | (128.6) | (419.1) | (388.9) |
Amortization of Deferred Acquisition Costs | 150.8 | 138.4 | 449.5 | 440.8 |
Compensation Expense | 285.9 | 241.6 | 794.1 | 725.9 |
Other Expenses | 247.3 | 251.5 | 744.4 | 746.8 |
Total Benefits and Expenses | 2,446.6 | 2,559.8 | 7,714.8 | 8,163.4 |
Income Before Income Tax | 515.3 | 409.9 | 1,270.5 | 871.3 |
Income Tax | ||||
Current | 156.9 | 46.5 | 383.8 | 164.4 |
Deferred | (52.3) | 34.8 | (147.9) | 42.4 |
Total Income Tax | 104.6 | 81.3 | 235.9 | 206.8 |
Net Income | $ 410.7 | $ 328.6 | $ 1,034.6 | $ 664.5 |
Net Income Per Common Share | ||||
Basic | $ 2.05 | $ 1.61 | $ 5.14 | $ 3.25 |
Assuming Dilution | $ 2.04 | $ 1.60 | $ 5.11 | $ 3.24 |
STATEMENT OF COMPREHENSIVE INCOME (Parenthetical) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
|
Statement of Comprehensive Income [Abstract] | ||||
Change in Net Unrealized Gain on Securities Before Adjustment, Tax Expense (Benefit) | $ (520.8) | $ (69.0) | $ (2,017.2) | $ (276.3) |
Change in Adjustment to Deferred Acquisition Costs and Reserves for Future Policy and Contract Benefits, Net of Reinsurance, Tax Expense (Benefit) | 184.3 | 49.5 | 1,141.7 | 215.5 |
Change in Net Gain on Hedges, Tax Benefit | (8.1) | (2.2) | (12.6) | (7.6) |
Change in Foreign Currency Translation Adjustment, Tax Expense (Benefit) | (5.4) | (1.8) | (11.5) | (3.4) |
Change in Unrecognized Pension and Postretirement Benefit costs, Tax Expense | $ 1.1 | $ 1.8 | $ 4.0 | $ 4.2 |
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) - $ / shares |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
|
Statement of Stockholders' Equity [Abstract] | ||||
Common Stock, Dividends, Per Share, Cash Paid | $ 0.330 | $ 0.300 | $ 0.930 | $ 0.870 |
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Millions |
9 Months Ended | |
---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
|
Cash Flows from Operating Activities | ||
Net Income | $ 1,034.6 | $ 664.5 |
Adjustments to Reconcile Net Income to Net Cash Provided by Operating Activities | ||
Change in Receivables | 437.8 | 427.2 |
Change in Deferred Acquisition Costs | (30.4) | (51.9) |
Change in Insurance Reserves and Liabilities | (125.5) | 131.8 |
Change in Income Taxes | (21.6) | 205.0 |
Change in Other Accrued Liabilities | (135.0) | (64.2) |
Non-cash Components of Net Investment Income | (293.0) | (175.8) |
Net Investment (Gain) Loss | 22.3 | (85.4) |
Depreciation | 83.5 | 90.0 |
Cash Related to Reinsurance Agreement | 0.0 | 456.8 |
Amortization of the Cost of Reinsurance | 48.5 | 59.4 |
Other, Net | (20.2) | 59.8 |
Net Cash Provided by Operating Activities | 1,061.8 | 907.4 |
Cash Flows from Investing Activities | ||
Proceeds from Sale of Debt Securities, Available-for-sale | 453.4 | 322.3 |
Proceeds from Maturities of Fixed Maturity Securities | 1,125.6 | 1,976.6 |
Proceeds from Sales and Maturities of Other Investments | 306.4 | 273.8 |
Payments to Acquire Debt Securities, Available-for-sale | (2,380.5) | (3,123.5) |
Purchases of Other Investments | (342.7) | (389.3) |
Net Sales of Short-term Investments | 204.9 | 67.1 |
Net Increase in Payables for Collateral on Investments | 12.5 | 50.0 |
Net Purchases of Property and Equipment | (70.8) | (82.4) |
Other, Net | 0.0 | 0.4 |
Net Cash Used by Investing Activities | (691.2) | (905.8) |
Cash Flows from Financing Activities | ||
Issuance of Long-term Debt | 349.2 | 588.1 |
Long-term Debt Repayment | (364.0) | (500.0) |
Cost Related to Early Retirement of Debt | (3.6) | (62.8) |
Issuance of Common Stock | 2.7 | 2.3 |
Payments for Repurchase of Common Stock | 136.1 | 0.0 |
Dividends Paid to Stockholders | (188.4) | (178.0) |
Proceeds from Policyholder Account Deposits | 90.9 | 97.5 |
Payments for Policyholder Account Withdrawals | (55.6) | (62.7) |
Cash Received Related to Active Life Volatility Cover Agreement | 5.2 | 40.4 |
Other, Net | (2.6) | (1.7) |
Net Cash Used by Financing Activities | (302.3) | (76.9) |
Net Increase (Decrease) in Cash and Bank Deposits | 68.3 | (75.3) |
Cash and Bank Deposits at Beginning of Year | 75.0 | 197.0 |
Cash and Bank Deposits at End of Period | $ 143.3 | $ 121.7 |
Basis of Presentation |
9 Months Ended |
---|---|
Sep. 30, 2022 | |
Accounting policies and error corrections [Abstract] | |
Basis of Presentation | The accompanying consolidated financial statements of Unum Group and its subsidiaries (the Company) have been prepared in accordance with U.S. generally accepted accounting principles (GAAP) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. For further information, refer to the consolidated financial statements and footnotes included in our annual report on Form 10-K for the year ended December 31, 2021. In 2021, we changed the presentation of policyholder account deposits and withdrawals related to our universal life products to present the activity on a gross basis within the financing activities section of the Consolidated Statements of Cash Flows. As a result of this change, we determined that certain historical adjustments related to the cost of insurance, policy administration expenses and surrender charges for these products were incorrectly presented as a component of net cash used by financing activities rather than as a component of net cash provided by operating activities. We determined that the impact of the error to the previously issued Consolidated Statements of Cash Flows was not material and we have corrected the error. The impact of this correction for the nine months ended September 30, 2021 was a decrease to the change in insurance reserves and liabilities within net cash used by operating activities of $91.9 million, with a corresponding decrease to net cash used by financing activities. Within net cash used by financing activities, the other, net line item was adjusted as a result of the error correction to separately present proceeds from policyholder account deposits and payments for policyholder account withdrawals. The error had no impact on our financial position or our results of operations. In our opinion, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Interim results are not necessarily indicative of full year performance, particularly when considering the risks and uncertainties associated with the coronavirus disease 2019 (COVID-19) and the impacts it may have on our financial position, results of operations, liquidity and capital resources, and overall business operations.
|
Accounting Developments |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounting Developments and New Accounting Policies [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounting Developments | Accounting Updates Adopted in 2022:
Accounting Updates Outstanding: ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting and related amendment The amendment in this update provide optional guidance, for a limited period of time, to ease the potential burden in accounting for and recognizing the effects of reference rate reform on financial reporting. The guidance allows for various practical expedients and exceptions when applying GAAP to contracts, hedging relationships, and other transactions affected either by discontinued rates as a direct result of reference rate reform or a market-wide change in interest rates used for discounting, margining or contract price alignment, if certain criteria are met. Specifically, the guidance provides certain practical expedients for contract modifications, fair value hedges, and cash flow hedges, and also provides certain exceptions related to changes in the critical terms of a hedging relationship. The guidance also allows for a one-time election to sell or transfer debt securities that were both classified as held-to-maturity prior to January 1, 2020 and reference a rate affected by the reform. The adoption of this update is permitted as of the beginning of the interim period that includes March 12, 2020 (the issuance date of the update), or any date thereafter, through December 31, 2022, at which point the guidance will sunset. We do not anticipate needing to adopt this guidance, but we will continue to monitor our contracts and hedging relationships throughout the adoption period. ASU 2018-12, Financial Services—Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts and related amendments This update significantly amends the accounting and disclosure requirements for long-duration insurance contracts. These changes include a requirement to review, and if necessary, update cash flow assumptions used to measure the liability for future policy benefits for traditional and limited-payment contracts at least annually, with changes recognized in earnings. In addition, an entity will be required to update the discount rate assumption at each reporting date using a yield that is reflective of an upper-medium grade fixed-income instrument, with changes recognized in other comprehensive income (loss) (OCI). These changes result in the elimination of the provision for risk of adverse deviation and premium deficiency (or loss recognition) testing. The update also requires that an entity measure all market risk benefits associated with deposit contracts at fair value, with changes recognized in earnings except for the portion attributable to a change in the instrument-specific credit risk, which is to be recognized in OCI. This update also simplifies the amortization of deferred acquisition costs by requiring amortization on a constant level basis over the expected term of the related contracts. Deferred acquisition costs are required to be written off for unexpected contract terminations but are no longer subject to an impairment test. Significant additional disclosures will also be required, which include disaggregated rollforwards of certain liability balances and the disclosure of qualitative and quantitative information about expected cash flows, estimates, and assumptions. The application of this guidance will vary based upon the specific requirements of the update but will generally result in either a modified retrospective or full retrospective approach with changes applied as of the beginning of the earliest period presented. Early adoption is permitted. The update is effective for periods beginning January 1, 2023. We will adopt this update effective January 1, 2023 using the modified retrospective approach with changes applied as of the beginning of the earliest period presented or January 1, 2021, also referred to as the transition date. We are continuing to evaluate the effects of implementing this update. We expect that the most significant impact at the transition date will be the requirement to update the discount rate assumption to reflect an upper-medium grade fixed-income instrument, which will be generally equivalent to a single-A interest rate matched to the duration of our insurance liabilities and will result in a decrease to accumulated other comprehensive income (loss) (AOCI) within our total stockholders’ equity balance of approximately $6.5 billion to $7 billion. After the transition date, we will be required to update the discount rate each subsequent reporting period with changes recorded in OCI and expect that this could have a material impact on OCI. We expect that the recast of our net income for 2021 will result in a net favorable impact due primarily to the following changes: •Updating the lifetime cohort net premium ratios (lifetime loss ratio) for actual experience each reporting period will generally cause earnings patterns to be more consistent from period to period, with variances in experience reflected in earnings over the cohort lifetime. We expect this to result in an unfavorable impact to income for 2021. •Alignment of amortization of deferred acquisition costs to a constant level basis and modification of amortization periods to reflect the expected term of the related contracts could result in either higher or lower income for the affected product lines. We expect this to result in a net favorable impact to income for 2021. •Accelerated recognition of the provision for adverse deviation or other differences from current best estimate values for policies issued prior to the transition date and due to not establishing the provision for policies issued on or after the transition date will generally result in higher income most notably in the initial years after the transition date. We expect this to result in a favorable impact to income for 2021. •Establishing reserves for claims incurred on or after the transition date at interest rates prescribed by the update could result in either higher or lower income for the affected product lines depending on the policy issue date and the interest rate environment at that time. We expect this to result in an unfavorable impact to income for 2021. •Updating cash flow assumptions. We expect this to result in a favorable impact to income for 2021. •Applying non-contemporaneous reinsurance accounting to the second phase of our Closed Block individual disability reinsurance transaction which was completed in the first quarter of 2021. The primary impacts of this change are. ◦Reversing the increase in benefits and change in reserves for future benefits resulting from the realization of previously unrealized investment gains and losses previously recorded in AOCI that will be removed as of the transition date which will have a favorable impact on income for 2021. ◦Remeasuring the ceded reserves as a separate cohort of reserves at interest rates prescribed by the update and the resulting change to the cost of reinsurance. We expect the differential in the discount rate applied to the direct and ceded cohorts of business will result in an unfavorable impact to income for 2021 partially offset by a decrease in the amortization of the cost of reinsurance as a result of a lower cost of reinsurance. This update will also significantly expand our disclosures. We do not have products with market risk benefits. ASU 2022-02, Financial Instruments—Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures The amendments in this update eliminate the troubled debt restructuring recognition and measurement guidance and instead require that an entity evaluate whether the modification represents a new loan or the continuation of an existing loan. The amendments also enhance the disclosure requirements related to certain modifications of receivables made to borrowers experiencing financial difficulty. In addition, the amendments in this update require that an entity disclose current-period gross write-offs by year of origination for financing receivables and net investment in leases. The amendments in this update should be applied prospectively, except for the transition method related to the recognition and measurement of troubled debt restructurings, for which an entity has the option to apply a modified retrospective transition method, resulting in a cumulative-effect adjustment to retained earnings in the period of adoption. This update is effective for periods beginning January 1, 2023, and we do not anticipate that the adoption of this update will have an effect on our financial position or results of operations but will expand our disclosures.
|
Fair Values of Financial Instruments |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Values of Financial Instruments | Fair Value Measurements for Financial Instruments Carried at Fair Value We report fixed maturity securities, which are classified as available-for-sale securities, derivative financial instruments, and unrestricted equity securities at fair value in our consolidated balance sheets. We report our investments in private equity partnerships at our share of the partnerships' net asset value or its equivalent (NAV) as a practical expedient for fair value. The degree of judgment utilized in measuring the fair value of financial instruments generally correlates to the level of pricing observability. Financial instruments with readily available active quoted prices or for which fair value can be measured from actively quoted prices in active markets generally have more pricing observability and less judgment utilized in measuring fair value. An active market for a financial instrument is a market in which transactions for an asset or a similar asset occur with sufficient frequency and volume to provide pricing information on an ongoing basis. A quoted price in an active market provides the most reliable evidence of fair value and should be used to measure fair value whenever available. Conversely, financial instruments rarely traded or not quoted have less observability and are measured at fair value using valuation techniques that require more judgment. Pricing observability is generally impacted by a number of factors, including the type of financial instrument, whether the financial instrument is new to the market and not yet established, the characteristics specific to the transaction, and overall market conditions. We classify financial instruments in accordance with a fair value hierarchy consisting of three levels based on the observability of valuation inputs: •Level 1 - the highest category of the fair value hierarchy classification wherein inputs are unadjusted and represent quoted prices in active markets for identical assets or liabilities at the measurement date. •Level 2 - valued using inputs (other than prices included in Level 1) that are either directly or indirectly observable for the asset or liability through correlation with market data at the measurement date and for the duration of the instrument's anticipated life. •Level 3 - the lowest category of the fair value hierarchy and reflects the judgment of management regarding what market participants would use in pricing assets or liabilities at the measurement date. Financial assets and liabilities categorized as Level 3 are generally those that are valued using unobservable inputs to extrapolate an estimated fair value. Valuation Methodologies of Financial Instruments Measured at Fair Value Valuation techniques used for assets and liabilities accounted for at fair value are generally categorized into three types. The market approach uses prices and other relevant information from market transactions involving identical or comparable assets or liabilities. The income approach converts future amounts, such as cash flows or earnings, to a single present amount, or a discounted amount. The cost approach is based upon the amount that currently would be required to replace the service capacity of an asset, or the current replacement cost. We use valuation techniques that are appropriate in the circumstances and for which sufficient data are available that can be obtained without undue cost and effort. In some cases, a single valuation technique will be appropriate (for example, when valuing an asset or liability using quoted prices in an active market for identical assets or liabilities). In other cases, multiple valuation techniques will be appropriate. If we use multiple valuation techniques to measure fair value, we evaluate and weigh the results, as appropriate, considering the reasonableness of the range indicated by those results. A fair value measurement is the point within that range that is most representative of fair value in the circumstances. The selection of the valuation method(s) to apply considers the definition of an exit price and depends on the nature of the asset or liability being valued. For assets and liabilities accounted for at fair value, we generally use valuation techniques consistent with the market approach, and to a lesser extent, the income approach. We believe the market approach provides more observable data than the income approach, considering the type of investments we hold. Our fair value measurements could differ significantly based on the valuation technique and available inputs. When using a pricing service, we obtain the vendor's pricing documentation to ensure we understand their methodologies. We periodically review and approve the selection of our pricing vendors to ensure we are in agreement with their current methodologies. When markets are less active, brokers may rely more on models with inputs based on the information available only to the broker. Our internal investment management professionals, which include portfolio managers and analysts, monitor securities priced by brokers and evaluate their prices for reasonableness based on benchmarking to available primary and secondary market information. In weighing a broker quote as an input to fair value, we place less reliance on quotes that do not reflect the result of market transactions. We also consider the nature of the quote, particularly whether it is a bid or market quote. If prices in an inactive market do not reflect current prices for the same or similar assets, adjustments may be necessary to arrive at fair value. When relevant market data is unavailable, which may be the case during periods of market uncertainty, the income approach can, in suitable circumstances, provide a more appropriate fair value. During 2022, we have applied valuation approaches and techniques on a consistent basis to similar assets and liabilities and consistent with those approaches and techniques used at year end 2021. Fixed Maturity and Equity Securities We use observable and unobservable inputs in measuring the fair value of our fixed maturity and equity securities. For securities categorized as Level 1, fair values equal active Trade Reporting and Compliance Engine (TRACE) pricing or unadjusted market maker prices. For securities categorized as Level 2 or Level 3, inputs that may be used in valuing each class of securities at any given time period are disclosed below. Actual inputs used to determine fair values will vary for each reporting period depending on the availability of inputs which may, at times, be affected by the lack of market liquidity.
The management of our investment portfolio includes establishing pricing policy and reviewing the reasonableness of sources and inputs used in developing pricing. We review all prices that vary between multiple pricing vendors by a threshold that is outside a normal market range for the asset type. In the event we receive a vendor's market price that does not appear reasonable based on our market analysis, we may challenge the price and request further information about the assumptions and methodologies used by the vendor to price the security. We may change the vendor price based on a better data source such as an actual trade. We also review all prices that did not change from the prior month to ensure that these prices are within our expectations. The overall valuation process for determining fair values may include adjustments to valuations obtained from our pricing sources when they do not represent a valid exit price. These adjustments may be made when, in our judgment and considering our knowledge of the financial conditions and industry in which the issuer operates, certain features of the financial instrument require that an adjustment be made to the value originally obtained from our pricing sources. These features may include the complexity of the financial instrument, the market in which the financial instrument is traded, counterparty credit risk, credit structure, concentration, or liquidity. Additionally, an adjustment to the price derived from a model typically reflects our judgment of the inputs that other participants in the market for the financial instrument being measured at fair value would consider in pricing that same financial instrument. In the event an asset is sold, we test the validity of the fair value determined by our valuation techniques by comparing the selling price to the fair value determined for the asset in the immediately preceding month end reporting period. Certain of our investments do not have readily determinable market prices and/or observable inputs or may at times be affected by the lack of market liquidity. For these securities, we use internally prepared valuations, including valuations based on estimates of future profitability, to estimate the fair value. Additionally, we may obtain prices from independent third-party brokers to aid in establishing valuations for certain of these securities. Key assumptions used by us to determine fair value for these securities include risk free interest rates, risk premiums, performance of underlying collateral (if any), and other factors involving significant assumptions which may or may not reflect those of an active market. The parameters and inputs used to validate a price on a security may be adjusted for assumptions about risk and current market conditions on a quarter to quarter basis, as certain features may be more significant drivers of valuation at the time of pricing. Changes to inputs in valuations are not changes to valuation methodologies; rather, the inputs are modified to reflect direct or indirect impacts on asset classes from changes in market conditions. At September 30, 2022, approximately 26.6 percent of our fixed maturity securities were valued using active trades from TRACE pricing or market maker prices for which there was current market activity in that specific security (comparable to receiving one binding quote). The prices obtained were not adjusted, and the assets were classified as Level 1. The remaining 73.4 percent of our fixed maturity securities were valued based on non-binding quotes or other observable and unobservable inputs, as discussed below: •57.0 percent of our fixed maturity securities were valued based on prices from pricing services that generally use observable inputs such as prices for securities or comparable securities in active markets in their valuation techniques. These assets were classified as Level 2. •15.2 percent of our fixed maturity securities were valued based on one or more non-binding broker quotes, if validated by observable market data. When only one price is available, it is used if observable inputs and analysis confirms that it is appropriate. These assets, for which we were able to validate the price using other observable market data, were classified as Level 2. •1.2 percent of our fixed maturity securities were valued based on prices of comparable securities, internal models, or pricing services or other non-binding quotes with no other observable market data. These assets were classified as either Level 2 or Level 3, with the categorization dependent on whether there was other observable market data. Derivatives Fair values for derivatives other than embedded derivatives in modified coinsurance arrangements are based on market quotes or pricing models and represent the net amount of cash we would have paid or received if the contracts had been settled or closed as of the last day of the period. Credit risk related to the counterparty and the Company is considered in determining the fair values of these derivatives. However, since we have collateralization agreements in place with each counterparty which limits our exposure, any credit risk is immaterial. Therefore, we determined that no adjustments for credit risk were required as of September 30, 2022 or December 31, 2021. Fair values for our embedded derivative in a modified coinsurance arrangement are estimated using internal pricing models and represent the hypothetical value of the duration mismatch of assets and liabilities, interest rate risk, and third party credit risk embedded in the modified coinsurance arrangement. We consider transactions in inactive markets to be less representative of fair value. We use all available observable inputs when measuring fair value, but when significant unobservable inputs are used, we classify these assets or liabilities as Level 3. Private Equity Partnerships Our private equity partnerships represent funds that are primarily invested in private credit, private equity, and real assets, as described below. Distributions received from the funds arise from income generated by the underlying investments as well as the liquidation of the underlying investments. There is generally not a public market for these investments. The following tables present additional information about our private equity partnerships, including commitments for additional investments which may or may not be funded:
(a)Private Credit - The limited partnerships described in this category employ various investment strategies, generally providing direct lending or other forms of debt financing including first-lien, second-lien, mezzanine, and subordinated loans. The limited partnerships have credit exposure to corporates, physical assets, and/or financial assets within a variety of industries (including manufacturing, healthcare, energy, business services, technology, materials, and retail) in North America and, to a lesser extent, outside of North America. As of September 30, 2022, the estimated remaining life of the investments that do not allow for redemptions is approximately 57 percent in the next 3 years, 33 percent during the period from 3 to 5 years, 8 percent during the period from 5 to 10 years, and 2 percent during the period from 10 to 15 years. (b)Private Equity - The limited partnerships described in this category employ various strategies generally investing in controlling or minority control equity positions directly in companies and/or assets across various industries (including manufacturing, healthcare, energy, business services, technology, materials, and retail), primarily in private markets within North America and, to a lesser extent, outside of North America. As of September 30, 2022, the estimated remaining life of the investments that do not allow for redemptions is approximately 39 percent in the next 3 years, 17 percent during the period from 3 to 5 years, 42 percent during the period from 5 to 10 years, and 2 percent during the period from 10 to 15 years. (c)Real Assets - The limited partnerships described in this category employ various strategies, which include investing in the equity and/or debt financing of physical assets, including infrastructure (energy, power, water/wastewater, communications), transportation (including airports, ports, toll roads, aircraft, railcars) and real estate in North America, Europe, South America, and Asia. As of September 30, 2022, the estimated remaining life of the investments that do not allow for redemptions is approximately 24 percent in the next 3 years, 30 percent during period from 3 to 5 years, and 46 percent during the period from 5 to 10 years. We record changes in our share of net asset value of the partnerships in net investment income. We receive financial information related to our investments in partnerships and generally record investment income on a one-quarter lag in accordance with our accounting policy. The following tables present information about financial instruments measured at fair value on a recurring basis by fair value level, based on the observability of the inputs used.
Changes in assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) are as follows:
Realized and unrealized investment gains and losses presented in the preceding tables represent gains and losses only for the time during which the applicable financial instruments were classified as Level 3. The transfers between levels resulted primarily from a change in observability of three inputs used to determine fair values of the securities transferred: (1) transactional data for new issuance and secondary trades, (2) broker/dealer quotes and pricing, primarily related to changes in the level of activity in the market and whether the market was considered orderly, and (3) comparable bond metrics from which to perform an analysis. For fair value measurements of financial instruments that were transferred either into or out of Level 3, we reflect the transfers using the fair value at the beginning of the period. We believe this allows for greater transparency, as all changes in fair value that arise during the reporting period of the transfer are disclosed as a component of our Level 3 reconciliation. The table below provides quantitative information regarding the significant unobservable inputs used in Level 3 fair value measurements derived from internal models. Unobservable inputs for fixed maturity securities are weighted by the fair value of the securities. Certain securities classified as Level 3 are excluded from the table below due to limitations in our ability to obtain the underlying inputs used by external pricing sources.
(a)Represents a decision to price based on discounted expected future cash flows (b)Represents a decision to price based on comparable underlying assets (c)Represents basis point adjustments to apply a discount due to the illiquidity of an investment (d)Represents basis point adjustments for credit-specific factors (e)Represents a decision to price based on par value, cost, owner's equity, or the price of the most recent capital funding round when limited data is available (f)Represents various actuarial assumptions required to derive the liability cash flows. Fair value of embedded derivative is most often driven by the change in the weighted average credit spread to the swap curve for the assets backing the hypothetical loan Other than market convention, the impact of isolated decreases in unobservable inputs will result in a higher estimated fair value, whereas isolated increases in unobservable inputs will result in a lower estimated fair value. The unobservable input for market convention is not sensitive to input movements. The projected liability cash flows used in the fair value measurement of our Level 3 embedded derivative are based on expected claim payments. If claim payments increase, the projected liability cash flows will increase, resulting in a decrease in the fair value of the embedded derivative. Decreases in projected liability cash flows will result in an increase in the fair value of the embedded derivative. Fair Value Measurements for Financial Instruments Not Carried at Fair Value The methods and assumptions used to estimate fair values of financial instruments not carried at fair value are discussed as follows: Mortgage Loans: Fair value of newly originated, seasoned performing, or sub-performing but likely to continue cash flowing loans are calculated using a discounted cash flow analysis. Loans’ cash flows are modeled and appropriately discounted by a rate based on current yields and credit spreads. For sub and non-performing loans where there is some probability the loan will not continue to pay, a price based approach would be used to estimate the loan’s value in the open market utilizing current transaction information from similar loans. Policy Loans: Fair values for policy loans, net of reinsurance ceded, are estimated using discounted cash flow analyses and interest rates currently being offered to policyholders with similar policies. Carrying amounts for ceded policy loans, which equal $3,354.6 million and $3,373.7 million as of September 30, 2022 and December 31, 2021, respectively, approximate fair value and are reported on a gross basis in our consolidated balance sheets. A change in interest rates for ceded policy loans will not impact our financial position because the benefits and risks are fully ceded to reinsuring counterparties. Miscellaneous Long-term Investments: Carrying amounts for tax credit partnerships equal the unamortized balance of our contractual commitments and approximate fair value. Our shares of Federal Home Loan Bank (FHLB) common stock are carried at cost, which approximates fair value. Long-term Debt: Fair values for long-term debt are obtained from independent pricing services or discounted cash flow analyses based on current incremental borrowing rates for similar types of borrowing arrangements. FHLB Funding Agreements: Funding agreements with the FHLB represent cash advances used for the purpose of investing in fixed maturity securities. Carrying amounts approximate fair value. Unfunded Commitments to Investment Partnerships: Unfunded equity commitments represent amounts that we have committed to fund certain investment partnerships. These commitments are legally binding, subject to the partnerships meeting specified conditions. Carrying amounts of these financial instruments approximate fair value. The following table presents the carrying amounts and estimated fair values of our financial instruments not measured at fair value and indicates the level in the fair value hierarchy of the estimated fair value measurement based on the observability of the inputs used:
The carrying values of financial instruments such as short-term investments, cash and bank deposits, accounts and premiums receivable, accrued investment income, securities lending agreements, and short-term debt approximate fair value due to the short-term nature of the instruments. As such, these financial instruments are not included in the above chart. Fair values for insurance contracts other than investment contracts are not required to be disclosed. However, the fair values of liabilities under all insurance contracts are taken into consideration in our overall management of interest rate risk, which seeks to minimize exposure to changing interest rates through the matching of investment maturities with amounts due under insurance contracts.
|
Investments |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments, Debt and Equity Securities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments | Fixed Maturity Securities At September 30, 2022 and December 31, 2021, all fixed maturity securities were classified as available-for-sale. The amortized cost and fair values of securities by security type are shown as follows:
(1) Allowance for Credit Losses The following charts indicate the length of time our fixed maturity securities have been in a gross unrealized loss position.
The following is a distribution of the maturity dates for fixed maturity securities. The maturity dates have not been adjusted for possible calls or prepayments.
The following chart depicts an analysis of our fixed maturity security portfolio between investment-grade and below-investment-grade categories as of September 30, 2022:
The unrealized losses on investment-grade fixed maturity securities principally relate to changes in interest rates or changes in market or sector credit spreads which occurred subsequent to the acquisition of the securities. Below-investment-grade fixed maturity securities are generally more likely to develop credit concerns than investment-grade securities. At September 30, 2022, the unrealized losses in our below-investment-grade fixed maturity securities were generally due to credit spreads in certain industries or sectors and, to a lesser extent, credit concerns related to specific securities. For each specific security in an unrealized loss position, we believe that there are positive factors which mitigate credit concerns and that the securities for which we have not recorded a credit loss will recover in value. We have the ability and intent to continue to hold these securities to recovery of amortized cost and believe that no credit losses have occurred. As of September 30, 2022, we held 892 individual investment-grade fixed maturity securities and 118 individual below-investment-grade fixed maturity securities that were in an unrealized loss position, of which 114 investment-grade fixed maturity securities and 11 below-investment-grade fixed maturity securities had been in an unrealized loss position continuously for over one year. In determining when a decline in fair value below amortized cost of a fixed maturity security represents a credit loss, we evaluate the following factors: •Whether we expect to recover the entire amortized cost basis of the security •Whether we intend to sell the security or will be required to sell the security before the recovery of its amortized cost basis •Whether the security is current as to principal and interest payments •The significance of the decline in value •Current and future business prospects and trends of earnings •The valuation of the security's underlying collateral •Relevant industry conditions and trends relative to their historical cycles •Market conditions •Rating agency and governmental actions •Bid and offering prices and the level of trading activity •Adverse changes in estimated cash flows for securitized investments •Changes in fair value subsequent to the balance sheet date •Any other key measures for the related security While determining whether a credit loss exists is a judgmental area, we utilize a formal, well-defined, and disciplined process to monitor and evaluate our fixed income investment portfolio, supported by issuer specific research and documentation as of the end of each period. The process results in a thorough evaluation of problem investments and the recording of credit losses on a timely basis for investments determined to have a credit loss. We calculate the allowance for credit losses of fixed maturity securities based on the present value of our best estimate of cash flows expected to be collected, discounted using the effective interest rate implicit in the security at the date of acquisition. When estimating future cash flows, we analyze the strength of the issuer’s balance sheet, its debt obligations and near-term funding arrangements, cash flow and liquidity, the profitability of its core businesses, the availability of marketable assets which could be sold to increase liquidity, its industry fundamentals and regulatory environment, and its access to capital markets. As of September 30, 2022, with respect to the fixed maturity securities for which the allowance for credit losses was recognized, we do not intend to sell these securities, and it is not more likely than not that we will be required to sell these securities before recovery of our estimated value. The following tables present a rollforward of the allowance for credit losses on available-for-sale fixed maturity securities, which were classified as "public utilities" during the three and nine months ended September 30, 2022 and "all other corporate bonds" during the nine months ended September 30, 2021, respectively.
At September 30, 2022, we had commitments of $30.5 million to fund private placement fixed maturity securities, the amount of which may or may not be funded. Variable Interest Entities We invest in variable interests issued by variable interest entities. These investments include tax credit partnerships, private equity partnerships, and special purpose entities. For those variable interests that are not consolidated in our financial statements, we are not the primary beneficiary because we have neither the power to direct the activities that are most significant to economic performance nor the responsibility to absorb a majority of the expected losses. The determination of whether we are the primary beneficiary is performed at the time of our initial investment and at the date of each subsequent reporting period. As of September 30, 2022, the carrying amount of our variable interest entity investments that are not consolidated in our financial statements was $1,127.6 million, comprised of $3.0 million of tax credit partnerships and $1,124.6 million of private equity partnerships. At December 31, 2021, the carrying amount of our variable interest entity investments that are not consolidated in our financial statements was $987.9 million, comprised of $9.3 million of tax credit partnerships and $978.6 million of private equity partnerships. These variable interest entity investments are reported as other long-term investments in our consolidated balance sheets. The Company invests in tax credit partnerships primarily for the receipt of income tax credits and tax benefits derived from passive losses on the investments. Amounts recognized in the consolidated statements of income are as follows:
Contractually, we are a limited partner in these tax credit partnerships, and our maximum exposure to loss is limited to the carrying value of our investment, which includes $0.7 million of unfunded unconditional commitments at September 30, 2022. See Note 3 for commitments to fund private equity partnerships. Mortgage Loans Our mortgage loan portfolio is well diversified by both geographic region and property type to reduce risk of concentration. All of our mortgage loans are collateralized by commercial real estate. When issuing a new loan, our general policy is not to exceed a loan-to-value ratio, or the ratio of the loan balance to the estimated fair value of the underlying collateral, of 75 percent. We update the loan-to-value ratios at least every three years for each loan, and properties undergo a general inspection at least every two years. Our general policy for newly issued loans is to have a debt service coverage ratio greater than 1.25 times on a normalized 25 year amortization period. We update our debt service coverage ratios annually. We carry our mortgage loans at amortized cost less an allowance for expected credit losses. The amortized cost of our mortgage loans was $2,485.1 million and $2,568.7 million at September 30, 2022 and December 31, 2021, respectively. The allowance for expected credit losses was $8.7 million and $8.3 million at September 30, 2022 and December 31, 2021, respectively. Interest income is accrued on the principal amount of the loan based on the loan's contractual interest rate. We report accrued interest income for our mortgage loans as accrued investment income on our consolidated balance sheets, and the amount of the accrued income was $7.7 million and $8.1 million at September 30, 2022 and December 31, 2021, respectively. The carrying amount of mortgage loans by property type and geographic region are presented below.
The risk in our mortgage loan portfolio is primarily related to vacancy rates. Events or developments, such as economic conditions that impact the ability of the borrowers to ensure occupancy of the property, may have a negative effect on our mortgage loan portfolio, particularly to the extent that our portfolio is concentrated in an affected region or property type. An increase in vacancies increases the probability of default, which would negatively affect our expected losses in our mortgage loan portfolio. We evaluate each of our mortgage loans individually for impairment and assign an internal quality rating based on a comprehensive rating system used to evaluate the risk of the loan. The factors we use to derive our internal quality ratings may include the following: •Loan-to-value ratio based on internal appraisal of property •Debt service coverage ratio based on current operating income •Property location, including regional economics, trends and demographics •Age, condition, and construction quality of property •Current and historical occupancy of property •Lease terms relative to market •Tenant size and financial strength •Borrower's financial strength •Borrower's equity in transaction •Additional collateral, if any Although all available and applicable factors are considered in our analysis, loan-to-value and debt service coverage ratios are the most critical factors in determining whether we will initially issue the loan and also in assigning values and determining impairment. We assign an overall rating to each loan using an internal rating scale of AA (highest quality) to B (lowest quality). We review and adjust, as needed, our internal quality ratings on an annual basis. This review process is performed more frequently for mortgage loans deemed to have a higher risk of delinquency. We estimate an allowance for credit losses that we expect to incur over the life of our mortgage loans using a probability of default method. For each loan, we estimate the probability that the loan will default before its maturity (probability of default) and the amount of the loss if the loan defaults (loss given default). These two factors result in an expected loss percentage that is applied to the amortized cost of each loan to determine the expected credit loss. As we are the original underwriter of the mortgage loans, the amortized cost generally equals the principal amount of the loan. We measure losses on defaults of our mortgage loans as the excess amortized cost of the mortgage loan over the fair value of the underlying collateral in the event that we foreclose on the loan or over the expected future cash flows of the loan if we retain the mortgage loan until payoff. We do not purchase mortgage loans with existing credit impairments. In estimating the probability of default, we consider historical experience, current market conditions, and reasonable and supportable forecasts about the future market conditions. We utilize our historical loan experience in combination with a large third-party industry database for a period of time that aligns with the average life of our loans based on the maturity dates of the loans and prepayment experience. Our model utilizes an industry database of the historical loss experience based on our actual portfolio characteristics such as loan-to-value, debt service coverage, collateral type, geography, and late payment history. In addition, because we actively manage our portfolio, we may extend the term of a loan in certain situations and will accordingly extend the maturity date in the estimate of probability of default. In estimating the loss given default, we primarily consider the type and value of collateral and secondarily the expected liquidation costs and time to recovery. The primary market factors that we consider in our forecast of future market conditions are gross domestic product, unemployment rates, interest rates, inflation, commercial real estate values, household formation, and retail sales. We also forecast certain loan specific factors such as growth in the fair value and net operating income of collateral by property type. We include our estimate of these factors over a two-year period and for the remainder of the loans’ estimated lives, adjusted for estimated prepayments. Past the two-year forecast period, we revert to the historical assumptions ratably by the end of the fifth year of the loan after which we utilize only historical assumptions. We utilize various scenarios to estimate our allowance for expected losses ranging from a base case scenario that reflects normal market conditions to a severe case scenario that reflects adverse market conditions. We will adjust our allowance each period to utilize the scenario or weighting of the scenarios that best reflects our view of current market conditions. The following tables present information about mortgage loans by the applicable internal quality indicators:
(1)Loan-to Value Ratio utilizes the most recent internal appraisal of the property The following tables present the amortized cost of our mortgage loans by year of origination and internal quality indicators at September 30, 2022 and December 31, 2021, respectively:
(1)Loan-to Value Ratio utilizes the most recent internal appraisal of the property The following table presents a roll-forward of the allowance for expected credit losses by loan-to-value ratio for the three and nine months ended September 30, 2022 and 2021:
(1)Loan-to Value Ratio utilizes the most recent internal appraisal of the property The marginal increase in our estimate of expected losses during the third quarter and first nine months of 2022 is primarily driven by heightened uncertainty surrounding the future macroeconomic outlook and reflects market conditions as of September 30, 2022. There were no troubled debt restructurings during the three and nine months ended September 30, 2022 and 2021. At September 30, 2022 and December 31, 2021, we held no mortgage loans that were greater than 90 days past due regarding principal and/or interest payments. We had no loan foreclosures for the three and nine months ended September 30, 2022 or 2021. We had no impaired mortgage loans during three and nine months ended September 30, 2022 or 2021, nor did we recognize any interest income on mortgage loans subsequent to impairment. At September 30, 2022, we had commitments of $9.0 million to fund certain commercial mortgage loans. Consistent with how we determine the estimate of current expected credit losses for our funded mortgage loans each period, we estimate expected credit losses for loans that have not been funded but we are committed to fund at the end of each period. At both September 30, 2022 and December 31, 2021 we had $0.1 million of expected credit losses related to unfunded commitments on our consolidated balance sheets. Investment Real Estate During the first quarter of 2022, we reclassified one property previously held for the production of income to property held for sale. The carrying value of the property was $40.1 million and $40.9 million as of September 30, 2022 and December 31, 2021, respectively, and is primarily recorded within our Corporate segment. The estimated fair value less cost to sell is above the carrying value of the property, and we expect to close the sale of the property in 2022. During the third quarter of 2022, we reclassified two additional properties previously held for the production of income to property held for sale. The properties had a combined carrying value of $4.2 million and $4.1 million as of September 30, 2022 and December 31, 2021, respectively, and are recorded within our Corporate segment. The estimated fair value less cost to sell is above the carrying value of each property, and we expect to close the sale of both properties within the next twelve months. Transfers of Financial Assets To manage our cash position more efficiently, we may enter into repurchase agreements with unaffiliated financial institutions. We generally use repurchase agreements as a means to finance the purchase of invested assets or for short-term general business purposes until projected cash flows become available from our operations or existing investments. Our repurchase agreements are typically outstanding for less than 30 days. We post collateral through our repurchase agreement transactions whereby the counterparty commits to purchase securities with the agreement to resell them to us at a later, specified date. The fair value of collateral posted is generally 102 percent of the cash received. Our investment policy also permits us to lend fixed maturity securities to unaffiliated financial institutions in short-term securities lending agreements. These agreements increase our investment income with minimal risk. Our securities lending policy requires that a minimum of 102 percent of the fair value of the securities loaned be maintained as collateral. We may receive cash and/or securities as collateral under these agreements. Cash received as collateral is typically reinvested in short-term investments. If securities are received as collateral, we are not permitted to sell or re-post them. As of September 30, 2022, the carrying amount of fixed maturity securities loaned to third parties under our securities lending program was $231.0 million, for which we received collateral in the form of cash and securities of $100.1 million and $139.1 million, respectively. As of December 31, 2021, the carrying amount of fixed maturity securities loaned to third parties under our securities lending program was $283.7 million, for which we received collateral in the form of cash and securities of $94.8 million and $198.6 million, respectively. We had no outstanding repurchase agreements at September 30, 2022 or December 31, 2021. The remaining contractual maturities of our securities lending agreements disaggregated by class of assets pledged are as follows:
Certain of our U.S. insurance subsidiaries are members of regional FHLBs. Membership, which requires that we purchase a minimum amount of FHLB common stock on which we receive dividends, provides access to low-cost funding. Advances received from the FHLB are used for the purchase of short-term investments or fixed maturity securities. Additional common stock purchases may be required, based on the amount of funds we borrow from the FHLBs. The carrying value of common stock owned, collateral posted, and advances received are as follows:
Offsetting of Financial Instruments We enter into master netting agreements with each of our derivative's counterparties. These agreements provide for conditional rights of set-off upon the occurrence of an early termination event. An early termination event is considered a default, and it allows the non-defaulting party to offset its contracts in a loss position against any gain positions or payments due to the defaulting party. Under our agreements, default type events are defined as failure to pay or deliver as contractually agreed, misrepresentation, bankruptcy, or merger without assumption. See Note 5 for further discussion of collateral related to our derivative contracts. We have securities lending agreements with unaffiliated financial institutions that post collateral to us in return for the use of our fixed maturity securities. A right of set-off exists that allows us to keep and apply collateral received in the event of default by the counterparty. Default within a securities lending agreement would typically occur if the counterparty failed to return the securities borrowed from us as contractually agreed. In addition, if we default by not returning collateral received, the counterparty has a right of set-off against our securities or any other amounts due to us. Shown below are our financial instruments that either meet the accounting requirements that allow them to be offset in our balance sheets or that are subject to an enforceable master netting arrangement or similar agreement. Our accounting policy is to not offset these financial instruments in our balance sheets. Net amounts disclosed below have been reduced by the amount of collateral pledged to or received from our counterparties.
Net Investment Income Net investment income reported in our consolidated statements of income is presented below.
1 The net unrealized gain recognized in net investment income for the three and nine months ended September 30, 2022 related to perpetual preferred securities still held at September 30, 2022 was $0.5 million and $1.5 million, respectively. The net unrealized gain (loss) recognized in net investment income for the three and nine months ended September 30, 2021 related to perpetual preferred securities still held at September 30, 2021 was $(0.2) million and $4.0 million, respectively. Investment Gain and Loss Investment gains and losses are as follows:
1Gross gains on sales of fixed maturity securities for the nine months ended September 30, 2021 includes gains of $67.6 million as a result of the second phase of the reinsurance transaction that we completed during the first quarter of 2021. See Note 12 for further discussion.
|
Derivative Financial Instruments |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Financial Instruments | Purpose of Derivatives We are exposed to certain risks relating to our ongoing business operations. The primary risks managed by using derivative instruments are interest rate risk, risk related to matching duration for our assets and liabilities, foreign currency risk, and credit risk. Historically, we have utilized current and forward interest rate swaps, current and forward currency swaps, forward benchmark interest rate locks, currency forward contracts, forward contracts on specific fixed income securities, and credit default swaps. Transactions hedging interest rate risk are primarily associated with our individual and group long-term care and individual and group disability products. All other product portfolios are periodically reviewed to determine if hedging strategies would be appropriate for risk management purposes. We do not use derivative financial instruments for speculative purposes. Derivatives designated as cash flow hedges and used to reduce our exposure to interest rate and duration risk are as follows: •Interest rate swaps were used to hedge interest rate risks and to improve the matching of assets and liabilities. An interest rate swap is an agreement in which we agree with other parties to exchange, at specified intervals, the difference between fixed rate and variable rate interest amounts. We used interest rate swaps to hedge the anticipated purchase of fixed maturity securities thereby protecting us from the potential adverse impact of declining interest rates on the associated policy reserves. We also used interest rate swaps to hedge the potential adverse impact of rising interest rates in anticipation of issuing fixed rate long-term debt. •Forward benchmark interest rate locks are used to minimize interest rate risk associated with the anticipated purchase or disposal of fixed maturity securities or the anticipated issuance of fixed rate long-term debt. A forward benchmark interest rate lock is a derivative contract without an initial investment where we and the counterparty agree to purchase or sell a specific benchmark interest rate fixed maturity bond at a future date at a pre-determined price or yield. Derivatives designated as fair value hedges and previously used to reduce our exposure to interest rate and duration risk included: •Interest rate swaps were used to effectively convert certain fixed rate, long-term debt into floating rate long-term debt. Under these swap agreements, we received a fixed rate of interest and paid a variable rate of interest. Derivatives designated as either cash flow or fair value hedges and used to reduce our exposure to foreign currency risk are as follows: •Foreign currency interest rate swaps are used to hedge the currency risk of certain foreign currency-denominated fixed maturity securities owned for portfolio diversification. Under these swap agreements, we agree to pay, at specified intervals, fixed rate foreign currency-denominated principal and interest payments in exchange for fixed rate payments in the functional currency of the operating segment. Derivatives not designated as hedging instruments and used to reduce our exposure to foreign currency risk, credit losses on securities owned and volatility of the underlying deferred assets in our non-qualified defined contribution plan are as follows: •Foreign currency interest rate swaps previously designated as hedges were used to hedge the currency risk of certain foreign currency-denominated fixed maturity securities owned for portfolio diversification. These derivatives were effective hedges prior to novation to a new counterparty. In conjunction with the novation, these derivatives were de-designated as hedges. We agree to pay, at specified intervals, fixed rate foreign currency-denominated principal and interest payments in exchange for fixed rate payments in the functional currency of the operating segment. We hold offsetting swaps wherein we agree to pay fixed rate principal and interest payments in the functional currency of the operating segment in exchange for fixed rate foreign currency-denominated payments. •Credit default swaps were used as economic hedges against credit risk but do not qualify for hedge accounting. A credit default swap is an agreement in which we agree with another party to pay, at specified intervals, a fixed-rate fee in exchange for insurance against a credit event on a specific investment. If a defined credit event occurred, our counterparty could have either paid us a net cash settlement, or we could have surrendered the specific investment to them in exchange for cash equal to the full notional amount of the swap. Credit events typically include events such as bankruptcy, failure to pay, or certain types of debt restructuring. •Foreign currency forward contracts are used to minimize foreign currency risk. A foreign currency forward is a derivative without an initial investment where we and the counterparty agree to exchange a specific amount of currencies, at a specific exchange rate, on a specific date. We use these forward contracts to hedge the currency risk arising from foreign-currency denominated investments. •Total Return Swaps are used to economically hedge a portion of the liability related to our non-qualified defined contribution plan. A total return swap is an agreement in which we pay a floating rate of interest to the counterparty and receive the total return on a portfolio of exchange traded funds. These swaps are cash settled on the last day of every month and the notional is re-established each month based on periodic distributions from and contributions to the plan assets. Derivative Risks The basic types of risks associated with derivatives are market risk (that the value of the derivative will be adversely impacted by changes in the market, primarily the change in interest and exchange rates) and credit risk (that the counterparty will not perform according to the terms of the contract). The market risk of the derivatives should generally offset the market risk associated with the hedged financial instrument or liability. To help limit the credit exposure of the derivatives, we enter into master netting agreements with our counterparties whereby contracts in a gain position can be offset against contracts in a loss position. We also typically enter into bilateral, cross-collateralization agreements with our counterparties to help limit the credit exposure of the derivatives. These agreements require the counterparty in a loss position to submit acceptable collateral with the other counterparty in the event the net loss position meets or exceeds an agreed upon amount. Credit exposure on derivatives is limited to the value of those contracts in a net gain position, including accrued interest receivable less collateral held. As of September 30, 2022 and December 31, 2021, we had $1.7 million and $1.3 million credit exposure on derivatives, respectively. The table below summarizes the nature and amount of collateral received from and posted to our derivative counterparties.
See Note 4 for further discussion of our master netting agreements. The majority of our derivative instruments contain provisions that require us to maintain specified issuer credit ratings and financial strength ratings. Should our ratings fall below these specified levels, we would be in violation of the provisions, and our derivatives counterparties could terminate our contracts and request immediate payment. The aggregate fair value of all derivative instruments with credit risk-related contingent features that were in a liability position was $56.4 million and $35.0 million at September 30, 2022 and December 31, 2021, respectively. Cash Flow Hedges As of September 30, 2022 and December 31, 2021, we had $178.0 million and $181.3 million, respectively, notional amount of receive fixed, pay fixed, open current and forward foreign currency interest rate swaps to hedge fixed income foreign currency-denominated securities. During the third quarter and first nine months of 2022, we entered into $500.0 million and $679.0 million, respectively, of notional forward benchmark interest rate locks in order to hedge the anticipated purchase of fixed maturity securities. As of September 30, 2022, we had $664.0 million notional amount of forward benchmark interest rate locks. During the second quarter of 2021, we entered into a $250.0 million notional forward benchmark interest rate lock in order to hedge the interest rate risk associated with the cash flows related to the early redemption of certain of our debt securities. We terminated the interest rate lock in the second quarter of 2021 and recognized a loss of $1.2 million that was reported as a cost related to the early retirement of debt in our income statement. During the first quarter of 2021, in connection with the Closed Block individual disability reinsurance transaction, we reclassified $0.6 million of deferred gains from accumulated other comprehensive income (loss) into earnings included in the net investment gain (loss) line item on our income statement. The deferred gains were related to previously terminated interest rate swaps designated as hedging instruments of fixed maturity securities in the Closed Block individual disability product line. See Note 12 for further discussion. As of September 30, 2022, we expect to amortize approximately $39.2 million of net deferred gains on derivative instruments during the next twelve months. This amount will be reclassified from accumulated other comprehensive income (loss) into earnings and reported on the same income statement line item as the hedged item. The income statement line items that will be affected by this amortization are net investment income and interest and debt expense. Additional amounts that may be reclassified from accumulated other comprehensive income (loss) into earnings to offset the earnings impact of foreign currency translation of hedged items are not estimable. As of September 30, 2022, we are hedging the variability of future cash flows associated with forecasted transactions through the year 2052. Fair Value Hedges As of September 30, 2022 and December 31, 2021, we had $558.2 million and $498.5 million notional amount of receive fixed, pay fixed, open current and forward foreign currency interest rate swaps to hedge fixed income foreign currency-denominated securities. The following table summarizes the carrying amount of hedged assets and the related cumulative basis adjustments related to our fair value hedges:
For the three and nine months ended September 30, 2022, $0.2 million and $13.9 million, respectively, of the derivative instruments' gain was excluded from the assessment of hedge effectiveness. For the three and nine months ended September 30, 2021, $0.4 million and $10.6 million, respectively, of the derivative instruments' gain was excluded from the assessment of hedge effectiveness. There were no instances wherein we discontinued fair value hedge accounting due to a hedged firm commitment no longer qualifying as a fair value hedge. Derivatives not Designated as Hedging Instruments At both September 30, 2022 and December 31, 2021, we held $148.2 million notional amount of receive fixed, pay fixed, foreign currency interest rate swaps. These derivatives are not designated as hedges, and as such, changes in fair value related to these derivatives are reported in earnings as a component of net investment gain or loss. As of September 30, 2022, we held no single name credit default swaps. As of December 31, 2021, we held $11.6 million notional amount of single name credit default swaps. We entered into these swaps in order to mitigate the credit risk associated with specific securities owned. As of September 30, 2022 and December 31, 2021, we held $54.3 million and $41.7 million, respectively, notional amount of foreign currency forwards to mitigate the foreign currency risk associated with specific securities owned. As of September 30, 2022 and December 31, 2021, we held $70.2 million and $89.2 million, respectively, notional amount of total return swaps to mitigate the volatility associated with changes in the fair value of the underlying notional assets in our non-qualified defined contribution plan. This derivative is an economic hedge not designated as a hedging instrument, and changes in fair value are reported as a component of other expenses in our income statement. We have an embedded derivative in a modified coinsurance arrangement for which we include in our net investment gains and losses, a calculation intended to estimate the value of the option of our reinsurance counterparty to cancel the reinsurance contract with us. However, neither party can unilaterally terminate the reinsurance agreement except in extreme circumstances resulting from regulatory supervision, delinquency proceedings, or other direct regulatory action. Cash settlements or collateral related to this embedded derivative are not required at any time during the reinsurance contract or at termination of the reinsurance contract. There are no credit-related counterparty triggers, and any accumulated embedded derivative gain or loss reduces to zero over time as the reinsured business winds down. Locations and Amounts of Derivative Financial Instruments The following tables summarize the notional amounts and fair values of derivative financial instruments, as reported in our consolidated balance sheets. Derivative assets are included in other long-term investments, while derivative liabilities are included in other liabilities within our consolidated balance sheets. The notional amounts represent the basis upon which our counterparty pay and receive amounts are calculated.
The following tables summarize the location of gains and losses of derivative financial instruments designated as hedging instruments, as reported in our consolidated statements of income.
The following table summarizes the location of gains and losses of derivative financial instruments designated as cash flow hedging instruments, as reported in our consolidated statements of comprehensive income (loss).
The following table summarizes the location of gains and losses on our derivatives not designated as hedging instruments, as reported in our consolidated statements of income.
|
Accumulated Other Comprehensive Income (Loss) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accumulated Other Comprehensive Income (Loss) | Components of our accumulated other comprehensive income (loss), after tax, and related changes are as follows:
The net unrealized gain (loss) on securities consists of the following components:
Amounts reclassified from accumulated other comprehensive income (loss) were recognized in our consolidated statements of income as follows:
|
Liability for Unpaid Claims and Claim Adjustment Expenses |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Insurance [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Liability for Unpaid Claims and Claims Adjustment Expenses Disclosure | Changes in the liability for unpaid claims and claim adjustment expenses are as follows:
Certain prior year amounts were reclassified to conform to current year presentation. The majority of the net balances are related to disability claims with long-tail payouts on which interest earned on assets backing liabilities is an integral part of pricing and reserving. Interest accrued on prior year reserves has been calculated on the opening reserve balance less one-half of the period's claim payments relative to prior years at our average reserve discount rate for the respective periods. "Incurred Related to Prior Years - All Other Incurred" shown in the preceding chart reflects the current year development of the prior year unpaid claims and claim adjustment expenses. For both 2022 and 2021 this line item includes reserve assumption updates as discussed in the following paragraphs. For 2021, this amount includes the increase in benefits and change in reserves for future benefits resulting from the realization of previously unrealized investment gains and losses as a result of the Closed Block individual disability reinsurance transaction. Excluding the reserve assumption updates and impacts from the reinsurance transaction, the variability exhibited year over year is primarily caused by the level of claim resolutions in the period relative to the long-term expectations reflected in the reserves, primarily in our Unum US group long-term disability and Closed Block long-term care product lines. Our claim resolution rate assumption used in determining reserves is our expectation of the resolution rate we will experience over the life of the block of business and will vary from actual experience in any one period, both favorably and unfavorably. 2022 Reserve Assumption Updates During the third quarter of 2022, we completed our annual review of policy and claim reserve adequacy, which incorporated our most recent experience and included a review of all material assumptions. Based on our analysis, during the third quarter of 2022, we updated our reserve assumptions to reflect our current estimate of future benefits obligations and determined that our claim reserves in our Unum US group long-term disability product line and our waiver of premium reserves for our Unum US group life product line should be reduced by $121.0 million and $34.0 million, respectively, due primarily to sustained improvement in claim recovery trends since our last assumption update, partially offset by lower social security benefit offsets for our group long-term disability product line. As a result, a reduction of approximately $155.0 million, which can be primarily attributed to prior year incurred claims, impacts the results shown in the preceding chart. We also increased our claim reserves for the reinsured portion of our Closed Block individual disability product line by $193.9 million resulting primarily from updates to mortality assumptions for the advanced age portion of our claimant population. This increase is entirely related to the block that was ceded as a part of the Closed Block individual disability reinsurance transaction with Commonwealth Annuity and Life Insurance Company (Commonwealth). As a result, the increase in the Closed Block individual disability claim reserves had no impact on the net activity shown in the preceding chart. 2021 Reserve Assumption Updates During the third quarter of 2021, we completed our annual review of policy and claim reserve adequacy, which incorporated our most recent experience and included a review of all material assumptions. Based on our analysis, during the third quarter of 2021, we updated our reserve assumptions and determined that our claim reserves should be reduced by $215.0 million in our Unum US group long-term disability product line due primarily to sustained improvement in claim recovery trends since our last assumption update. We also increased our claim reserves for our Closed Block long-term care and individual disability product lines by $2.1 million and $6.4 million, respectively, to reflect our current estimate of future benefit obligations. As a result, a net reduction of $206.5 million, which can be primarily attributed to prior year incurred claims, impacts the results shown in the preceding chart. We increased policy reserves in our Closed Block group pension product line by $25.1 million as a result of this review which did not affect the results shown in the preceding chart. Closed Block Individual Disability Reinsurance Transaction In connection with the second phase of the Closed Block individual disability reinsurance transaction that closed in March 2021, we recorded a reinsurance recoverable of $990.0 million representing the ceded reserves related to the cohort of policies on claim status as of January 1, 2021 and an increase in benefits and change in reserves for future benefits of $133.1 million resulting from the realization of previously unrealized investment gains and losses recorded in accumulated other comprehensive income (loss). These impacts are reflected in the chart shown above and the reconciliation shown below. See Note 12 for further discussion regarding the total impacts of the Closed Block individual disability reinsurance transaction. Reconciliation A reconciliation of policy and contract benefits and reserves for future policy and contract benefits as reported in our consolidated balance sheets to the liability for unpaid claims and claim adjustment expenses is as follows:
|
Segment Information |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Information | We have three principal operating business segments: Unum US, Unum International, and Colonial Life. Our other segments are Closed Block and Corporate. Segment information is as follows:
We measure and analyze our segment performance on the basis of "adjusted operating revenue" and "adjusted operating income" or "adjusted operating loss", which differ from total revenue and income before income tax as presented in our consolidated statements of income due to the exclusion of investment gains and losses and the amortization of the cost of reinsurance as well as certain other items as specified in the reconciliations below. We believe adjusted operating revenue and adjusted operating income or loss are better performance measures and better indicators of the revenue and profitability and underlying trends in our business. These performance measures are in accordance with GAAP guidance for segment reporting, but they should not be viewed as a substitute for total revenue, income before income tax, or net income. Investment gains or losses primarily include realized investment gains or losses, expected investment credit losses, and gains or losses on derivatives. Investment gains or losses depend on market conditions and do not necessarily relate to decisions regarding the underlying business of our segments. Our investment focus is on investment income to support our insurance liabilities as opposed to the generation of investment gains or losses. Although we may experience investment gains or losses which will affect future earnings levels, a long-term focus is necessary to maintain profitability over the life of the business since our underlying business is long-term in nature, and we need to earn the interest rates assumed in calculating our liabilities. We have exited a substantial portion of our Closed Block individual disability product line through the two phases of the reinsurance transaction that were executed in December 2020 and March 2021. As a result, we exclude the amortization of the cost of reinsurance that was recognized as a result of the exit of the business related to the DLR cohort of policies. We believe that the exclusion of the amortization of the cost of reinsurance provides a better view of our results from our ongoing businesses. See Note 12 for further discussion regarding the total impacts of the Closed Block individual disability reinsurance transaction and the amortization of the cost of reinsurance. We may at other times exclude certain other items from our discussion of financial ratios and metrics in order to enhance the understanding and comparability of our operational performance and the underlying fundamentals but this exclusion is not an indication that similar items may not recur and does not replace net income or net loss as a measure of our overall profitability. A reconciliation of total revenue to "adjusted operating revenue" and income before income tax to "adjusted operating income" is as follows:
|
Employee Benefit Plans |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Retirement Benefits [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pension and Other Postretirement Benefits Disclosure | Defined Benefit Pension and Other Postretirement Benefit (OPEB) Plans We sponsor several defined benefit pension and OPEB plans for our employees, including non-qualified pension plans. The U.S. qualified and non-qualified defined benefit pension plans comprise the majority of our total benefit obligation and benefit cost. We maintain a separate defined benefit plan for eligible employees in our U.K. operation. The U.S. defined benefit pension plans were closed to new entrants on December 31, 2013, the OPEB plan was closed to new entrants on December 31, 2012, and the U.K. plan was closed to new entrants on December 31, 2002. The following table provides the components of the net periodic benefit cost (credit) for the defined benefit pension and OPEB plans.
The service cost component of net periodic pension and postretirement benefit cost (credit) is included as a component of compensation expense in our consolidated statements of income. All other components of net periodic pension and postretirement benefit cost (credit) are included in other expenses.
|
Stockholders' Equity and Earnings Per Common Share |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity and Earnings Per Common Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share Disclosure | Earnings Per Common Share Net income per common share is determined as follows:
We compute basic earnings per share by dividing net income by the weighted average number of common shares outstanding for the period. In computing earnings per share assuming dilution, we include potential common shares that are dilutive (those that reduce earnings per share). We use the treasury stock method to account for the effect of outstanding stock options, nonvested stock success units, nonvested restricted stock units, and nonvested performance share units on the computation of diluted earnings per share. Under this method, the potential common shares from stock options, nonvested stock success units, and nonvested restricted stock units will each have a dilutive effect, as individually measured, when the average market price of Unum Group common stock during the period exceeds the exercise price of the stock options and the grant price of the nonvested stock success units and nonvested restricted stock units. The outstanding nonvested stock success units and nonvested restricted stock units have grant prices ranging from $12.45 to $39.82. There were no outstanding stock options as of September 30, 2022. Potential common shares from performance based share units will have a dilutive effect as the attainment of performance conditions is progressively achieved during the vesting period. Potential common shares not included in the computation of diluted earnings per share because the impact would be antidilutive were de minimis and 0.1 million for the three and nine months ended September 30, 2022, respectively. There were approximately 1.3 million and 1.1 million potential common shares that were antidilutive for the three and nine months ended September 30, 2021, respectively.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity Disclosure | Common Stock As part of our capital deployment strategy, we may repurchase shares of Unum Group's common stock, as authorized by our board of directors. During the first nine months of 2021, we did not have an open share repurchase program and did not repurchase any shares. During October 2021, our board of directors authorized the repurchase of up to $250.0 million of Unum Group's outstanding common stock through December 31, 2022, with the timing and amount of repurchase activity to be based on market conditions and other considerations, including the level of available cash, alternative uses for cash, and our stock price. Common stock repurchases, which are accounted for using the cost method and classified as treasury stock until otherwise retired, were as follows:
1Includes a de minimis amount and $0.1 million of commissions for the three and nine months ended September 30, 2022. In February 2022, we entered into an accelerated share repurchase agreement with a financial counterparty to repurchase $50.0 million of Unum Group's common stock in aggregate. As part of this transaction, we paid $50.0 million to the financial counterparty and received an initial delivery of 1.3 million shares of our common stock, which represented approximately 75 percent of the total delivery under the agreement. We simultaneously entered into a forward contract indexed to the price of Unum Group common stock, which subjected the transaction to a future price adjustment. Under the terms of the share repurchase agreement, we were to receive, or be required to pay, a price adjustment based on the volume weighted average price of Unum Group common stock during the term of the agreement, less a discount. Any price adjustment payable to us was to be settled in shares of Unum Group common stock. Any price adjustment we would have been required to pay would have been settled in either cash or common stock at our option. The final price adjustment settlement, along with the delivery of the remaining shares, occurred in April 2022, resulting in the delivery to us of 0.4 million additional shares. In total, we repurchased 1.7 million shares pursuant to the February 2022 accelerated share repurchase agreement. During the three and nine months ended September 30, 2022, we repurchased 1.2 million and 2.5 million shares, respectively, in open market transactions at a cost of $42.6 million and $87.5 million, respectively. As of September 30, 2022, the remaining repurchase amount under the current share repurchase program was $62.5 million. Preferred Stock Unum Group has 25.0 million shares of preferred stock authorized with a par value of $0.10 per share. No preferred stock has been issued to date.
|
Commitments and Contingent Liabilities |
9 Months Ended |
---|---|
Sep. 30, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies Disclosure | Contingent Liabilities We are a defendant in a number of litigation matters that have arisen in the normal course of business, including the matters discussed below. Further, state insurance regulatory authorities and other federal and state authorities regularly make inquiries and conduct investigations concerning our compliance with applicable insurance and other laws and regulations. Given the complexity and scope of our litigation and regulatory matters, it is not possible to predict the ultimate outcome of all pending investigations or legal proceedings or provide reasonable estimates of potential losses, except if noted in connection with specific matters. In some of these matters, no specified amount is sought. In others, very large or indeterminate amounts, including punitive and treble damages, are asserted. There is a wide variation of pleading practice permitted in the United States courts with respect to requests for monetary damages, including some courts in which no specified amount is required and others which allow the plaintiff to state only that the amount sought is sufficient to invoke the jurisdiction of that court. Further, some jurisdictions permit plaintiffs to allege damages well in excess of reasonably possible verdicts. Based on our extensive experience and that of others in the industry with respect to litigating or resolving claims through settlement over an extended period of time, we believe that the monetary damages asserted in a lawsuit or claim bear little relation to the merits of the case, or the likely disposition value. Therefore, the specific monetary relief sought is not stated. Unless indicated otherwise in the descriptions below, reserves have not been established for litigation and contingencies. An estimated loss is accrued when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Claims Handling Matters We and our insurance subsidiaries, in the ordinary course of our business, are engaged in claim litigation where disputes arise as a result of a denial or termination of benefits. Most typically these lawsuits are filed on behalf of a single claimant or policyholder, and in some of these individual actions punitive damages are sought, such as claims alleging bad faith in the handling of insurance claims. For our general claim litigation, we maintain reserves based on experience to satisfy judgments and settlements in the normal course. We expect that the ultimate liability, if any, with respect to general claim litigation, after consideration of the reserves maintained, will not be material to our consolidated financial condition. Nevertheless, given the inherent unpredictability of litigation, it is possible that an adverse outcome in certain claim litigation involving punitive damages could, from time to time, have a material adverse effect on our consolidated results of operations in a period, depending on the results of operations for the particular period. From time to time class action allegations are pursued where the claimant or policyholder purports to represent a larger number of individuals who are similarly situated. Since each insurance claim is evaluated based on its own merits, there is rarely a single act or series of actions which can properly be addressed by a class action. Nevertheless, we monitor these cases closely and defend ourselves appropriately where these allegations are made.
|
Other |
9 Months Ended |
---|---|
Sep. 30, 2022 | |
Debt and Other Disclosures [Abstract] | |
Debt | Debt, Term Loan Facility, and Credit Facility Renewal In September 2022, pursuant to privately negotiated transactions, we purchased, and the Provident Financing Trust I (the Trust) retired, $14.0 million aggregate liquidation amount of the Trust's 7.405% capital securities due 2038, which resulted in the reduction of a corresponding principal amount of our 7.405% junior subordinated debt securities due 2038 then held by the Trust. We incurred costs of $1.2 million related to the early retirement of the junior subordinated debt securities. In August 2022, we entered into a five-year $350.0 million senior unsecured delayed draw term loan facility with a syndicate of lenders. Also in August 2022, we drew the entire amount of the term loan facility, which is scheduled to mature in August 2027. Amounts due under the term loan facility incur interest based on the prime rate, the federal funds rate or the Secured Overnight Financing Rate (SOFR). The proceeds from the term loan facility were used to redeem $350.0 million aggregate principal amount of our 4.000% senior notes due 2024. We incurred costs of $3.0 million related to the early retirement of these unsecured senior notes. In April 2022, we amended and restated our existing credit agreement providing for a five-year $500 million senior unsecured revolving credit facility with a syndicate of lenders. The credit facility, which was previously set to expire in April 2024, was extended through April 2027. We may request that the lenders’ aggregate commitments of $500 million under the facility be increased by up to an additional $200 million. Certain of our traditional U.S. life insurance subsidiaries, Unum Life Insurance Company of America, Provident Life and Accident Insurance Company, and Colonial Life & Accident Insurance Company, joined the agreement and may borrow under the credit facility, and we can elect to add additional insurance subsidiaries to the facility at any later date. Any obligation of a subsidiary under the credit facility is several only and not joint and is subject to an unconditional guarantee by Unum Group. We may also request, on up to two occasions, that the lenders' commitment termination dates be extended by one year. The credit facility provides for borrowings at an interest rate based on the prime rate, the federal funds rate or the SOFR. The credit facility also provides for the issuance of letters of credit subject to certain terms and limitations. At September 30, 2022, there were no borrowed amounts outstanding under the credit facility and letters of credit totaling $0.4 million had been issued. Borrowings under the term loan facility and the credit facility are subject to financial covenants, negative covenants, and events of default that are customary. The term loan facility and the credit facility include financial covenants based on our leverage ratio and consolidated net worth. We are also subject to covenants that limit subsidiary indebtedness. In June 2021, we issued $600.0 million of 4.125% senior notes due 2051. The notes are callable at or above par and rank equally in the right of payment with all of our other unsecured and unsubordinated debt. Also in June 2021, we redeemed $500.0 million aggregate principal amount of our 4.500% senior notes due 2025, for which we incurred costs of $67.3 million related to the early retirement of debt.
|
Income Tax Disclosure | Income TaxIn June 2021, the Finance Bill 2021 was enacted, resulting in a U.K. tax rate increase from 19 percent to 25 percent, effective April 1, 2023, which resulted in $24.2 million of additional tax expense in operating earnings for the revaluation of our deferred tax assets and liabilities in the second quarter of 2021. |
Allowance for Expected Credit Losses on Premiums Receivable | Allowance for Expected Credit Losses on Premiums Receivable At September 30, 2022, June 30, 2022, and December 31, 2021, the allowance for expected credit losses on premiums receivable was $31.4 million, $34.3 million, and $34.2 million, respectively, on gross premiums receivable of $561.1 million, $593.4 million, and $530.7 million, respectively. The decrease in the allowance of $2.9 million and $2.8 million during the three and nine months ended September 30, 2022, respectively, was driven primarily by an improvement in the age of premiums due to be collected and a decline in the gross receivable balance. At September 30, 2021, June 30, 2021, and December 31, 2020, the allowance for expected credit losses on premiums receivable was $32.6 million, $31.0 million, and $38.8 million, respectively, on gross premiums receivable of $575.8 million, $576.3 million, and $525.8 million, respectively. The increase in the allowance of $1.6 million during the three months ended September 30, 2021 was driven primarily by increases in the age of premiums due to be collected. The decrease of $6.2 million during the nine months ended September 30, 2021, was driven primarily by improvements in the age of premiums due to be collected and improvements in unemployment levels.
|
Impairment Loss on Internal-Use Software | Impairment Loss on Internal-Use Software During the third quarter of 2021, we recognized an impairment loss of $12.1 million for previously capitalized internal-use software that we no longer plan to utilize. We determined that this internal-use software would no longer be developed in order to focus our efforts on the development of software that better supports our long-term strategic goals. The impairment loss reduced the carrying value of the internal-use software to zero and has been recorded within other expenses in the consolidated statement of income and is included within our Corporate segment.
|
Impairment Loss on Right-of-Use Asset | Impairment Loss on Right-of-Use Asset During the second quarter of 2021, we recognized an impairment loss of $13.9 million on the right-of-use (ROU) asset related to one of our operating leases for office space that we do not plan to continue using to support our general operations. The impairment loss was recorded as a result of a decrease in the fair value of the ROU asset compared to its carrying value. The fair value of the ROU asset was determined based on a discounted cash flow model utilizing estimated market rates for sub-lease rentals. The impairment loss is recorded within other expenses in the consolidated statement of income and is included within our Corporate segment.
|
Reinsurance | Reinsurance In December 2020, we completed the first phase of a reinsurance transaction, pursuant to which Provident Life and Accident Insurance Company, The Paul Revere Life Insurance Company, and Unum Life Insurance Company of America, wholly-owned domestic insurance subsidiaries of Unum Group, and collectively referred to as "the ceding companies", each entered into separate reinsurance agreements with Commonwealth, to reinsure on a coinsurance basis effective as of July 1, 2020, approximately 75 percent of the Closed Block individual disability business, primarily direct business written by the ceding companies. On March 31, 2021, we completed the second phase of the reinsurance transaction, pursuant to which the ceding companies and Commonwealth amended and restated their respective reinsurance agreements to reinsure on a coinsurance and modified coinsurance basis effective as of January 1, 2021, a substantial portion of the remaining Closed Block individual disability business that was not ceded in December 2020, primarily business previously assumed by the ceding companies. Commonwealth established and will maintain collateralized trust accounts for the benefit of the ceding companies to secure its obligations under the reinsurance agreements. In December 2020, Provident Life and Casualty Insurance Company (PLC), also a wholly-owned domestic insurance subsidiary of Unum Group, entered into an agreement with Commonwealth whereby PLC will provide a 12-year volatility cover to Commonwealth for the active life cohort (ALR cohort). On March 31, 2021, PLC and Commonwealth amended and restated this agreement to incorporate the ALR cohort related to the additional business that was reinsured between the ceding companies and Commonwealth as part of the second phase of the transaction. As part of the amended and restated volatility cover, PLC received a payment from Commonwealth of approximately $18 million. At the end of the 12-year coverage period, Commonwealth will retain the remaining incidence and claims risk on the ALR cohort of the ceded business. In connection with the second phase of the reinsurance transaction, Commonwealth paid a total ceding commission to the ceding companies of $18.2 million. The ceding companies transferred assets of $767.0 million, which consisted primarily of cash and fixed maturity securities. In addition, we recognized the following in the first quarter of 2021 related to the second phase: •Net realized investment gains totaling $67.6 million related to the transfer of investments. •Increase in benefits and change in reserves for future benefits of $133.1 million resulting from the realization of previously unrealized investment gains and losses recorded in accumulated other comprehensive income (loss). •Transaction costs totaling $6.2 million. •Reinsurance recoverable of $990.0 million related to the policies on claim status. •Payable of $307.2 million related to the portfolio of invested assets associated with the business ceded on a modified coinsurance basis. •Cost of reinsurance, or prepaid reinsurance premium, of $43.1 million related to the DLR cohort. The total cost of reinsurance recognized on a combined basis for the first and second phases was $854.8 million for which we amortized $15.2 million and $48.5 million during the three and nine months ended September 30, 2022, respectively, and $19.7 million and $59.4 million during the three and nine month periods ended September 30, 2021, respectively. •Deposit asset of $5.0 million related to the ALR cohort. The total deposit asset recognized on a combined basis for the first and second phases was $91.8 million.
|
Basis of Presentation (Policies) |
9 Months Ended |
---|---|
Sep. 30, 2022 | |
Accounting policies and error corrections [Abstract] | |
Basis of Presentation | The accompanying consolidated financial statements of Unum Group and its subsidiaries (the Company) have been prepared in accordance with U.S. generally accepted accounting principles (GAAP) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. For further information, refer to the consolidated financial statements and footnotes included in our annual report on Form 10-K for the year ended December 31, 2021. |
Fair Values of Financial Instruments (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share | The following tables present additional information about our private equity partnerships, including commitments for additional investments which may or may not be funded:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Values by Fair Value Hierarchy Input level | The following tables present information about financial instruments measured at fair value on a recurring basis by fair value level, based on the observability of the inputs used.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Changes in Assets and Liabilities Measured at Fair Value on a Recurring Basis using Significant Unobservable Inputs | Changes in assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantitative Information Regarding Significant Unobservable Inputs | The table below provides quantitative information regarding the significant unobservable inputs used in Level 3 fair value measurements derived from internal models. Unobservable inputs for fixed maturity securities are weighted by the fair value of the securities. Certain securities classified as Level 3 are excluded from the table below due to limitations in our ability to obtain the underlying inputs used by external pricing sources.
(a)Represents a decision to price based on discounted expected future cash flows (b)Represents a decision to price based on comparable underlying assets (c)Represents basis point adjustments to apply a discount due to the illiquidity of an investment (d)Represents basis point adjustments for credit-specific factors (e)Represents a decision to price based on par value, cost, owner's equity, or the price of the most recent capital funding round when limited data is available (f)Represents various actuarial assumptions required to derive the liability cash flows. Fair value of embedded derivative is most often driven by the change in the weighted average credit spread to the swap curve for the assets backing the hypothetical loan
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Carrying Amount and Fair Value of Financial Instruments | The following table presents the carrying amounts and estimated fair values of our financial instruments not measured at fair value and indicates the level in the fair value hierarchy of the estimated fair value measurement based on the observability of the inputs used:
|
Investments (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments, Debt and Equity Securities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amortized Cost and Fair Values of Securities by Security Type | At September 30, 2022 and December 31, 2021, all fixed maturity securities were classified as available-for-sale. The amortized cost and fair values of securities by security type are shown as follows:
(1) Allowance for Credit Losses
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Length of Time Fixed Maturity Securities had been in a Gross Unrealized Loss Position | The following charts indicate the length of time our fixed maturity securities have been in a gross unrealized loss position.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Distribution of the Maturity Dates for Fixed Maturity Securities | The following is a distribution of the maturity dates for fixed maturity securities. The maturity dates have not been adjusted for possible calls or prepayments.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Distribution by External Credit Rating for Fixed Maturity Securities | The following chart depicts an analysis of our fixed maturity security portfolio between investment-grade and below-investment-grade categories as of September 30, 2022:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Securities, Available-for-sale, Allowance for Credit Loss | The following tables present a rollforward of the allowance for credit losses on available-for-sale fixed maturity securities, which were classified as "public utilities" during the three and nine months ended September 30, 2022 and "all other corporate bonds" during the nine months ended September 30, 2021, respectively.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Low Income Housing Tax Credits | The Company invests in tax credit partnerships primarily for the receipt of income tax credits and tax benefits derived from passive losses on the investments. Amounts recognized in the consolidated statements of income are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mortgage Loans by Property Type and Geographic Region | The carrying amount of mortgage loans by property type and geographic region are presented below.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Participating Mortgage Loans by Internal Credit Rating and Loan to Value | The following tables present information about mortgage loans by the applicable internal quality indicators:
(1)Loan-to Value Ratio utilizes the most recent internal appraisal of the property
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mortgage Loans by Credit Quality Indicators | The following tables present the amortized cost of our mortgage loans by year of origination and internal quality indicators at September 30, 2022 and December 31, 2021, respectively:
(1)Loan-to Value Ratio utilizes the most recent internal appraisal of the property
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financing Receivable, Allowance for Credit Loss | The following table presents a roll-forward of the allowance for expected credit losses by loan-to-value ratio for the three and nine months ended September 30, 2022 and 2021:
(1)Loan-to Value Ratio utilizes the most recent internal appraisal of the property
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Remaining Contractual Maturity of Securities Lending Agreements | The remaining contractual maturities of our securities lending agreements disaggregated by class of assets pledged are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Federal Home Loan Bank Common Stock Carrying Amounts, Amounts Posted, and Advances Received | The carrying value of common stock owned, collateral posted, and advances received are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Financial Instrument and Derivative Offsetting | Shown below are our financial instruments that either meet the accounting requirements that allow them to be offset in our balance sheets or that are subject to an enforceable master netting arrangement or similar agreement. Our accounting policy is to not offset these financial instruments in our balance sheets. Net amounts disclosed below have been reduced by the amount of collateral pledged to or received from our counterparties.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net Investment Income | Net Investment Income Net investment income reported in our consolidated statements of income is presented below.
1 The net unrealized gain recognized in net investment income for the three and nine months ended September 30, 2022 related to perpetual preferred securities still held at September 30, 2022 was $0.5 million and $1.5 million, respectively. The net unrealized gain (loss) recognized in net investment income for the three and nine months ended September 30, 2021 related to perpetual preferred securities still held at September 30, 2021 was $(0.2) million and $4.0 million, respectively.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment Gains and Losses Reported in Consolidated Statements of Income | Investment Gain and Loss Investment gains and losses are as follows:
1Gross gains on sales of fixed maturity securities for the nine months ended September 30, 2021 includes gains of $67.6 million as a result of the second phase of the reinsurance transaction that we completed during the first quarter of 2021. See Note 12 for further discussion.
|
Derivative Financial Instruments (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nature and Amount of Collateral Received From and Posted To Derivative Counterparty | The table below summarizes the nature and amount of collateral received from and posted to our derivative counterparties.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Hedges Carrying Amount of Hedged Assets and Liabilities and Cumulative Basis Adjustments | The following table summarizes the carrying amount of hedged assets and the related cumulative basis adjustments related to our fair value hedges:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Location and Fair Values of Derivative Financial Instruments | The following tables summarize the notional amounts and fair values of derivative financial instruments, as reported in our consolidated balance sheets. Derivative assets are included in other long-term investments, while derivative liabilities are included in other liabilities within our consolidated balance sheets. The notional amounts represent the basis upon which our counterparty pay and receive amounts are calculated.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Location of Gains and Losses on Derivative Instruments Designated as Cash Flow Hedging Instruments | The following tables summarize the location of gains and losses of derivative financial instruments designated as hedging instruments, as reported in our consolidated statements of income.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) | The following table summarizes the location of gains and losses of derivative financial instruments designated as cash flow hedging instruments, as reported in our consolidated statements of comprehensive income (loss).
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gains and Losses on Derivatives Not Designated as Hedging Instruments | The following table summarizes the location of gains and losses on our derivatives not designated as hedging instruments, as reported in our consolidated statements of income.
|
Accumulated Other Comprehensive Income (Loss) (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Accumulated Other Comprehensive Income (Loss) | Components of our accumulated other comprehensive income (loss), after tax, and related changes are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Components of Unrealized Gain (Loss) on Securities | The net unrealized gain (loss) on securities consists of the following components:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Reclassification out of Accumulated Other Comprehensive Income (Loss) | Amounts reclassified from accumulated other comprehensive income (loss) were recognized in our consolidated statements of income as follows:
|
Liability for Unpaid Claims and Claim Adjustment Expenses (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Insurance [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Liability for Unpaid Claims and Claims Adjustment Expense | Changes in the liability for unpaid claims and claim adjustment expenses are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reconciliation of Policy and Contract Benefits and Reserves for Future Policy and Contract Benefits to Balance Sheet Amounts | A reconciliation of policy and contract benefits and reserves for future policy and contract benefits as reported in our consolidated balance sheets to the liability for unpaid claims and claim adjustment expenses is as follows:
|
Segment Information (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Premium Income by Major Line of Business within Each Segment | Segment information is as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Selected Operating Statement Data by Segment |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Assets by Segment |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reconciliation of Total Revenue and Income Before Income Tax to Adjusted Operating Revenue and Adjusted Operating Income | A reconciliation of total revenue to "adjusted operating revenue" and income before income tax to "adjusted operating income" is as follows:
|
Employee Benefit Plans (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Retirement Benefits [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Net Benefit Costs | The following table provides the components of the net periodic benefit cost (credit) for the defined benefit pension and OPEB plans.
|
Stockholders' Equity and Earnings Per Common Share (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity and Earnings Per Common Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Basic and Diluted Earnings Per Share | Net income per common share is determined as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Treasury Stock Transactions | Common stock repurchases, which are accounted for using the cost method and classified as treasury stock until otherwise retired, were as follows:
1Includes a de minimis amount and $0.1 million of commissions for the three and nine months ended September 30, 2022.
|
Accounting Policies (Details) - USD ($) $ in Millions |
9 Months Ended | |
---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
|
New Accounting Pronouncements or Change in Accounting Principle | ||
Change in Insurance Reserves and Liabilities | $ (125.5) | $ 131.8 |
Previously Reported | ||
New Accounting Pronouncements or Change in Accounting Principle | ||
Change in Insurance Reserves and Liabilities | $ 91.9 |
Fair Values of Financial Instruments Private Equity Partnerships (Details) - Private Equity Funds - USD ($) $ in Millions |
Sep. 30, 2022 |
Dec. 31, 2021 |
||||||
---|---|---|---|---|---|---|---|---|
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share | ||||||||
Alternative Investments | $ 1,124.6 | $ 978.6 | ||||||
Alternative Investments, Unfunded Commitments | 806.2 | 753.2 | ||||||
Private Credit | ||||||||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share | ||||||||
Alternative Investments | 275.4 | 279.4 | ||||||
Alternative Investments, Unfunded Commitments | 109.9 | 150.5 | ||||||
Private Credit | Not Redeemable | ||||||||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share | ||||||||
Alternative Investments | [1] | 238.5 | 240.6 | |||||
Alternative Investments, Unfunded Commitments | 98.8 | 143.7 | ||||||
Private Credit | Initial 2 year lock on each new investment / Quarterly after 2 year lock with 90 days notice | ||||||||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share | ||||||||
Alternative Investments | 36.9 | 38.8 | ||||||
Alternative Investments, Unfunded Commitments | 11.1 | 6.8 | ||||||
Private Equity Limited Partnership | ||||||||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share | ||||||||
Alternative Investments | 446.9 | 384.6 | ||||||
Alternative Investments, Unfunded Commitments | 430.3 | 324.6 | ||||||
Private Equity Limited Partnership | Not Redeemable | ||||||||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share | ||||||||
Alternative Investments | [2] | 417.6 | 365.8 | |||||
Alternative Investments, Unfunded Commitments | 387.8 | 274.3 | ||||||
Private Equity Limited Partnership | Initial 5.5 year lock on each new investment / Quarterly after 5.5 year lock with 90 days notice | ||||||||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share | ||||||||
Alternative Investments | 29.3 | 18.8 | ||||||
Alternative Investments, Unfunded Commitments | 42.5 | 50.3 | ||||||
Real Assets | ||||||||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share | ||||||||
Alternative Investments | 402.3 | 314.6 | ||||||
Alternative Investments, Unfunded Commitments | 266.0 | 278.1 | ||||||
Real Assets | Not Redeemable | ||||||||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share | ||||||||
Alternative Investments | [3] | 342.5 | 256.2 | |||||
Alternative Investments, Unfunded Commitments | 266.0 | 278.1 | ||||||
Real Assets | Quarterly / 90 days notice | ||||||||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share | ||||||||
Alternative Investments | 59.8 | 58.4 | ||||||
Alternative Investments, Unfunded Commitments | $ 0.0 | $ 0.0 | ||||||
|
Fair Value Measurements by Input Level (Detail) - USD ($) $ in Millions |
Sep. 30, 2022 |
Dec. 31, 2021 |
---|---|---|
Assets, Fair Value Disclosure | ||
Fixed Maturity Securities | $ 34,148.2 | $ 43,336.0 |
Derivative Assets | 128.1 | 39.5 |
Equity Securities | 40.2 | 33.7 |
Other Long-term Investments | 1,430.4 | 1,203.0 |
Assets, Fair Value Disclosure | 35,441.1 | 44,387.8 |
Liabilities | ||
Derivative Liabilities | 75.8 | 65.1 |
Liabilities, Fair Value Disclosure | 75.8 | 65.1 |
Foreign Exchange Contracts | ||
Liabilities | ||
Derivative Liabilities | 27.4 | 35.0 |
Embedded Derivative in Modified Coinsurance Arrangement | ||
Liabilities | ||
Derivative Liabilities | 19.4 | 30.1 |
Interest Rate Swaps | ||
Liabilities | ||
Derivative Liabilities | 29.0 | |
Fair Value, Measurements, Recurring | ||
Assets, Fair Value Disclosure | ||
Other Long-term Investments | 1,292.9 | 1,051.8 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 | ||
Assets, Fair Value Disclosure | ||
Fixed Maturity Securities | 9,107.5 | 3,519.5 |
Derivative Assets | 0.0 | 0.0 |
Equity Securities | 17.8 | |
Other Long-term Investments | 17.8 | 0.0 |
Assets, Fair Value Disclosure | 9,125.3 | 3,519.5 |
Liabilities | ||
Liabilities, Fair Value Disclosure | 0.0 | 0.0 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 | Foreign Exchange Contracts | ||
Liabilities | ||
Derivative Liabilities | 0.0 | 0.0 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 | Embedded Derivative in Modified Coinsurance Arrangement | ||
Liabilities | ||
Derivative Liabilities | 0.0 | 0.0 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 | Interest Rate Swaps | ||
Liabilities | ||
Derivative Liabilities | 0.0 | |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | ||
Assets, Fair Value Disclosure | ||
Fixed Maturity Securities | 24,872.7 | 38,689.1 |
Derivative Assets | 128.1 | 39.5 |
Equity Securities | 8.9 | 27.9 |
Other Long-term Investments | 137.0 | 67.4 |
Assets, Fair Value Disclosure | 25,009.7 | 38,756.5 |
Liabilities | ||
Liabilities, Fair Value Disclosure | 56.4 | 35.0 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | Foreign Exchange Contracts | ||
Liabilities | ||
Derivative Liabilities | 27.4 | 35.0 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | Embedded Derivative in Modified Coinsurance Arrangement | ||
Liabilities | ||
Derivative Liabilities | 0.0 | 0.0 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | Interest Rate Swaps | ||
Liabilities | ||
Derivative Liabilities | 29.0 | |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3 | ||
Assets, Fair Value Disclosure | ||
Fixed Maturity Securities | 168.0 | 1,127.4 |
Derivative Assets | 0.0 | 0.0 |
Equity Securities | 13.5 | 5.8 |
Other Long-term Investments | 13.5 | 5.8 |
Assets, Fair Value Disclosure | 181.5 | 1,133.2 |
Liabilities | ||
Liabilities, Fair Value Disclosure | 19.4 | 30.1 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3 | Foreign Exchange Contracts | ||
Liabilities | ||
Derivative Liabilities | 0.0 | 0.0 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3 | Embedded Derivative in Modified Coinsurance Arrangement | ||
Liabilities | ||
Derivative Liabilities | 19.4 | 30.1 |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3 | Interest Rate Swaps | ||
Liabilities | ||
Derivative Liabilities | 0.0 | |
Fair Value, Measurements, Recurring | Fair Value Measured at Net Asset Value Per Share | ||
Assets, Fair Value Disclosure | ||
Fixed Maturity Securities | 0.0 | 0.0 |
Derivative Assets | 0.0 | 0.0 |
Equity Securities | 0.0 | 0.0 |
Other Long-term Investments | 1,124.6 | 978.6 |
Assets, Fair Value Disclosure | 1,124.6 | 978.6 |
Liabilities | ||
Liabilities, Fair Value Disclosure | 0.0 | 0.0 |
Fair Value, Measurements, Recurring | Fair Value Measured at Net Asset Value Per Share | Foreign Exchange Contracts | ||
Liabilities | ||
Derivative Liabilities | 0.0 | 0.0 |
Fair Value, Measurements, Recurring | Fair Value Measured at Net Asset Value Per Share | Embedded Derivative in Modified Coinsurance Arrangement | ||
Liabilities | ||
Derivative Liabilities | 0.0 | 0.0 |
Fair Value, Measurements, Recurring | Fair Value Measured at Net Asset Value Per Share | Interest Rate Swaps | ||
Liabilities | ||
Derivative Liabilities | 0.0 | |
United States Government and Government Agencies and Authorities | ||
Assets, Fair Value Disclosure | ||
Fixed Maturity Securities | 466.3 | 580.1 |
United States Government and Government Agencies and Authorities | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 | ||
Assets, Fair Value Disclosure | ||
Fixed Maturity Securities | 81.5 | 0.0 |
United States Government and Government Agencies and Authorities | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | ||
Assets, Fair Value Disclosure | ||
Fixed Maturity Securities | 384.8 | 580.1 |
United States Government and Government Agencies and Authorities | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3 | ||
Assets, Fair Value Disclosure | ||
Fixed Maturity Securities | 0.0 | 0.0 |
United States Government and Government Agencies and Authorities | Fair Value, Measurements, Recurring | Fair Value Measured at Net Asset Value Per Share | ||
Assets, Fair Value Disclosure | ||
Fixed Maturity Securities | 0.0 | 0.0 |
States, Municipalities, and Political Subdivisions | ||
Assets, Fair Value Disclosure | ||
Fixed Maturity Securities | 3,635.5 | 4,727.5 |
States, Municipalities, and Political Subdivisions | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 | ||
Assets, Fair Value Disclosure | ||
Fixed Maturity Securities | 18.7 | 0.0 |
States, Municipalities, and Political Subdivisions | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | ||
Assets, Fair Value Disclosure | ||
Fixed Maturity Securities | 3,616.6 | 4,714.1 |
States, Municipalities, and Political Subdivisions | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3 | ||
Assets, Fair Value Disclosure | ||
Fixed Maturity Securities | 0.2 | 13.4 |
States, Municipalities, and Political Subdivisions | Fair Value, Measurements, Recurring | Fair Value Measured at Net Asset Value Per Share | ||
Assets, Fair Value Disclosure | ||
Fixed Maturity Securities | 0.0 | 0.0 |
Foreign Governments | ||
Assets, Fair Value Disclosure | ||
Fixed Maturity Securities | 809.1 | 1,146.6 |
Foreign Governments | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 | ||
Assets, Fair Value Disclosure | ||
Fixed Maturity Securities | 0.0 | 0.0 |
Foreign Governments | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | ||
Assets, Fair Value Disclosure | ||
Fixed Maturity Securities | 789.1 | 1,125.8 |
Foreign Governments | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3 | ||
Assets, Fair Value Disclosure | ||
Fixed Maturity Securities | 20.0 | 20.8 |
Foreign Governments | Fair Value, Measurements, Recurring | Fair Value Measured at Net Asset Value Per Share | ||
Assets, Fair Value Disclosure | ||
Fixed Maturity Securities | 0.0 | 0.0 |
Public Utilities | ||
Assets, Fair Value Disclosure | ||
Fixed Maturity Securities | 4,910.9 | 6,416.0 |
Public Utilities | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 | ||
Assets, Fair Value Disclosure | ||
Fixed Maturity Securities | 593.7 | 230.8 |
Public Utilities | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | ||
Assets, Fair Value Disclosure | ||
Fixed Maturity Securities | 4,304.0 | 6,140.7 |
Public Utilities | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3 | ||
Assets, Fair Value Disclosure | ||
Fixed Maturity Securities | 13.2 | 44.5 |
Public Utilities | Fair Value, Measurements, Recurring | Fair Value Measured at Net Asset Value Per Share | ||
Assets, Fair Value Disclosure | ||
Fixed Maturity Securities | 0.0 | 0.0 |
Mortgage/Asset-backed Securities | ||
Assets, Fair Value Disclosure | ||
Fixed Maturity Securities | 530.3 | 638.3 |
Mortgage/Asset-backed Securities | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 | ||
Assets, Fair Value Disclosure | ||
Fixed Maturity Securities | 0.0 | 0.0 |
Mortgage/Asset-backed Securities | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | ||
Assets, Fair Value Disclosure | ||
Fixed Maturity Securities | 519.1 | 451.1 |
Mortgage/Asset-backed Securities | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3 | ||
Assets, Fair Value Disclosure | ||
Fixed Maturity Securities | 11.2 | 187.2 |
Mortgage/Asset-backed Securities | Fair Value, Measurements, Recurring | Fair Value Measured at Net Asset Value Per Share | ||
Assets, Fair Value Disclosure | ||
Fixed Maturity Securities | 0.0 | 0.0 |
Corporate Debt Securities | ||
Assets, Fair Value Disclosure | ||
Fixed Maturity Securities | 23,792.6 | 29,823.4 |
Corporate Debt Securities | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 | ||
Assets, Fair Value Disclosure | ||
Fixed Maturity Securities | 8,413.6 | 3,288.7 |
Corporate Debt Securities | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | ||
Assets, Fair Value Disclosure | ||
Fixed Maturity Securities | 15,255.6 | 25,673.2 |
Corporate Debt Securities | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3 | ||
Assets, Fair Value Disclosure | ||
Fixed Maturity Securities | 123.4 | 861.5 |
Corporate Debt Securities | Fair Value, Measurements, Recurring | Fair Value Measured at Net Asset Value Per Share | ||
Assets, Fair Value Disclosure | ||
Fixed Maturity Securities | 0.0 | 0.0 |
Redeemable Preferred Stocks | ||
Assets, Fair Value Disclosure | ||
Fixed Maturity Securities | 3.5 | 4.1 |
Redeemable Preferred Stocks | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 | ||
Assets, Fair Value Disclosure | ||
Fixed Maturity Securities | 0.0 | 0.0 |
Redeemable Preferred Stocks | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | ||
Assets, Fair Value Disclosure | ||
Fixed Maturity Securities | 3.5 | 4.1 |
Redeemable Preferred Stocks | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3 | ||
Assets, Fair Value Disclosure | ||
Fixed Maturity Securities | 0.0 | 0.0 |
Redeemable Preferred Stocks | Fair Value, Measurements, Recurring | Fair Value Measured at Net Asset Value Per Share | ||
Assets, Fair Value Disclosure | ||
Fixed Maturity Securities | 0.0 | 0.0 |
Forwards | ||
Assets, Fair Value Disclosure | ||
Derivative Assets | 7.3 | |
Forwards | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 | ||
Assets, Fair Value Disclosure | ||
Derivative Assets | 0.0 | |
Forwards | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | ||
Assets, Fair Value Disclosure | ||
Derivative Assets | 7.3 | |
Forwards | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3 | ||
Assets, Fair Value Disclosure | ||
Derivative Assets | 0.0 | |
Forwards | Fair Value, Measurements, Recurring | Fair Value Measured at Net Asset Value Per Share | ||
Assets, Fair Value Disclosure | ||
Derivative Assets | 0.0 | |
Foreign Exchange Contracts | ||
Assets, Fair Value Disclosure | ||
Derivative Assets | 120.8 | 39.5 |
Foreign Exchange Contracts | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 | ||
Assets, Fair Value Disclosure | ||
Derivative Assets | 0.0 | 0.0 |
Foreign Exchange Contracts | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | ||
Assets, Fair Value Disclosure | ||
Derivative Assets | 120.8 | 39.5 |
Foreign Exchange Contracts | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3 | ||
Assets, Fair Value Disclosure | ||
Derivative Assets | 0.0 | 0.0 |
Foreign Exchange Contracts | Fair Value, Measurements, Recurring | Fair Value Measured at Net Asset Value Per Share | ||
Assets, Fair Value Disclosure | ||
Derivative Assets | 0.0 | 0.0 |
Private Equity Funds | ||
Assets, Fair Value Disclosure | ||
Alternative Investments | 1,124.6 | 978.6 |
Private Equity Funds | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 | ||
Assets, Fair Value Disclosure | ||
Alternative Investments | 0.0 | 0.0 |
Private Equity Funds | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | ||
Assets, Fair Value Disclosure | ||
Alternative Investments | 0.0 | 0.0 |
Private Equity Funds | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3 | ||
Assets, Fair Value Disclosure | ||
Alternative Investments | 0.0 | 0.0 |
Private Equity Funds | Fair Value, Measurements, Recurring | Fair Value Measured at Net Asset Value Per Share | ||
Assets, Fair Value Disclosure | ||
Alternative Investments | 1,124.6 | 978.6 |
Derivatives | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 | ||
Liabilities | ||
Derivative Liabilities | 0.0 | 0.0 |
Derivatives | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | ||
Liabilities | ||
Derivative Liabilities | 56.4 | 35.0 |
Derivatives | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3 | ||
Liabilities | ||
Derivative Liabilities | 19.4 | 30.1 |
Derivatives | Fair Value, Measurements, Recurring | Fair Value Measured at Net Asset Value Per Share | ||
Liabilities | ||
Derivative Liabilities | $ 0.0 | $ 0.0 |
Changes in Assets and Liabilities Measured at Fair Value on a Recurring Basis using Significant Unobservable Inputs (Level 3) (Detail) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||||||
---|---|---|---|---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
Jun. 30, 2022 |
Dec. 31, 2021 |
Jun. 30, 2021 |
Dec. 31, 2020 |
|
Embedded Derivative in Modified Coinsurance Arrangement | ||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI | $ 0.0 | $ 0.0 | $ 0.0 | $ 0.0 | ||||
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss) | 14.9 | 2.6 | 10.7 | 21.2 | ||||
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs | (19.4) | (18.6) | (19.4) | (18.6) | $ (34.3) | $ (30.1) | $ (21.2) | $ (39.8) |
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Earnings | 14.9 | 2.6 | 10.7 | 21.2 | ||||
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Other Comprehensive Income (Loss) | 0.0 | 0.0 | 0.0 | 0.0 | ||||
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Purchases | 0.0 | 0.0 | 0.0 | 0.0 | ||||
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Sales | 0.0 | 0.0 | 0.0 | 0.0 | ||||
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Transfers into Level 3 | 0.0 | 0.0 | 0.0 | 0.0 | ||||
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Transfers out of Level 3 | 0.0 | 0.0 | 0.0 | 0.0 | ||||
US States and Political Subdivisions Debt Securities | ||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value | 0.2 | 0.0 | 0.2 | 0.0 | 0.0 | 13.4 | 15.5 | |
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings | 0.0 | 0.0 | 0.0 | |||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss) | (0.1) | (0.1) | 0.0 | |||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases | 0.0 | 0.3 | 0.0 | |||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales/Maturities | 0.0 | 0.0 | 0.0 | |||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 | 0.3 | 0.0 | 0.0 | |||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 | 0.0 | (13.4) | (15.5) | |||||
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI | (0.1) | (0.1) | 0.0 | |||||
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss) | 0.0 | 0.0 | 0.0 | |||||
Foreign Governments | ||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value | 20.0 | 21.1 | 20.0 | 21.1 | 20.2 | 20.8 | 21.5 | 21.8 |
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings | 0.0 | 0.0 | 0.0 | 0.0 | ||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss) | (0.2) | (0.4) | (0.8) | (0.7) | ||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases | 0.0 | 0.0 | 0.0 | 0.0 | ||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales/Maturities | 0.0 | 0.0 | 0.0 | 0.0 | ||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 | 0.0 | 0.0 | 0.0 | 0.0 | ||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 | 0.0 | 0.0 | 0.0 | 0.0 | ||||
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI | (0.2) | (0.3) | (0.8) | (0.7) | ||||
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss) | 0.0 | 0.0 | 0.0 | 0.0 | ||||
Public Utilities | ||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value | 13.2 | 44.6 | 13.2 | 44.6 | 13.6 | 44.5 | 104.5 | 185.7 |
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings | (0.4) | 0.0 | (4.6) | 0.0 | ||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss) | 0.0 | (0.4) | 2.2 | (2.3) | ||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases | 0.0 | 0.0 | 0.0 | 0.0 | ||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales/Maturities | 0.0 | 0.0 | (10.8) | (21.3) | ||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 | 0.0 | 0.0 | 15.6 | 36.0 | ||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 | 0.0 | (59.5) | (33.7) | (153.5) | ||||
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI | 0.0 | (0.4) | 2.2 | (2.3) | ||||
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss) | (0.4) | 0.0 | (4.6) | 0.0 | ||||
Mortgage/Asset-backed Securities | ||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value | 11.2 | 33.9 | 11.2 | 33.9 | 11.6 | 187.2 | 14.9 | 81.3 |
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings | 0.0 | 0.0 | 0.0 | 0.0 | ||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss) | 0.6 | (17.1) | (1.2) | (37.2) | ||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases | 0.0 | 0.0 | 9.9 | 0.0 | ||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales/Maturities | (0.3) | (2.0) | (9.5) | (62.0) | ||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 | 0.2 | 48.3 | 0.0 | 62.1 | ||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 | (0.9) | (10.2) | (175.2) | (10.3) | ||||
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI | 0.6 | (17.1) | (1.2) | (37.2) | ||||
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss) | 0.0 | 0.0 | 0.0 | 0.0 | ||||
Corporate Debt Securities | ||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value | 123.4 | 614.6 | 123.4 | 614.6 | 103.5 | 861.5 | 401.0 | 943.1 |
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings | 0.0 | 0.0 | 0.0 | 0.0 | ||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss) | (5.4) | (6.0) | (29.5) | (19.7) | ||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases | 1.3 | 50.0 | 8.8 | 133.9 | ||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales/Maturities | (13.0) | (4.4) | (20.9) | (17.4) | ||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 | 57.9 | 256.0 | 18.3 | 47.5 | ||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 | (20.9) | (82.0) | (714.8) | (472.8) | ||||
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI | (5.4) | (6.0) | (29.5) | (19.7) | ||||
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss) | 0.0 | 0.0 | 0.0 | 0.0 | ||||
Fixed Maturity Securities | ||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value | 168.0 | 714.2 | 168.0 | 714.2 | 148.9 | 1,127.4 | 541.9 | 1,247.4 |
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings | (0.4) | 0.0 | (4.6) | 0.0 | ||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss) | (5.1) | (23.9) | (29.4) | (59.9) | ||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases | 1.3 | 50.0 | 19.0 | 133.9 | ||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales/Maturities | (13.3) | (6.4) | (41.2) | (100.7) | ||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 | 58.4 | 304.3 | 33.9 | 145.6 | ||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 | (21.8) | (151.7) | (937.1) | (652.1) | ||||
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI | (5.1) | (23.8) | (29.4) | (59.9) | ||||
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss) | (0.4) | 0.0 | (4.6) | 0.0 | ||||
Equity Securities | ||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value | 13.5 | 5.6 | 13.5 | 5.6 | $ 10.9 | $ 5.8 | $ 5.5 | $ 4.7 |
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings | (0.1) | 0.1 | 2.7 | 0.1 | ||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss) | 0.0 | 0.0 | 0.0 | 0.0 | ||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases | 2.7 | 0.0 | 5.0 | 0.8 | ||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales/Maturities | 0.0 | 0.0 | 0.0 | 0.0 | ||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 | 0.0 | 0.0 | 0.0 | 0.0 | ||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 | 0.0 | 0.0 | 0.0 | 0.0 | ||||
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI | 0.0 | 0.0 | 0.0 | 0.0 | ||||
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss) | $ (0.1) | $ 0.1 | $ 2.7 | $ 0.1 |
Quantitative Information Regarding Significant Unobservable Inputs (Details) $ in Millions |
Sep. 30, 2022
USD ($)
Rate
|
Dec. 31, 2021
USD ($)
Rate
|
||||
---|---|---|---|---|---|---|
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||
Fixed Maturity Securities | $ 34,148.2 | $ 43,336.0 | ||||
Equity Securities | 40.2 | 33.7 | ||||
Public Utilities | ||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||
Fixed Maturity Securities | 4,910.9 | 6,416.0 | ||||
Corporate Debt Securities | ||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||
Fixed Maturity Securities | 23,792.6 | 29,823.4 | ||||
Mortgage/Asset-backed Securities | ||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||
Fixed Maturity Securities | 530.3 | 638.3 | ||||
Fair Value, Inputs, Level 3 | Discounted Cash Flow | Embedded Derivative in Modified Coinsurance Arrangement | ||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||
Embedded Derivative in Modified Coinsurance Arrangement | $ (19.4) | $ (30.1) | ||||
Fair Value, Inputs, Level 3 | Discounted Cash Flow | Embedded Derivative in Modified Coinsurance Arrangement | Weighted Average | Spread of Swap Curve | ||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||
Embedded Derivative Liability, Measurement Input | Rate | 0.007 | 0.007 | ||||
Fair Value, Inputs, Level 3 | Public Utilities | Discounted Cash Flow | ||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||
Fixed Maturity Securities | $ 13.2 | |||||
Fair Value, Inputs, Level 3 | Corporate Debt Securities | Market Approach | ||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||
All Other Corporate Bonds - Private | $ 15.9 | $ 111.8 | ||||
Fair Value, Inputs, Level 3 | Corporate Debt Securities | Market Approach | Minimum | Lack of Marketability | ||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||
All Other Corporate Bonds - Private, Measurement Input | Rate | [1] | 0.0014 | ||||
Fair Value, Inputs, Level 3 | Corporate Debt Securities | Market Approach | Minimum | Volatility of Credit | ||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||
All Other Corporate Bonds - Private, Measurement Input | Rate | [2] | 0.0461 | 0.0630 | |||
Fair Value, Inputs, Level 3 | Corporate Debt Securities | Market Approach | Maximum | Lack of Marketability | ||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||
All Other Corporate Bonds - Private, Measurement Input | Rate | [1] | 0.0073 | ||||
Fair Value, Inputs, Level 3 | Corporate Debt Securities | Market Approach | Maximum | Volatility of Credit | ||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||
All Other Corporate Bonds - Private, Measurement Input | Rate | [2] | 0.0461 | 0.0630 | |||
Fair Value, Inputs, Level 3 | Corporate Debt Securities | Market Approach | Weighted Average | Lack of Marketability | ||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||
All Other Corporate Bonds - Private, Measurement Input | Rate | [1] | 0.0051 | ||||
Fair Value, Inputs, Level 3 | Corporate Debt Securities | Market Approach | Weighted Average | Volatility of Credit | ||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||
All Other Corporate Bonds - Private, Measurement Input | Rate | [2] | 0.0461 | 0.0630 | |||
Fair Value, Inputs, Level 3 | Equity Securities | Market Approach | ||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||
Equity Securities | $ 13.5 | $ 5.8 | ||||
Fair Value, Inputs, Level 3 | Mortgage/Asset-backed Securities | Market Approach | ||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||
Fixed Maturity Securities | $ 9.7 | |||||
|
Fair Values of Financial Instruments Carrying Amounts and Estimated Fair value of Financial Instruments Not Measured at Fair Value (Details) - USD ($) $ in Millions |
Sep. 30, 2022 |
Dec. 31, 2021 |
---|---|---|
Fair Value, Balance Sheet Grouping, Financial Statement Captions | ||
Mortgage Loans, Carrying Amount | $ 2,476.4 | $ 2,560.4 |
Policy Loans | 3,640.8 | 3,662.9 |
Other Long-term Investments | 1,430.4 | 1,203.0 |
Long-term Debt | 3,429.2 | 3,442.2 |
Unfunded Commitments | 0.7 | |
Liabilities, Fair Value Disclosure | 75.8 | 65.1 |
Fair Value, Nonrecurring | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions | ||
Mortgage Loans, Fair Value Disclosure | 2,210.4 | 2,677.8 |
Mortgage Loans, Carrying Amount | 2,476.4 | 2,560.4 |
Policy Loans, Fair Value Disclosure | 3,714.6 | 3,807.1 |
Policy Loans | 3,640.8 | 3,662.9 |
Miscellaneous Long-Term Investments, Fair Value Disclosure | 20.6 | 31.6 |
Other Long-term Investments | 20.6 | 31.6 |
Financial Instruments, Financial Assets Fair Value Disclosure | 5,945.6 | 6,516.5 |
Total Financial Instrument Assets Not Carried at Fair Value | 6,137.8 | 6,254.9 |
Long-term Debt, Fair Value Disclosure | 3,039.2 | 3,879.1 |
Long-term Debt | 3,429.2 | 3,442.2 |
Federal Home Loan Bank Funding Agreements, Fair Value Disclosure | 118.5 | 160.9 |
Federal Home Loan Bank Funding Agreements | 118.5 | 160.9 |
Unfunded Commitments | 0.7 | 0.7 |
Liabilities, Fair Value Disclosure | 3,158.4 | 3,879.8 |
Total Financial Instrument Liabilities Not Carried at Fair Value | 3,548.4 | 3,442.9 |
Fair Value, Inputs, Level 1 | Fair Value, Nonrecurring | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions | ||
Mortgage Loans, Fair Value Disclosure | 0.0 | 0.0 |
Policy Loans, Fair Value Disclosure | 0.0 | 0.0 |
Miscellaneous Long-Term Investments, Fair Value Disclosure | 0.0 | 0.0 |
Financial Instruments, Financial Assets Fair Value Disclosure | 0.0 | 0.0 |
Long-term Debt, Fair Value Disclosure | 2,487.0 | 2,237.3 |
Federal Home Loan Bank Funding Agreements, Fair Value Disclosure | 0.0 | 0.0 |
Unfunded Commitments | 0.0 | 0.0 |
Liabilities, Fair Value Disclosure | 2,487.0 | 2,237.3 |
Fair Value, Inputs, Level 2 | Fair Value, Nonrecurring | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions | ||
Mortgage Loans, Fair Value Disclosure | 2,210.4 | 2,677.8 |
Policy Loans, Fair Value Disclosure | 0.0 | 0.0 |
Miscellaneous Long-Term Investments, Fair Value Disclosure | 17.3 | 22.1 |
Financial Instruments, Financial Assets Fair Value Disclosure | 2,227.7 | 2,699.9 |
Long-term Debt, Fair Value Disclosure | 552.2 | 1,641.8 |
Federal Home Loan Bank Funding Agreements, Fair Value Disclosure | 118.5 | 160.9 |
Unfunded Commitments | 0.7 | 0.7 |
Liabilities, Fair Value Disclosure | 671.4 | 1,642.5 |
Fair Value, Inputs, Level 3 | Fair Value, Nonrecurring | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions | ||
Mortgage Loans, Fair Value Disclosure | 0.0 | 0.0 |
Policy Loans, Fair Value Disclosure | 3,714.6 | 3,807.1 |
Miscellaneous Long-Term Investments, Fair Value Disclosure | 3.3 | 9.5 |
Financial Instruments, Financial Assets Fair Value Disclosure | 3,717.9 | 3,816.6 |
Long-term Debt, Fair Value Disclosure | 0.0 | 0.0 |
Federal Home Loan Bank Funding Agreements, Fair Value Disclosure | 0.0 | 0.0 |
Unfunded Commitments | 0.0 | 0.0 |
Liabilities, Fair Value Disclosure | $ 0.0 | $ 0.0 |
Fair Value of Financial Instruments Additional Information (Detail) - USD ($) $ in Millions |
Sep. 30, 2022 |
Dec. 31, 2021 |
---|---|---|
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis | ||
Ceded Policy Loans | $ 3,354.6 | $ 3,373.7 |
Fair Value, Inputs, Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis | ||
Percentage of Total Fair Value of Fixed Maturities Securities | 26.60% | |
Fair Value, Inputs, Level 2 | Pricing Service | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis | ||
Percentage of Total Fair Value of Fixed Maturities Securities | 57.00% | |
Fair Value, Inputs, Level 2 | Other Observable Market Data | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis | ||
Percentage of Total Fair Value of Fixed Maturities Securities | 15.20% | |
Fair Value Inputs Other Than Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis | ||
Percentage of Total Fair Value of Fixed Maturities Securities | 73.40% | |
Fair Value Inputs Level 2 Or Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis | ||
Percentage of Total Fair Value of Fixed Maturities Securities | 1.20% |
Amortized Cost and Fair Values of Securities by Security Type (Detail) - USD ($) $ in Millions |
Sep. 30, 2022 |
Jun. 30, 2022 |
Dec. 31, 2021 |
Sep. 30, 2021 |
Jun. 30, 2021 |
Dec. 31, 2020 |
---|---|---|---|---|---|---|
Debt Securities, Available-for-sale | ||||||
Amortized Cost of Fixed Maturity Securities | $ 37,721.4 | $ 37,386.7 | ||||
Debt Securities, Available-for-sale, Allowance for credit losses for Fixed Maturity Securities | 4.6 | 0.0 | ||||
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | 638.5 | |||||
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | 4,207.1 | |||||
Debt Securities, Available-for-sale, Total | 34,148.2 | 43,336.0 | ||||
United States Government and Government Agencies and Authorities | ||||||
Debt Securities, Available-for-sale | ||||||
Amortized Cost of Fixed Maturity Securities | 466.2 | 460.1 | ||||
Debt Securities, Available-for-sale, Allowance for credit losses for Fixed Maturity Securities | 0.0 | 0.0 | ||||
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | 23.1 | 120.1 | ||||
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | 23.0 | 0.1 | ||||
Debt Securities, Available-for-sale, Total | 466.3 | 580.1 | ||||
States, Municipalities, and Political Subdivisions | ||||||
Debt Securities, Available-for-sale | ||||||
Amortized Cost of Fixed Maturity Securities | 4,286.9 | 4,150.2 | ||||
Debt Securities, Available-for-sale, Allowance for credit losses for Fixed Maturity Securities | 0.0 | 0.0 | ||||
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | 80.4 | 584.2 | ||||
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | 731.8 | 6.9 | ||||
Debt Securities, Available-for-sale, Total | 3,635.5 | 4,727.5 | ||||
Foreign Governments | ||||||
Debt Securities, Available-for-sale | ||||||
Amortized Cost of Fixed Maturity Securities | 872.6 | 952.0 | ||||
Debt Securities, Available-for-sale, Allowance for credit losses for Fixed Maturity Securities | 0.0 | 0.0 | ||||
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | 36.3 | 215.3 | ||||
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | 99.8 | 20.7 | ||||
Debt Securities, Available-for-sale, Total | 809.1 | 1,146.6 | ||||
Public Utilities | ||||||
Debt Securities, Available-for-sale | ||||||
Amortized Cost of Fixed Maturity Securities | 5,175.4 | 5,266.4 | ||||
Debt Securities, Available-for-sale, Allowance for credit losses for Fixed Maturity Securities | 4.6 | $ 4.1 | 0.0 | |||
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | 126.7 | 1,159.4 | ||||
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | 386.6 | 9.8 | ||||
Debt Securities, Available-for-sale, Total | 4,910.9 | 6,416.0 | ||||
Mortgage/Asset-backed Securities | ||||||
Debt Securities, Available-for-sale | ||||||
Amortized Cost of Fixed Maturity Securities | 555.0 | 587.9 | ||||
Debt Securities, Available-for-sale, Allowance for credit losses for Fixed Maturity Securities | 0.0 | 0.0 | ||||
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | 7.4 | 50.4 | ||||
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | 32.1 | 0.0 | ||||
Debt Securities, Available-for-sale, Total | 530.3 | 638.3 | ||||
All Other Corporate Bonds | ||||||
Debt Securities, Available-for-sale | ||||||
Amortized Cost of Fixed Maturity Securities | 26,361.3 | 25,966.1 | ||||
Debt Securities, Available-for-sale, Allowance for credit losses for Fixed Maturity Securities | 0.0 | 0.0 | $ 0.0 | $ 0.0 | $ 6.8 | |
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | 364.6 | 3,919.9 | ||||
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | 2,933.3 | 62.6 | ||||
Debt Securities, Available-for-sale, Total | 23,792.6 | 29,823.4 | ||||
Redeemable Preferred Stocks | ||||||
Debt Securities, Available-for-sale | ||||||
Amortized Cost of Fixed Maturity Securities | 4.0 | 4.0 | ||||
Debt Securities, Available-for-sale, Allowance for credit losses for Fixed Maturity Securities | 0.0 | 0.0 | ||||
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | 0.0 | 0.1 | ||||
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | 0.5 | 0.0 | ||||
Debt Securities, Available-for-sale, Total | 3.5 | 4.1 | ||||
Fixed Maturity Securities | ||||||
Debt Securities, Available-for-sale | ||||||
Amortized Cost of Fixed Maturity Securities | 37,721.4 | 37,386.7 | ||||
Debt Securities, Available-for-sale, Allowance for credit losses for Fixed Maturity Securities | 4.6 | 0.0 | ||||
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | 638.5 | 6,049.4 | ||||
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | 4,207.1 | 100.1 | ||||
Debt Securities, Available-for-sale, Total | $ 34,148.2 | $ 43,336.0 |
Length of Time Fixed Maturity Securities had been in a Gross Unrealized Loss Position (Detail) - USD ($) $ in Millions |
Sep. 30, 2022 |
Dec. 31, 2021 |
---|---|---|
United States Government and Government Agencies and Authorities | ||
Debt Securities, Available-for-sale, Unrealized Loss Position | ||
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | $ 204.7 | $ 9.3 |
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | 22.5 | 0.1 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | 4.5 | 0.0 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | 0.5 | 0.0 |
States, Municipalities, and Political Subdivisions | ||
Debt Securities, Available-for-sale, Unrealized Loss Position | ||
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | 2,420.8 | 326.4 |
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | 713.7 | 6.9 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | 35.0 | 0.4 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | 18.1 | 0.0 |
Foreign Governments | ||
Debt Securities, Available-for-sale, Unrealized Loss Position | ||
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | 218.4 | 234.4 |
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | 74.3 | 18.9 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | 45.4 | 10.7 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | 25.5 | 1.8 |
Public Utilities | ||
Debt Securities, Available-for-sale, Unrealized Loss Position | ||
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | 2,640.6 | 263.3 |
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | 340.6 | 9.1 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | 104.0 | 17.6 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | 46.0 | 0.7 |
Mortgage/Asset-backed Securities | ||
Debt Securities, Available-for-sale, Unrealized Loss Position | ||
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | 399.5 | 29.2 |
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | 32.1 | 0.0 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | 0.1 | 0.1 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | 0.0 | 0.0 |
All Other Corporate Bonds | ||
Debt Securities, Available-for-sale, Unrealized Loss Position | ||
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | 17,240.4 | 2,146.3 |
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | 2,606.5 | 51.6 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | 850.8 | 199.4 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | 326.8 | 11.0 |
Redeemable Preferred Stocks | ||
Debt Securities, Available-for-sale, Unrealized Loss Position | ||
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | 3.5 | |
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | 0.5 | |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | 0.0 | |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | 0.0 | |
Fixed Maturity Securities | ||
Debt Securities, Available-for-sale, Unrealized Loss Position | ||
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | 23,127.9 | 3,008.9 |
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | 3,790.2 | 86.6 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | 1,039.8 | 228.2 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | $ 416.9 | $ 13.5 |
Investments Distribution of the Maturity Dates for Fixed Maturity Securities (Details) - USD ($) $ in Millions |
Sep. 30, 2022 |
Dec. 31, 2021 |
---|---|---|
Debt Securities, Available-for-sale, Amortized Cost, Net of Allowance for Credit Losses, Fiscal Year Maturity | ||
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One, Net | $ 1,155.4 | $ 767.3 |
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five, Net | 6,680.4 | 6,613.2 |
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10, Net | 10,456.2 | 10,614.3 |
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10, Net | 18,869.8 | 18,804.0 |
Available for sale Securities Debt Maturities Amortized Cost Gross Subtotal, Net | 37,161.8 | 36,798.8 |
Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Amortized Cost, Net | 555.0 | 587.9 |
Debt Securities, Available-for-sale, Amortized Cost, Net of Allowance for Credit Losses | 37,716.8 | 37,386.7 |
Available for Sale Securities Unrealized Gain Position Gross Gain | ||
Available For Sale Securities Debt Maturities Within One Year Unrealized Gain Position Gross Gain | 3.8 | 17.6 |
Available For Sale Securities Debt Maturities After One Through Five Years Unrealized Gain Position Gross Gain | 74.8 | 540.2 |
Available For Sale Securities Debt Maturities After Five Through Ten Years Unrealized Gain Position Gross Gain | 267.7 | 1,453.3 |
Available For Sale Securities Debt Maturities After Ten Years Unrealized Gain Position Gross Gain | 284.8 | 3,987.9 |
Available For Sale Securities Debt Maturities Unrealized Gain Position Gross Gain Gross Subtotal | 631.1 | 5,999.0 |
Available For Sale Securities Debt Maturities Without Single Maturity Date Unrealized Gain Position Gross Gain | 7.4 | 50.4 |
Available for sale Securities, Debt Maturities Unrealized Gain Position Gross Gain | 638.5 | 6,049.4 |
Available for Sale Securities Unrealized Loss Position Gross Loss | ||
Available For Sale Securities Debt Maturities Within One Year Unrealized Loss Position Gross Loss | 9.2 | 0.1 |
Available For Sale Securities Debt Maturities After One Through Five Years Unrealized Loss Position Gross Loss | 268.2 | 6.0 |
Available For Sale Securities Debt Maturities After Five Through Ten Years Unrealized Loss Position Gross Loss | 1,013.3 | 26.0 |
Available For Sale Securities Debt Maturities After Ten Years Unrealized Loss Position Gross Loss | 2,884.3 | 68.0 |
Available For Sale Securities Debt Maturities Unrealized Gain Position Gross Loss Gross Subtotal | 4,175.0 | 100.1 |
Available For Sale Securities Debt Maturities Without Single Maturity Date Unrealized Loss Position Gross Loss | 32.1 | 0.0 |
Available For Sale Securities Unrealized Loss Position Gross Loss Subtotal | 4,207.1 | 100.1 |
Fair Value Maturity Distribution | ||
Debt Securities, Available-for-sale, Total | 34,148.2 | 43,336.0 |
Available for Sale Securities Unrealized Gain Position Fair Value | ||
Fair Value Maturity Distribution | ||
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Fair Value | 481.5 | 756.0 |
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Fair Value | 1,671.1 | 7,050.5 |
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after Five Through Ten Years, Fair Value | 3,537.7 | 10,905.0 |
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after 10 Years, Fair Value | 4,159.5 | 20,778.4 |
Available for sale Securities Debt Maturities Fair Value Gross Subtotal | 9,849.8 | 39,489.9 |
Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Fair Value | 130.7 | 609.0 |
Debt Securities, Available-for-sale, Total | 9,980.5 | 40,098.9 |
Available for Sale Securities Unrealized Loss Position Fair Value | ||
Fair Value Maturity Distribution | ||
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Fair Value | 668.5 | 28.9 |
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Fair Value | 4,815.9 | 96.9 |
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after Five Through Ten Years, Fair Value | 6,172.9 | 1,136.6 |
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after 10 Years, Fair Value | 12,110.8 | 1,945.4 |
Available for sale Securities Debt Maturities Fair Value Gross Subtotal | 23,768.1 | 3,207.8 |
Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Fair Value | 399.6 | 29.3 |
Debt Securities, Available-for-sale, Total | $ 24,167.7 | $ 3,237.1 |
Investments Distribution by External Credit Rating for Fixed Maturity Securities (Details) - USD ($) $ in Millions |
Sep. 30, 2022 |
Dec. 31, 2021 |
---|---|---|
Debt Securities, Available-for-sale | ||
Fixed Maturity Securities | $ 34,148.2 | $ 43,336.0 |
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | 638.5 | |
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | $ 4,207.1 | |
Fixed maturity securities in unrealized loss position percent of total | 100.00% | |
External Credit Rating, Investment Grade | ||
Debt Securities, Available-for-sale | ||
Fixed Maturity Securities | $ 32,134.9 | |
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | 633.6 | |
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | $ 3,973.5 | |
Fixed maturity securities in unrealized loss position percent of total | 94.40% | |
External Credit Rating, Below-Investment-Grade | ||
Debt Securities, Available-for-sale | ||
Fixed Maturity Securities | $ 2,013.3 | |
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | 4.9 | |
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | $ 233.6 | |
Fixed maturity securities in unrealized loss position percent of total | 5.60% |
Debt Securities, Available-for-sale, Allowance for Credit Losses Rollforward (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
|
Debt Securities, Available-for-sale, Allowance for Credit Loss | ||||
Debt Securities, Available-for-sale, Allowance for Credit Loss, Beginning Balance | $ 0.0 | |||
Debt Securities, Available-for-sale, Allowance for Credit Loss, Ending Balance | $ 4.6 | 4.6 | ||
All Other Corporate Bonds | ||||
Debt Securities, Available-for-sale, Allowance for Credit Loss | ||||
Debt Securities, Available-for-sale, Allowance for Credit Loss, Beginning Balance | $ 0.0 | 0.0 | $ 6.8 | |
Debt Securities, Available-for-sale, Credit losses on securities for which credit losses were not previously recorded | 0.0 | |||
Debt Securities, Available-for-sale, Allowance for Credit Loss, Change in allowance due to change in intent to hold securities to maturity | 0.0 | 0.5 | ||
Debt Securities, Available-for-sale, Allowance for Credit Loss, Securities Sold | (7.3) | |||
Debt Securities, Available-for-sale, Allowance for Credit Loss, Ending Balance | 0.0 | $ 0.0 | 0.0 | $ 0.0 |
Public Utilities | ||||
Debt Securities, Available-for-sale, Allowance for Credit Loss | ||||
Debt Securities, Available-for-sale, Allowance for Credit Loss, Beginning Balance | 4.1 | 0.0 | ||
Debt Securities, Available-for-sale, Credit losses on securities for which credit losses were not previously recorded | 4.6 | |||
Debt Securities, Available-for-sale, Allowance for Credit Loss, Change in allowance due to change in intent to hold securities to maturity | 0.5 | 0.0 | ||
Debt Securities, Available-for-sale, Allowance for Credit Loss, Securities Sold | 0.0 | |||
Debt Securities, Available-for-sale, Allowance for Credit Loss, Ending Balance | $ 4.6 | $ 4.6 |
Investments Low Income Housing Tax Credits (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
|
Low Income Housing Tax Credits [Abstract] | ||||
Affordable Housing Tax Credits | $ 1.9 | $ 5.1 | $ 6.0 | $ 15.9 |
Amortization of Affordable Housing Tax Credit Investments | (1.4) | (4.0) | (4.4) | (11.4) |
Tax Benefits from Low Income Housing Investments | $ 0.5 | $ 1.1 | $ 1.6 | $ 4.5 |
Mortgage Loans by Property Type and Geographic Region (Detail) - USD ($) $ in Millions |
Sep. 30, 2022 |
Dec. 31, 2021 |
---|---|---|
Mortgage Loans on Real Estate | ||
Mortgage Loans, Carrying Amount | $ 2,476.4 | $ 2,560.4 |
New England | ||
Mortgage Loans on Real Estate | ||
Mortgage Loans, Carrying Amount | $ 53.1 | $ 54.9 |
Mortgage Loans, Percent of Total | 2.10% | 2.10% |
Mid-Atlantic | ||
Mortgage Loans on Real Estate | ||
Mortgage Loans, Carrying Amount | $ 194.5 | $ 214.7 |
Mortgage Loans, Percent of Total | 7.90% | 8.40% |
East North Central | ||
Mortgage Loans on Real Estate | ||
Mortgage Loans, Carrying Amount | $ 315.2 | $ 298.4 |
Mortgage Loans, Percent of Total | 12.70% | 11.70% |
West North Central | ||
Mortgage Loans on Real Estate | ||
Mortgage Loans, Carrying Amount | $ 183.1 | $ 193.1 |
Mortgage Loans, Percent of Total | 7.40% | 7.50% |
South Atlantic | ||
Mortgage Loans on Real Estate | ||
Mortgage Loans, Carrying Amount | $ 571.1 | $ 582.1 |
Mortgage Loans, Percent of Total | 23.10% | 22.70% |
East South Central | ||
Mortgage Loans on Real Estate | ||
Mortgage Loans, Carrying Amount | $ 102.7 | $ 120.7 |
Mortgage Loans, Percent of Total | 4.10% | 4.70% |
West South Central | ||
Mortgage Loans on Real Estate | ||
Mortgage Loans, Carrying Amount | $ 214.7 | $ 243.2 |
Mortgage Loans, Percent of Total | 8.70% | 9.60% |
Mountain | ||
Mortgage Loans on Real Estate | ||
Mortgage Loans, Carrying Amount | $ 294.7 | $ 290.6 |
Mortgage Loans, Percent of Total | 11.90% | 11.30% |
Pacific | ||
Mortgage Loans on Real Estate | ||
Mortgage Loans, Carrying Amount | $ 547.3 | $ 562.7 |
Mortgage Loans, Percent of Total | 22.10% | 22.00% |
Total | ||
Mortgage Loans on Real Estate | ||
Mortgage Loans, Percent of Total | 100.00% | 100.00% |
Apartment | ||
Mortgage Loans on Real Estate | ||
Mortgage Loans, Carrying Amount | $ 693.1 | $ 780.0 |
Mortgage Loans, Percent of Total | 28.00% | 30.50% |
Industrial | ||
Mortgage Loans on Real Estate | ||
Mortgage Loans, Carrying Amount | $ 741.3 | $ 734.4 |
Mortgage Loans, Percent of Total | 29.90% | 28.70% |
Office | ||
Mortgage Loans on Real Estate | ||
Mortgage Loans, Carrying Amount | $ 450.0 | $ 467.2 |
Mortgage Loans, Percent of Total | 18.20% | 18.20% |
Retail | ||
Mortgage Loans on Real Estate | ||
Mortgage Loans, Carrying Amount | $ 547.7 | $ 533.3 |
Mortgage Loans, Percent of Total | 22.10% | 20.80% |
Other Property | ||
Mortgage Loans on Real Estate | ||
Mortgage Loans, Carrying Amount | $ 44.3 | $ 45.5 |
Mortgage Loans, Percent of Total | 1.80% | 1.80% |
Total | ||
Mortgage Loans on Real Estate | ||
Mortgage Loans, Percent of Total | 100.00% | 100.00% |
Schedule of Participating Mortgage Loans by Internal Credit Rating and Loan to Value (Details) - USD ($) $ in Millions |
Sep. 30, 2022 |
Dec. 31, 2021 |
---|---|---|
Mortgage Loans on Real Estate | ||
Mortgage Loans, Carrying Amount | $ 2,476.4 | $ 2,560.4 |
Loan to Value Ratio Below or Equal to 65 Percent | ||
Mortgage Loans on Real Estate | ||
Mortgage Loans, Carrying Amount | $ 1,317.6 | $ 1,346.1 |
Mortgage Loans, Percent of Total | 53.30% | 52.60% |
Loan To Value Ratio Above 65 To 75 Percent | ||
Mortgage Loans on Real Estate | ||
Mortgage Loans, Carrying Amount | $ 1,043.3 | $ 1,076.8 |
Mortgage Loans, Percent of Total | 42.10% | 42.00% |
Loan To Value Ratio Above 75 To 85 Percent | ||
Mortgage Loans on Real Estate | ||
Mortgage Loans, Carrying Amount | $ 109.9 | $ 114.9 |
Mortgage Loans, Percent of Total | 4.40% | 4.50% |
Loan To Value Ratio Above 85 Percent | ||
Mortgage Loans on Real Estate | ||
Mortgage Loans, Carrying Amount | $ 5.6 | $ 22.6 |
Mortgage Loans, Percent of Total | 0.20% | 0.90% |
Total | ||
Mortgage Loans on Real Estate | ||
Mortgage Loans, Percent of Total | 100.00% | 100.00% |
AA Credit Rating | ||
Mortgage Loans on Real Estate | ||
Mortgage Loans, Carrying Amount | $ 30.1 | $ 27.3 |
Mortgage Loans, Percent of Total | 1.20% | 1.10% |
A Credit Rating | ||
Mortgage Loans on Real Estate | ||
Mortgage Loans, Carrying Amount | $ 695.5 | $ 709.6 |
Mortgage Loans, Percent of Total | 28.10% | 27.70% |
BBB Credit Rating | ||
Mortgage Loans on Real Estate | ||
Mortgage Loans, Carrying Amount | $ 1,730.6 | $ 1,802.6 |
Mortgage Loans, Percent of Total | 69.90% | 70.40% |
BB Credit Rating | ||
Mortgage Loans on Real Estate | ||
Mortgage Loans, Carrying Amount | $ 20.2 | $ 20.9 |
Mortgage Loans, Percent of Total | 0.80% | 0.80% |
Total | ||
Mortgage Loans on Real Estate | ||
Mortgage Loans, Percent of Total | 100.00% | 100.00% |
Mortgage Loans, Sorted by Applicable Credit Quality Indicators (Detail) - USD ($) $ in Millions |
Sep. 30, 2022 |
Jun. 30, 2022 |
Dec. 31, 2021 |
Sep. 30, 2021 |
Jun. 30, 2021 |
Dec. 31, 2020 |
---|---|---|---|---|---|---|
Mortgage Loans on Real Estate | ||||||
Mortgage Loans, Carrying Amount | $ 2,476.4 | $ 2,560.4 | ||||
Loan to Value Ratio Below or Equal to 65 Percent | ||||||
Mortgage Loans on Real Estate | ||||||
Mortgage Loans, Carrying Amount | 1,317.6 | 1,346.1 | ||||
Loan To Value Ratio Above 65 To 75 Percent | ||||||
Mortgage Loans on Real Estate | ||||||
Mortgage Loans, Carrying Amount | 1,043.3 | 1,076.8 | ||||
Loan To Value Ratio Above 75 To 85 Percent | ||||||
Mortgage Loans on Real Estate | ||||||
Mortgage Loans, Carrying Amount | 109.9 | 114.9 | ||||
Loan To Value Ratio Above 85 Percent | ||||||
Mortgage Loans on Real Estate | ||||||
Mortgage Loans, Carrying Amount | 5.6 | 22.6 | ||||
Originated Five or More Years before Last Fiscal Year | ||||||
Mortgage Loans on Real Estate | ||||||
Mortgage Loans, Carrying Amount | 1,146.7 | 981.5 | ||||
Originated Four Years before Last Fiscal Year | ||||||
Mortgage Loans on Real Estate | ||||||
Mortgage Loans, Carrying Amount | 377.0 | 304.1 | ||||
Originated Three Years before Last Fiscal Year | ||||||
Mortgage Loans on Real Estate | ||||||
Mortgage Loans, Carrying Amount | 345.4 | 383.0 | ||||
Originated Two Years before Last Fiscal Year | ||||||
Mortgage Loans on Real Estate | ||||||
Mortgage Loans, Carrying Amount | 170.4 | 359.4 | ||||
Originated in Fiscal Year before Latest Fiscal Year | ||||||
Mortgage Loans on Real Estate | ||||||
Mortgage Loans, Carrying Amount | 357.4 | 180.0 | ||||
Originated in Current Fiscal Year | ||||||
Mortgage Loans on Real Estate | ||||||
Mortgage Loans, Carrying Amount | 79.5 | 352.4 | ||||
Commercial Real Estate | ||||||
Mortgage Loans on Real Estate | ||||||
Financing Receivable, Originated Five or More Years before Latest Fiscal Year | 1,150.7 | 984.1 | ||||
Financing Receivable, Originated Four Years before Latest Fiscal Year | 378.6 | 305.5 | ||||
Financing Receivable, Originated Three Years before Latest Fiscal Year | 346.8 | 384.4 | ||||
Financing Receivable, Originated Two Years before Latest Fiscal Year | 170.9 | 360.8 | ||||
Financing Receivable, Originated in Fiscal Year before Latest Fiscal Year | 358.2 | 180.7 | ||||
Financing Receivable, Originated in Current Fiscal Year | 79.9 | 353.2 | ||||
Financing Receivable, before Allowance for Credit Loss | 2,485.1 | 2,568.7 | ||||
Financing Receivable, Allowance for Credit Losses, Mortgage Loans | 8.7 | 8.3 | ||||
Commercial Real Estate | Loan to Value Ratio Below or Equal to 65 Percent | ||||||
Mortgage Loans on Real Estate | ||||||
Financing Receivable, Originated Five or More Years before Latest Fiscal Year | 812.7 | 779.1 | ||||
Financing Receivable, Originated Four Years before Latest Fiscal Year | 190.0 | 146.9 | ||||
Financing Receivable, Originated Three Years before Latest Fiscal Year | 102.3 | 163.0 | ||||
Financing Receivable, Originated Two Years before Latest Fiscal Year | 68.4 | 80.7 | ||||
Financing Receivable, Originated in Fiscal Year before Latest Fiscal Year | 129.7 | 54.3 | ||||
Financing Receivable, Originated in Current Fiscal Year | 17.0 | 124.7 | ||||
Financing Receivable, before Allowance for Credit Loss | 1,320.1 | 1,348.7 | ||||
Financing Receivable, Allowance for Credit Losses, Mortgage Loans | 2.5 | $ 2.3 | 2.6 | $ 3.2 | $ 3.2 | $ 3.4 |
Commercial Real Estate | Loan To Value Ratio Above 65 To 75 Percent | ||||||
Mortgage Loans on Real Estate | ||||||
Financing Receivable, Originated Five or More Years before Latest Fiscal Year | 227.4 | 115.7 | ||||
Financing Receivable, Originated Four Years before Latest Fiscal Year | 182.7 | 115.4 | ||||
Financing Receivable, Originated Three Years before Latest Fiscal Year | 244.5 | 215.4 | ||||
Financing Receivable, Originated Two Years before Latest Fiscal Year | 102.5 | 280.1 | ||||
Financing Receivable, Originated in Fiscal Year before Latest Fiscal Year | 228.5 | 126.4 | ||||
Financing Receivable, Originated in Current Fiscal Year | 62.9 | 228.5 | ||||
Financing Receivable, before Allowance for Credit Loss | 1,048.5 | 1,081.5 | ||||
Financing Receivable, Allowance for Credit Losses, Mortgage Loans | 5.2 | 4.8 | 4.7 | 6.2 | 6.2 | 7.3 |
Commercial Real Estate | Loan To Value Ratio Above 75 To 85 Percent | ||||||
Mortgage Loans on Real Estate | ||||||
Financing Receivable, Originated Five or More Years before Latest Fiscal Year | 110.6 | 89.3 | ||||
Financing Receivable, Originated Four Years before Latest Fiscal Year | 0.0 | 26.3 | ||||
Financing Receivable, Originated Three Years before Latest Fiscal Year | 0.0 | 0.0 | ||||
Financing Receivable, Originated Two Years before Latest Fiscal Year | 0.0 | 0.0 | ||||
Financing Receivable, Originated in Fiscal Year before Latest Fiscal Year | 0.0 | 0.0 | ||||
Financing Receivable, Originated in Current Fiscal Year | 0.0 | 0.0 | ||||
Financing Receivable, before Allowance for Credit Loss | 110.6 | 115.6 | ||||
Financing Receivable, Allowance for Credit Losses, Mortgage Loans | 0.7 | 0.9 | 0.7 | 1.4 | 1.5 | 1.3 |
Commercial Real Estate | Loan To Value Ratio Above 85 Percent | ||||||
Mortgage Loans on Real Estate | ||||||
Financing Receivable, Originated Five or More Years before Latest Fiscal Year | 0.0 | 0.0 | ||||
Financing Receivable, Originated Four Years before Latest Fiscal Year | 5.9 | 16.9 | ||||
Financing Receivable, Originated Three Years before Latest Fiscal Year | 0.0 | 6.0 | ||||
Financing Receivable, Originated Two Years before Latest Fiscal Year | 0.0 | 0.0 | ||||
Financing Receivable, Originated in Fiscal Year before Latest Fiscal Year | 0.0 | 0.0 | ||||
Financing Receivable, Originated in Current Fiscal Year | 0.0 | 0.0 | ||||
Financing Receivable, before Allowance for Credit Loss | 5.9 | 22.9 | ||||
Financing Receivable, Allowance for Credit Losses, Mortgage Loans | 0.3 | $ 0.4 | 0.3 | $ 0.5 | $ 0.5 | $ 1.1 |
Commercial Real Estate | Originated Five or More Years before Last Fiscal Year | ||||||
Mortgage Loans on Real Estate | ||||||
Financing Receivable, Allowance for Credit Losses, Mortgage Loans | 4.0 | 2.6 | ||||
Commercial Real Estate | Originated Four Years before Last Fiscal Year | ||||||
Mortgage Loans on Real Estate | ||||||
Financing Receivable, Allowance for Credit Losses, Mortgage Loans | 1.6 | 1.4 | ||||
Commercial Real Estate | Originated Three Years before Last Fiscal Year | ||||||
Mortgage Loans on Real Estate | ||||||
Financing Receivable, Allowance for Credit Losses, Mortgage Loans | 1.4 | 1.4 | ||||
Commercial Real Estate | Originated Two Years before Last Fiscal Year | ||||||
Mortgage Loans on Real Estate | ||||||
Financing Receivable, Allowance for Credit Losses, Mortgage Loans | 0.5 | 1.4 | ||||
Commercial Real Estate | Originated in Fiscal Year before Latest Fiscal Year | ||||||
Mortgage Loans on Real Estate | ||||||
Financing Receivable, Allowance for Credit Losses, Mortgage Loans | 0.8 | 0.7 | ||||
Commercial Real Estate | Originated in Current Fiscal Year | ||||||
Mortgage Loans on Real Estate | ||||||
Financing Receivable, Allowance for Credit Losses, Mortgage Loans | 0.4 | 0.8 | ||||
AA Credit Rating | ||||||
Mortgage Loans on Real Estate | ||||||
Mortgage Loans, Carrying Amount | 30.1 | 27.3 | ||||
AA Credit Rating | Commercial Real Estate | ||||||
Mortgage Loans on Real Estate | ||||||
Financing Receivable, Originated Five or More Years before Latest Fiscal Year | 6.1 | 3.3 | ||||
Financing Receivable, Originated Four Years before Latest Fiscal Year | 24.0 | 0.0 | ||||
Financing Receivable, Originated Three Years before Latest Fiscal Year | 0.0 | 24.0 | ||||
Financing Receivable, Originated Two Years before Latest Fiscal Year | 0.0 | 0.0 | ||||
Financing Receivable, Originated in Fiscal Year before Latest Fiscal Year | 0.0 | 0.0 | ||||
Financing Receivable, Originated in Current Fiscal Year | 0.0 | 0.0 | ||||
Financing Receivable, before Allowance for Credit Loss | 30.1 | 27.3 | ||||
A Credit Rating | ||||||
Mortgage Loans on Real Estate | ||||||
Mortgage Loans, Carrying Amount | 695.5 | 709.6 | ||||
A Credit Rating | Commercial Real Estate | ||||||
Mortgage Loans on Real Estate | ||||||
Financing Receivable, Originated Five or More Years before Latest Fiscal Year | 453.3 | 414.6 | ||||
Financing Receivable, Originated Four Years before Latest Fiscal Year | 78.0 | 68.0 | ||||
Financing Receivable, Originated Three Years before Latest Fiscal Year | 43.2 | 71.1 | ||||
Financing Receivable, Originated Two Years before Latest Fiscal Year | 17.3 | 28.9 | ||||
Financing Receivable, Originated in Fiscal Year before Latest Fiscal Year | 80.8 | 17.6 | ||||
Financing Receivable, Originated in Current Fiscal Year | 24.2 | 110.6 | ||||
Financing Receivable, before Allowance for Credit Loss | 696.8 | 710.8 | ||||
BBB Credit Rating | ||||||
Mortgage Loans on Real Estate | ||||||
Mortgage Loans, Carrying Amount | 1,730.6 | 1,802.6 | ||||
BBB Credit Rating | Commercial Real Estate | ||||||
Mortgage Loans on Real Estate | ||||||
Financing Receivable, Originated Five or More Years before Latest Fiscal Year | 676.6 | 561.2 | ||||
Financing Receivable, Originated Four Years before Latest Fiscal Year | 270.7 | 227.3 | ||||
Financing Receivable, Originated Three Years before Latest Fiscal Year | 303.6 | 283.3 | ||||
Financing Receivable, Originated Two Years before Latest Fiscal Year | 153.6 | 331.9 | ||||
Financing Receivable, Originated in Fiscal Year before Latest Fiscal Year | 277.4 | 163.1 | ||||
Financing Receivable, Originated in Current Fiscal Year | 55.7 | 242.6 | ||||
Financing Receivable, before Allowance for Credit Loss | 1,737.6 | 1,809.4 | ||||
BB Credit Rating | ||||||
Mortgage Loans on Real Estate | ||||||
Mortgage Loans, Carrying Amount | 20.2 | 20.9 | ||||
BB Credit Rating | Commercial Real Estate | ||||||
Mortgage Loans on Real Estate | ||||||
Financing Receivable, Originated Five or More Years before Latest Fiscal Year | 14.7 | 5.0 | ||||
Financing Receivable, Originated Four Years before Latest Fiscal Year | 5.9 | 10.2 | ||||
Financing Receivable, Originated Three Years before Latest Fiscal Year | 0.0 | 6.0 | ||||
Financing Receivable, Originated Two Years before Latest Fiscal Year | 0.0 | 0.0 | ||||
Financing Receivable, Originated in Fiscal Year before Latest Fiscal Year | 0.0 | 0.0 | ||||
Financing Receivable, Originated in Current Fiscal Year | 0.0 | 0.0 | ||||
Financing Receivable, before Allowance for Credit Loss | $ 20.6 | $ 21.2 |
Mortgage Loans, Allowance for Credit Losses Rollforward (Details) - Commercial Real Estate - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
|
Financing Receivable, Allowance for Credit Loss Rollforward, Mortgage Loans | ||||
Financing Receivable, Allowance for Credit Loss, Beginning Balance | $ 8.3 | |||
Financing Receivable, Allowance for Credit Loss, Ending Balance | $ 8.7 | 8.7 | ||
Loan to Value Ratio Below or Equal to 65 Percent | ||||
Financing Receivable, Allowance for Credit Loss Rollforward, Mortgage Loans | ||||
Financing Receivable, Allowance for Credit Loss, Beginning Balance | 2.3 | $ 3.2 | 2.6 | $ 3.4 |
Current Period Provisions | 0.2 | 0.0 | (0.1) | (0.2) |
Write-offs | 0.0 | 0.0 | 0.0 | 0.0 |
Recoveries | 0.0 | 0.0 | 0.0 | 0.0 |
Financing Receivable, Allowance for Credit Loss, Ending Balance | 2.5 | 3.2 | 2.5 | 3.2 |
Loan To Value Ratio Above 65 To 75 Percent | ||||
Financing Receivable, Allowance for Credit Loss Rollforward, Mortgage Loans | ||||
Financing Receivable, Allowance for Credit Loss, Beginning Balance | 4.8 | 6.2 | 4.7 | 7.3 |
Current Period Provisions | 0.4 | 0.0 | 0.5 | (1.1) |
Write-offs | 0.0 | 0.0 | 0.0 | 0.0 |
Recoveries | 0.0 | 0.0 | 0.0 | 0.0 |
Financing Receivable, Allowance for Credit Loss, Ending Balance | 5.2 | 6.2 | 5.2 | 6.2 |
Loan To Value Ratio Above 75 To 85 Percent | ||||
Financing Receivable, Allowance for Credit Loss Rollforward, Mortgage Loans | ||||
Financing Receivable, Allowance for Credit Loss, Beginning Balance | 0.9 | 1.5 | 0.7 | 1.3 |
Current Period Provisions | (0.2) | (0.1) | 0.0 | 0.1 |
Write-offs | 0.0 | 0.0 | 0.0 | 0.0 |
Recoveries | 0.0 | 0.0 | 0.0 | 0.0 |
Financing Receivable, Allowance for Credit Loss, Ending Balance | 0.7 | 1.4 | 0.7 | 1.4 |
Loan To Value Ratio Above 85 Percent | ||||
Financing Receivable, Allowance for Credit Loss Rollforward, Mortgage Loans | ||||
Financing Receivable, Allowance for Credit Loss, Beginning Balance | 0.4 | 0.5 | 0.3 | 1.1 |
Current Period Provisions | (0.1) | 0.0 | 0.0 | (0.6) |
Write-offs | 0.0 | 0.0 | 0.0 | 0.0 |
Recoveries | 0.0 | 0.0 | 0.0 | 0.0 |
Financing Receivable, Allowance for Credit Loss, Ending Balance | 0.3 | 0.5 | 0.3 | 0.5 |
Loan to Value Ratio Total | ||||
Financing Receivable, Allowance for Credit Loss Rollforward, Mortgage Loans | ||||
Financing Receivable, Allowance for Credit Loss, Beginning Balance | 8.4 | 11.4 | 8.3 | 13.1 |
Current Period Provisions | 0.3 | (0.1) | 0.4 | (1.8) |
Write-offs | 0.0 | 0.0 | 0.0 | 0.0 |
Recoveries | 0.0 | 0.0 | 0.0 | 0.0 |
Financing Receivable, Allowance for Credit Loss, Ending Balance | $ 8.7 | $ 11.3 | $ 8.7 | $ 11.3 |
Investments Remaining Contractual Maturity of Secruity Lending Agreements (Details) - Overnight and Continuous - USD ($) $ in Millions |
Sep. 30, 2022 |
Dec. 31, 2021 |
---|---|---|
Transfer of Certain Financial Assets Accounted for as Secured Borrowings | ||
Securities Loaned, Including Not Subject to Master Netting Arrangement and Assets other than Securities Transferred | $ 100.1 | $ 94.8 |
Securities Loaned and Securities Sold under Agreement to Repurchase, Gross Including Not Subject to Master Netting Arrangement | 100.1 | 94.8 |
Secured Borrowings, Gross, Difference, Amount | 0.0 | 0.0 |
US Treasury and Government | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings | ||
Securities Loaned, Including Not Subject to Master Netting Arrangement and Assets other than Securities Transferred | 0.0 | 0.1 |
States, Municipalities, and Political Subdivisions | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings | ||
Securities Loaned, Including Not Subject to Master Netting Arrangement and Assets other than Securities Transferred | 3.4 | 0.1 |
Public Utilities | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings | ||
Securities Loaned, Including Not Subject to Master Netting Arrangement and Assets other than Securities Transferred | 8.6 | 3.1 |
All Other Corporate Bonds | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings | ||
Securities Loaned, Including Not Subject to Master Netting Arrangement and Assets other than Securities Transferred | $ 88.1 | $ 91.5 |
Investments Federal Home Loan Bank Carrying Amount, Collateral Posted and Advances Received (Details) - USD ($) $ in Millions |
Sep. 30, 2022 |
Dec. 31, 2021 |
---|---|---|
Federal Home Loan Bank Carrying Value of Common Stock, Collateral Posted and Advances | ||
Federal Home Loan Bank Common Stock | $ 17.3 | $ 22.1 |
Federal Home Loan Bank, Advances | 118.5 | 160.9 |
Federal Home Loan Bank, Collateral Posted to FHLB | 1,355.2 | 1,716.1 |
Fixed Maturity Securities | ||
Federal Home Loan Bank Carrying Value of Common Stock, Collateral Posted and Advances | ||
Federal Home Loan Bank, Collateral Posted to FHLB | 546.8 | 786.1 |
Commercial Mortgage Loans | ||
Federal Home Loan Bank Carrying Value of Common Stock, Collateral Posted and Advances | ||
Federal Home Loan Bank, Collateral Posted to FHLB | $ 808.4 | $ 930.0 |
Investments Schedule of Financial Instrument and Derivative Offsetting (Details) - USD ($) $ in Millions |
Sep. 30, 2022 |
Dec. 31, 2021 |
---|---|---|
Offsetting Derivative Assets | ||
Derivative Asset, Fair Value, Gross Asset | $ 128.1 | $ 39.5 |
Derivative Liabilities Offsetting Derivative Assets in Balance Sheet | 0.0 | 0.0 |
Net Derivative Assets Reported in Balance Sheet | 128.1 | 39.5 |
Securities Received as Collateral on Derivative Assets | (45.5) | (9.8) |
Cash Collateral from Counterparties | (80.9) | (28.4) |
Derivative Assets Net of Collateral | 1.7 | 1.3 |
Offsetting Securities Borrowed | ||
Gross Securities Borrowed | 100.1 | 94.8 |
Liabilities Offsetting Securities Borrowed in Balance Sheet | 0.0 | 0.0 |
Net Securities Borrowed Reported in Balance Sheet | 100.1 | 94.8 |
Securities Received as Collateral on Securities Borrowed | (100.1) | (94.8) |
Cash Received as Collateral on Securities Borrowed | 0.0 | 0.0 |
Securities Borrowed Net of Collateral | 0.0 | 0.0 |
Offsetting Financial Assets | ||
Gross Financial Assets | 359.1 | 323.2 |
Financial Liabilities Offsetting Financial Assets in Balance Sheet | 0.0 | 0.0 |
Net Financial Assets Reported in Balance Sheet | 359.1 | 323.2 |
Securities Received as Collateral on Financial Assets | (176.4) | (198.7) |
Cash Received as Collateral on Financial Assets | (181.0) | (123.2) |
Financial Assets Net of Collateral | 1.7 | 1.3 |
Offsetting Derivative Liabilities | ||
Net Derivative Liabilities Reported in Balance Sheet | 75.8 | 65.1 |
Offsetting Securities Loaned | ||
Gross Securities Loaned | 231.0 | 283.7 |
Assets Offsetting Securities Loaned in Balance Sheet | 0.0 | 0.0 |
Net Securities Loaned Reported in Balance Sheet | 231.0 | 283.7 |
Securities Given as Collateral on Securities Loaned | (130.9) | (188.9) |
Cash Given as Collateral on Securities Loaned | (100.1) | (94.8) |
Securities Loaned Net of Collateral | 0.0 | 0.0 |
Offsetting Financial Liabilities | ||
Gross Financial Liability | 156.5 | 129.8 |
Financial Assets Offsetting Financial Liabilities in Balance Sheet | 0.0 | 0.0 |
Net Financial Liabilities Reported in Balance Sheet | 156.5 | 129.8 |
Securities Given as Collateral on Financial Liabilities | (154.7) | (128.8) |
Cash Given as Collateral on Financial Liabilities | 0.0 | 0.0 |
Financial Liabilities Net of Collateral | 1.8 | 1.0 |
Over the Counter | ||
Offsetting Derivative Liabilities | ||
Gross Derivative Liability | 56.4 | 35.0 |
Derivative Assets Offsetting Derivative Liabilities in Balance Sheet | 0.0 | 0.0 |
Net Derivative Liabilities Reported in Balance Sheet | 56.4 | 35.0 |
Securities Given as Collateral on Derivative Liabilities | (54.6) | (34.0) |
Cash Collateral to counterparties | 0.0 | 0.0 |
Derivative Liabilities Net of Collateral | $ 1.8 | $ 1.0 |
Investments Investment Income (Detail) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||||
---|---|---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
|||
Net Investment Income | ||||||
Investment Income, Interest and Dividend | $ 524.6 | $ 564.3 | $ 1,635.8 | $ 1,697.9 | ||
Less Investment Expenses | 10.0 | 10.8 | 29.1 | 26.1 | ||
Less Investment Income on PFA Assets | 3.0 | 3.3 | 8.9 | 9.4 | ||
Net Investment Income | 511.6 | 550.2 | 1,597.8 | 1,662.4 | ||
Fixed Maturity Securities | ||||||
Net Investment Income | ||||||
Investment Income, Interest and Dividend | 456.7 | 478.5 | 1,379.9 | 1,419.7 | ||
Derivatives | ||||||
Net Investment Income | ||||||
Investment Income, Interest and Dividend | 14.9 | 15.2 | 45.1 | 49.1 | ||
Mortgage Loans | ||||||
Net Investment Income | ||||||
Investment Income, Interest and Dividend | 24.7 | 26.5 | 77.6 | 77.5 | ||
Policy Loans | ||||||
Net Investment Income | ||||||
Investment Income, Interest and Dividend | 5.1 | 4.9 | 14.8 | 14.7 | ||
Perpetual Preferred Securities | ||||||
Net Investment Income | ||||||
Investment Income, Interest and Dividend | [1] | 1.1 | 0.4 | 3.2 | 6.0 | |
Unrealized Gain (Loss) on Investments | 0.5 | (0.2) | 1.5 | 4.0 | ||
Private Equity Partnerships | ||||||
Net Investment Income | ||||||
Investment Income, Interest and Dividend | 12.6 | 38.3 | 98.6 | 126.1 | ||
Other Long-term Investments | ||||||
Net Investment Income | ||||||
Investment Income, Interest and Dividend | 3.6 | 0.3 | 7.4 | 3.7 | ||
Short-term Investments | ||||||
Net Investment Income | ||||||
Investment Income, Interest and Dividend | $ 5.9 | $ 0.2 | $ 9.2 | $ 1.1 | ||
|
Investment Gains and Losses Reported in Consolidated Statements of Income (Detail) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | |||||
---|---|---|---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
||||
Fixed Maturity Securities | |||||||
Gross Gains on Sales | $ 0.0 | $ 1.3 | $ 0.8 | [1] | $ 74.9 | ||
Gross Losses on Sales | (13.4) | (5.4) | (26.4) | (9.0) | |||
Credit Losses | (0.5) | 0.0 | (4.6) | (9.3) | |||
Mortgage Loans and Other Invested Assets | |||||||
Gross Gains on Sales | 0.0 | 1.5 | 1.4 | 5.0 | |||
Credit Losses | 0.4 | 0.0 | 0.3 | (1.6) | |||
All other investment gains and losses | |||||||
Embedded Derivative in Modified Coinsurance Arrangement | 14.9 | 2.6 | 10.7 | 21.2 | |||
All Other Derivatives | (0.9) | 0.7 | 4.6 | 2.3 | |||
Foreign Currency Transactions | (4.1) | (0.8) | (8.5) | (1.3) | |||
Net Investment Gain (Loss) | $ (4.4) | $ (0.1) | $ (22.3) | 85.4 | |||
Closed Block Individual Disability Reinsurance Transaction | Phase 2 | |||||||
All other investment gains and losses | |||||||
Net Investment Gain (Loss) | $ 67.6 | ||||||
|
Investments - Additional Information (Detail) |
3 Months Ended | 9 Months Ended | |||
---|---|---|---|---|---|
Sep. 30, 2022
USD ($)
Integer
|
Sep. 30, 2021
USD ($)
Integer
|
Sep. 30, 2022
USD ($)
Integer
|
Sep. 30, 2021
USD ($)
Integer
|
Dec. 31, 2021
USD ($)
|
|
Schedule of Investments | |||||
Other Long-term Investments | $ 1,430,400,000 | $ 1,430,400,000 | $ 1,203,000,000 | ||
Unfunded Commitments | 700,000 | 700,000 | |||
Accrued Investment Income | 717,200,000 | 717,200,000 | 602,700,000 | ||
Loan Foreclosure Expense | 0 | $ 0 | 0 | $ 0 | |
Commitments to Fund Commercial Mortgage Loans | 9,000,000 | 9,000,000 | |||
Real Estate Held-for-sale | $ 44,300,000 | $ 44,300,000 | 45,000,000.0 | ||
Repurchase agreements - Typical Days outstanding | 30 | ||||
Minimum percent of the fair value of securities loaned or securities purchased under repurchase agreements be maintained as collateral | 102.00% | 102.00% | |||
Gross Securities Loaned | $ 231,000,000 | $ 231,000,000 | 283,700,000 | ||
Gross Securities Borrowed | 100,100,000 | 100,100,000 | 94,800,000 | ||
Outstanding Repurchase Agreements | 0 | 0 | 0 | ||
Off Balance Sheet Amount | |||||
Schedule of Investments | |||||
Securities Received as Collateral | 139,100,000 | 139,100,000 | 198,600,000 | ||
Cash Collateral for Borrowed Securities | 100,100,000 | 100,100,000 | 94,800,000 | ||
Commercial Real Estate | |||||
Schedule of Investments | |||||
Financing Receivable, before Allowance for Credit Loss, Mortgage Loans | 2,485,100,000 | 2,485,100,000 | 2,568,700,000 | ||
Financing Receivable, Allowance for Credit Losses, Mortgage Loans | 8,700,000 | 8,700,000 | 8,300,000 | ||
Accrued Investment Income | $ 7,700,000 | $ 7,700,000 | 8,100,000 | ||
Financing Receivable, Modifications, Number of Contracts | Integer | 0 | 0 | 0 | 0 | |
Financing Receivable, Recorded Investment, 90 Days Past Due and Still Accruing | $ 0 | $ 0 | 0 | ||
Impaired Financing Receivable, with No Related Allowance, Average Recorded Investment | 0 | $ 0 | 0 | $ 0 | |
Unfunded Mortgage Loan Commitments | |||||
Schedule of Investments | |||||
Allowance for Credit Losses, Unfunded Mortgage Loan Commitments | 100,000 | 100,000 | 100,000 | ||
Variable Interest Entity, Not Primary Beneficiary | |||||
Schedule of Investments | |||||
Other Long-term Investments | 1,127,600,000 | 1,127,600,000 | 987,900,000 | ||
Tax Credit Partnership | Variable Interest Entity, Not Primary Beneficiary | |||||
Schedule of Investments | |||||
Other Long-term Investments | 3,000,000 | 3,000,000 | 9,300,000 | ||
Equity Method Investments | Variable Interest Entity, Not Primary Beneficiary | |||||
Schedule of Investments | |||||
Other Long-term Investments | 1,124,600,000 | 1,124,600,000 | $ 978,600,000 | ||
Private Placement Fixed Maturity | |||||
Schedule of Investments | |||||
Fair Value Disclosure, off-Balance-Sheet Risks, Amount, Liability | $ 30,500,000 | $ 30,500,000 | |||
External Credit Rating, Investment Grade | |||||
Schedule of Investments | |||||
Number of Fixed Maturity Securities in an Unrealized Loss Position | 892 | 892 | |||
Number of Fixed Maturity Securities in an Unrealized Loss Position Continuously for Over One Year | 114 | 114 | |||
External Credit Rating, Below-Investment-Grade | |||||
Schedule of Investments | |||||
Number of Fixed Maturity Securities in an Unrealized Loss Position | 118 | 118 | |||
Number of Fixed Maturity Securities in an Unrealized Loss Position Continuously for Over One Year | 11 | 11 |
Derivative Financial Instruments Nature and Amount of Collateral Received From and Posted To Our Derivative Counterparties (Details) - USD ($) $ in Millions |
Sep. 30, 2022 |
Dec. 31, 2021 |
---|---|---|
Derivative | ||
Cash Collateral from Counterparties | $ 80.9 | $ 28.4 |
Carrying Value of Fixed Maturity Securities Posted as Collateral to Counterparties | 45.5 | 9.8 |
Derivative Asset, Fair Value, Amount Offset Against Collateral | 95.4 | 32.0 |
Derivative Liability, Subject to Master Netting Arrangement, Deduction of Financial Instrument Not Offset | 26.8 | 27.6 |
Cash | ||
Derivative | ||
Cash Collateral from Counterparties | 81.7 | 32.0 |
Cash Collateral Posted to Counterparties | 6.1 | 0.0 |
Fixed Maturity Securities | ||
Derivative | ||
Carrying Value of Fixed Maturity Securities Posted as Collateral to Counterparties | 13.7 | 0.0 |
FMS Collateral Posted to Counterparties | $ 20.7 | $ 27.6 |
Derivative Financial Instruments Fair Value Hedges Carrying Amount of Hedged Assets and Liabilities and Cumulative Basis Adjustments (Details) - Interest Rate Swaps - Receive Fixed/Pay Fixed - Designated as Hedging Instrument - Fair Value Hedging - Fixed Maturity Securities - USD ($) $ in Millions |
Sep. 30, 2022 |
Dec. 31, 2021 |
---|---|---|
Derivative Instruments and Hedging Activities Disclosures | ||
Hedged Asset, Fair Value Hedge | $ 346.6 | $ 466.3 |
Hedged Asset, Fair Value Hedge, Cumulative Increase | $ (60.6) | $ 2.0 |
Location and Fair Values of Derivative Financial Instruments (Detail) - USD ($) $ in Millions |
Sep. 30, 2022 |
Dec. 31, 2021 |
---|---|---|
Derivative | ||
Derivative, Notional Amount | $ 1,672.9 | $ 970.5 |
Asset Derivatives Fair Value | 128.1 | 39.5 |
Other Long-term Investments | ||
Derivative | ||
Asset Derivatives Fair Value | 128.1 | 39.5 |
Other Liabilities | ||
Derivative | ||
Liability Derivatives Fair Value | 75.8 | 65.1 |
Designated as Hedging Instrument | ||
Derivative | ||
Derivative, Notional Amount | 1,400.2 | 679.8 |
Designated as Hedging Instrument | Cash Flow Hedging | ||
Derivative | ||
Derivative, Notional Amount | 842.0 | |
Designated as Hedging Instrument | Forwards | Cash Flow Hedging | ||
Derivative | ||
Derivative, Notional Amount | 664.0 | |
Designated as Hedging Instrument | Interest Rate Swaps | Cash Flow Hedging | ||
Derivative | ||
Derivative, Notional Amount | 178.0 | 181.3 |
Designated as Hedging Instrument | Interest Rate Swaps | Fair Value Hedging | ||
Derivative | ||
Derivative, Notional Amount | 558.2 | 498.5 |
Designated as Hedging Instrument | Other Long-term Investments | ||
Derivative | ||
Asset Derivatives Fair Value | 120.8 | 38.1 |
Designated as Hedging Instrument | Other Long-term Investments | Cash Flow Hedging | ||
Derivative | ||
Asset Derivatives Fair Value | 22.4 | |
Designated as Hedging Instrument | Other Long-term Investments | Forwards | Cash Flow Hedging | ||
Derivative | ||
Asset Derivatives Fair Value | 0.0 | |
Designated as Hedging Instrument | Other Long-term Investments | Interest Rate Swaps | Cash Flow Hedging | ||
Derivative | ||
Asset Derivatives Fair Value | 22.4 | 16.2 |
Designated as Hedging Instrument | Other Long-term Investments | Interest Rate Swaps | Fair Value Hedging | ||
Derivative | ||
Asset Derivatives Fair Value | 98.4 | 21.9 |
Designated as Hedging Instrument | Other Liabilities | ||
Derivative | ||
Liability Derivatives Fair Value | 37.0 | 12.7 |
Designated as Hedging Instrument | Other Liabilities | Cash Flow Hedging | ||
Derivative | ||
Liability Derivatives Fair Value | 31.2 | |
Designated as Hedging Instrument | Other Liabilities | Forwards | Cash Flow Hedging | ||
Derivative | ||
Liability Derivatives Fair Value | 29.0 | |
Designated as Hedging Instrument | Other Liabilities | Interest Rate Swaps | Cash Flow Hedging | ||
Derivative | ||
Liability Derivatives Fair Value | 2.2 | 7.0 |
Designated as Hedging Instrument | Other Liabilities | Interest Rate Swaps | Fair Value Hedging | ||
Derivative | ||
Liability Derivatives Fair Value | 5.8 | 5.7 |
Not Designated as Hedging Instrument | ||
Derivative | ||
Derivative, Notional Amount | 272.7 | 290.7 |
Not Designated as Hedging Instrument | Credit Default Swaps | ||
Derivative | ||
Derivative, Notional Amount | 11.6 | |
Not Designated as Hedging Instrument | Forwards | ||
Derivative | ||
Derivative, Notional Amount | 54.3 | 41.7 |
Not Designated as Hedging Instrument | Interest Rate Swaps | ||
Derivative | ||
Derivative, Notional Amount | 148.2 | 148.2 |
Not Designated as Hedging Instrument | Total Return Swap | ||
Derivative | ||
Derivative, Notional Amount | 70.2 | 89.2 |
Not Designated as Hedging Instrument | Embedded Derivative in Modified Coinsurance Arrangement | ||
Derivative | ||
Derivative, Notional Amount | 0.0 | 0.0 |
Not Designated as Hedging Instrument | Other Long-term Investments | ||
Derivative | ||
Asset Derivatives Fair Value | 7.3 | 1.4 |
Not Designated as Hedging Instrument | Other Long-term Investments | Credit Default Swaps | ||
Derivative | ||
Asset Derivatives Fair Value | 0.0 | |
Not Designated as Hedging Instrument | Other Long-term Investments | Forwards | ||
Derivative | ||
Asset Derivatives Fair Value | 7.3 | 0.0 |
Not Designated as Hedging Instrument | Other Long-term Investments | Interest Rate Swaps | ||
Derivative | ||
Asset Derivatives Fair Value | 0.0 | 1.4 |
Not Designated as Hedging Instrument | Other Long-term Investments | Total Return Swap | ||
Derivative | ||
Asset Derivatives Fair Value | 0.0 | 0.0 |
Not Designated as Hedging Instrument | Other Long-term Investments | Embedded Derivative in Modified Coinsurance Arrangement | ||
Derivative | ||
Asset Derivatives Fair Value | 0.0 | 0.0 |
Not Designated as Hedging Instrument | Other Liabilities | ||
Derivative | ||
Liability Derivatives Fair Value | 38.8 | 52.4 |
Not Designated as Hedging Instrument | Other Liabilities | Credit Default Swaps | ||
Derivative | ||
Liability Derivatives Fair Value | 0.0 | |
Not Designated as Hedging Instrument | Other Liabilities | Forwards | ||
Derivative | ||
Liability Derivatives Fair Value | 0.0 | 0.0 |
Not Designated as Hedging Instrument | Other Liabilities | Interest Rate Swaps | ||
Derivative | ||
Liability Derivatives Fair Value | 19.4 | 22.3 |
Not Designated as Hedging Instrument | Other Liabilities | Total Return Swap | ||
Derivative | ||
Liability Derivatives Fair Value | 0.0 | 0.0 |
Not Designated as Hedging Instrument | Other Liabilities | Embedded Derivative in Modified Coinsurance Arrangement | ||
Derivative | ||
Liability Derivatives Fair Value | $ 19.4 | $ 30.1 |
Derivative Financial Instruments Location of Gains and Losses Designated as Hedging Instruments, Consolidated Statements of Income (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
|
Derivative Instruments, Gain (Loss) | ||||
Net Investment Income | $ 511.6 | $ 550.2 | $ 1,597.8 | $ 1,662.4 |
Net Investment Gain (Loss) | (4.4) | (0.1) | (22.3) | 85.4 |
Interest and Debt Expense | 47.0 | 44.7 | 141.3 | 134.4 |
Derivative, Gain (Loss) on Derivative, Net | 0.9 | (0.7) | (4.6) | (2.3) |
Designated as Hedging Instrument | Interest Rate Swaps | Net Investment Income | Cash Flow Hedging | ||||
Derivative Instruments, Gain (Loss) | ||||
Net Investment Income | 50.2 | 63.4 | 150.9 | 170.2 |
Derivative, Gain (Loss) on Derivative, Net | 14.1 | 14.6 | 40.5 | 46.6 |
Designated as Hedging Instrument | Interest Rate Swaps | Net Investment Gain (Loss) | Cash Flow Hedging | ||||
Derivative Instruments, Gain (Loss) | ||||
Net Investment Gain (Loss) | 0.0 | 0.3 | 0.0 | 2.7 |
Derivative, Gain (Loss) on Derivative, Net | 0.0 | 0.2 | 0.0 | 2.0 |
Designated as Hedging Instrument | Interest Rate Swaps | Interest and Debt Expense | Cash Flow Hedging | ||||
Derivative Instruments, Gain (Loss) | ||||
Interest and Debt Expense | 0.7 | 7.3 | 2.1 | 21.9 |
Derivative, Gain (Loss) on Derivative, Net | 0.0 | 0.1 | 0.0 | 0.3 |
Designated as Hedging Instrument | Foreign Exchange Contracts | Net Investment Income | Cash Flow Hedging | ||||
Derivative Instruments, Gain (Loss) | ||||
Net Investment Income | 2.7 | 2.9 | 8.3 | 10.1 |
Derivative, Gain (Loss) on Derivative, Net | (1.5) | 0.3 | (0.9) | 1.2 |
Designated as Hedging Instrument | Foreign Exchange Contracts | Net Investment Income | Fair Value Hedging | ||||
Derivative Instruments, Gain (Loss) | ||||
Net Investment Income | 2.9 | 2.5 | 8.7 | 7.2 |
Derivative, Gain (Loss) on Derivative, Net | 1.0 | 0.9 | 5.1 | 3.1 |
Designated as Hedging Instrument | Foreign Exchange Contracts | Net Investment Gain (Loss) | Cash Flow Hedging | ||||
Derivative Instruments, Gain (Loss) | ||||
Net Investment Gain (Loss) | (0.5) | 0.0 | (0.5) | 0.0 |
Derivative, Gain (Loss) on Derivative, Net | 0.0 | (0.1) | 0.0 | (0.1) |
Designated as Hedging Instrument | Foreign Exchange Contracts | Net Investment Gain (Loss) | Fair Value Hedging | ||||
Derivative Instruments, Gain (Loss) | ||||
Net Investment Gain (Loss) | (29.6) | (10.4) | (62.5) | (18.8) |
Derivative, Gain (Loss) on Derivative, Net | 29.6 | 10.4 | 62.5 | 18.8 |
Designated as Hedging Instrument | Foreign Exchange Contracts | Interest and Debt Expense | Cash Flow Hedging | ||||
Derivative Instruments, Gain (Loss) | ||||
Interest and Debt Expense | 0.0 | 0.0 | 0.0 | 0.0 |
Derivative, Gain (Loss) on Derivative, Net | 0.0 | 0.0 | 0.0 | 0.0 |
Designated as Hedging Instrument | Foreign Exchange Contracts | Interest and Debt Expense | Fair Value Hedging | ||||
Derivative Instruments, Gain (Loss) | ||||
Interest and Debt Expense | 0.0 | 0.0 | 0.0 | 0.0 |
Derivative, Gain (Loss) on Derivative, Net | 0.0 | 0.0 | 0.0 | 0.0 |
Designated as Hedging Instrument | Forwards | Net Investment Income | Cash Flow Hedging | ||||
Derivative Instruments, Gain (Loss) | ||||
Net Investment Income | 0.2 | 0.0 | 0.2 | 0.0 |
Derivative, Gain (Loss) on Derivative, Net | 0.0 | 0.0 | 0.0 | 0.0 |
Designated as Hedging Instrument | Forwards | Net Investment Gain (Loss) | Cash Flow Hedging | ||||
Derivative Instruments, Gain (Loss) | ||||
Net Investment Gain (Loss) | 0.0 | 0.0 | 0.0 | 0.0 |
Derivative, Gain (Loss) on Derivative, Net | 0.0 | 0.0 | 0.0 | 0.0 |
Designated as Hedging Instrument | Forwards | Interest and Debt Expense | Cash Flow Hedging | ||||
Derivative Instruments, Gain (Loss) | ||||
Interest and Debt Expense | 0.0 | 0.0 | 0.0 | 0.0 |
Derivative, Gain (Loss) on Derivative, Net | $ 0.0 | $ 0.0 | $ 0.0 | $ 0.0 |
Location of Gains and Losses on Derivative Instruments Designated as Cash Flow Hedging Instruments (Detail) - Designated as Hedging Instrument - Cash Flow Hedging - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
|
Derivative Instruments, Gain (Loss) | ||||
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax | $ (27.2) | $ 4.4 | $ (20.6) | $ 3.3 |
Forwards | ||||
Derivative Instruments, Gain (Loss) | ||||
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax | (34.3) | (0.2) | (32.0) | (0.2) |
Foreign Exchange Contracts | ||||
Derivative Instruments, Gain (Loss) | ||||
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax | $ 7.1 | $ 4.6 | $ 11.4 | $ 3.5 |
Gains and Losses on Derivatives Not Designated as Hedging Instruments (Detail) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
|
Derivative Instruments, Gain (Loss) | ||||
Net Gain (Loss) on Derivatives | $ (0.9) | $ 0.7 | $ 4.6 | $ 2.3 |
Not Designated as Hedging Instrument | ||||
Derivative Instruments, Gain (Loss) | ||||
Net Gain (Loss) on Derivatives | 14.0 | 3.3 | 15.3 | 23.5 |
Credit Default Swaps | Not Designated as Hedging Instrument | ||||
Derivative Instruments, Gain (Loss) | ||||
Net Gain (Loss) on Derivatives | 0.0 | (0.1) | 0.0 | (0.3) |
Foreign Exchange Contracts | Not Designated as Hedging Instrument | ||||
Derivative Instruments, Gain (Loss) | ||||
Net Gain (Loss) on Derivatives | (0.9) | 0.8 | 4.6 | 2.6 |
Embedded Derivative in Modified Coinsurance Arrangement | Not Designated as Hedging Instrument | ||||
Derivative Instruments, Gain (Loss) | ||||
Net Gain (Loss) on Derivatives | 14.9 | 2.6 | 10.7 | 21.2 |
Total Return Swap | Not Designated as Hedging Instrument | ||||
Derivative Instruments, Gain (Loss) | ||||
Net Gain (Loss) on Derivatives | $ 4.3 | $ 0.6 | $ 23.0 | $ (3.1) |
Derivative Financial Instruments - Additional Information (Detail) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | |||
---|---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
Dec. 31, 2021 |
|
Derivative | |||||
Aggregate fair value of all derivative instruments with credit risk-related contingent features in a liability position | $ 56.4 | $ 56.4 | $ 35.0 | ||
Interest Rate Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net | $ 0.6 | ||||
Approximate amount of net deferred gains on derivative instruments expected to be amortized during the next twelve months | 39.2 | ||||
Component of Derivative Gain (Loss) Excluded from the Assessment of Hedge Effectiveness | 0.2 | $ 0.4 | 13.9 | 10.6 | |
Discontinued Hedge Accounting Due to Instrument No Longer Qualifying as Fair Value Hedge | 0.0 | $ 0.0 | 0.0 | 0.0 | |
Derivative, Notional Amount | 1,672.9 | 1,672.9 | 970.5 | ||
Derivative Asset, Fair Value, Gross Asset | 128.1 | 128.1 | 39.5 | ||
Designated as Hedging Instrument | |||||
Derivative | |||||
Derivative, Notional Amount | 1,400.2 | 1,400.2 | 679.8 | ||
Not Designated as Hedging Instrument | |||||
Derivative | |||||
Derivative, Notional Amount | 272.7 | 272.7 | 290.7 | ||
Cash Flow Hedging | Designated as Hedging Instrument | |||||
Derivative | |||||
Derivative, Notional Amount | 842.0 | 842.0 | |||
Interest Rate Swaps | Not Designated as Hedging Instrument | |||||
Derivative | |||||
Derivative, Notional Amount | 148.2 | 148.2 | 148.2 | ||
Interest Rate Swaps | Cash Flow Hedging | Designated as Hedging Instrument | |||||
Derivative | |||||
Derivative, Notional Amount | 178.0 | 178.0 | 181.3 | ||
Interest Rate Swaps | Fair Value Hedging | Designated as Hedging Instrument | |||||
Derivative | |||||
Derivative, Notional Amount | 558.2 | 558.2 | 498.5 | ||
Credit Default Swap | Credit Default Swaps | Not Designated as Hedging Instrument | |||||
Derivative | |||||
Derivative, Notional Amount | 0.0 | 0.0 | 11.6 | ||
Forwards | Not Designated as Hedging Instrument | |||||
Derivative | |||||
Derivative, Notional Amount | 54.3 | 54.3 | 41.7 | ||
Forwards | Cash Flow Hedging | Designated as Hedging Instrument | |||||
Derivative | |||||
Derivative, Notional Amount | 664.0 | 664.0 | |||
Notional Amount Of Derivatives Additions | 500.0 | 679.0 | 250.0 | ||
Notional Amount Of Derivatives Terminations | 250.0 | ||||
Derivative, Loss on Derivative | $ 1.2 | ||||
Total Return Swap | Not Designated as Hedging Instrument | |||||
Derivative | |||||
Derivative, Notional Amount | 70.2 | 70.2 | 89.2 | ||
Embedded Derivative in Modified Coinsurance Arrangement | Not Designated as Hedging Instrument | |||||
Derivative | |||||
Derivative, Notional Amount | 0.0 | 0.0 | 0.0 | ||
Receive Fixed/Pay Fixed | Interest Rate Swaps | Not Designated as Hedging Instrument | |||||
Derivative | |||||
Derivative, Notional Amount | 148.2 | 148.2 | 148.2 | ||
Receive Fixed/Pay Fixed | Interest Rate Swaps | Cash Flow Hedging | Designated as Hedging Instrument | |||||
Derivative | |||||
Derivative, Notional Amount | 178.0 | 178.0 | 181.3 | ||
Receive Fixed/Pay Fixed | Interest Rate Swaps | Fair Value Hedging | Designated as Hedging Instrument | |||||
Derivative | |||||
Derivative, Notional Amount | 558.2 | 558.2 | 498.5 | ||
Credit Exposure | |||||
Derivative | |||||
Credit Exposure on Derivatives | $ 1.7 | $ 1.7 | $ 1.3 |
Schedule of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
|
Accumulated Other Comprehensive Income (Loss) | ||||
Balance at Beginning of Year | $ (1,772.2) | $ 222.1 | $ 354.1 | $ 374.2 |
Other Comprehensive Income (Loss) Before Reclassifications | (1,366.8) | (104.5) | (3,490.7) | (297.8) |
Amounts Reclassified from Accumulated Other Comprehensive Income or Loss | (4.3) | 3.7 | (1.9) | (37.5) |
Net Other Comprehensive Income (Loss) | (1,362.5) | (108.2) | (3,488.8) | (260.3) |
Balance at End of Period | (3,134.7) | 113.9 | (3,134.7) | 113.9 |
Net Unrealized Gain (Loss) on Securities | ||||
Accumulated Other Comprehensive Income (Loss) | ||||
Balance at Beginning of Year | (1,064.9) | 911.4 | 962.2 | 1,067.7 |
Other Comprehensive Income (Loss) Before Reclassifications | (1,275.5) | (79.3) | (3,315.4) | (295.1) |
Amounts Reclassified from Accumulated Other Comprehensive Income or Loss | (11.1) | (3.9) | (23.9) | (63.4) |
Net Other Comprehensive Income (Loss) | (1,264.4) | (75.4) | (3,291.5) | (231.7) |
Balance at End of Period | (2,329.3) | 836.0 | (2,329.3) | 836.0 |
Net Gain on Hedges | ||||
Accumulated Other Comprehensive Income (Loss) | ||||
Balance at Beginning of Year | 46.4 | 77.5 | 61.8 | 97.8 |
Other Comprehensive Income (Loss) Before Reclassifications | (23.0) | 3.9 | (17.1) | 10.8 |
Amounts Reclassified from Accumulated Other Comprehensive Income or Loss | 9.9 | 11.9 | 31.2 | 39.1 |
Net Other Comprehensive Income (Loss) | (32.9) | (8.0) | (48.3) | (28.3) |
Balance at End of Period | 13.5 | 69.5 | 13.5 | 69.5 |
Foreign Currency Translation Adjustment | ||||
Accumulated Other Comprehensive Income (Loss) | ||||
Balance at Beginning of Year | (366.9) | (244.7) | (273.9) | (261.3) |
Other Comprehensive Income (Loss) Before Reclassifications | (71.1) | (30.5) | (164.1) | (13.9) |
Amounts Reclassified from Accumulated Other Comprehensive Income or Loss | 0.0 | 0.0 | 0.0 | 0.0 |
Net Other Comprehensive Income (Loss) | (71.1) | (30.5) | (164.1) | (13.9) |
Balance at End of Period | (438.0) | (275.2) | (438.0) | (275.2) |
Unrecognized Pension and Postretirement Benefit Costs | ||||
Accumulated Other Comprehensive Income (Loss) | ||||
Balance at Beginning of Year | (386.8) | (522.1) | (396.0) | (530.0) |
Other Comprehensive Income (Loss) Before Reclassifications | 2.8 | 1.4 | 5.9 | 0.4 |
Amounts Reclassified from Accumulated Other Comprehensive Income or Loss | (3.1) | (4.3) | (9.2) | (13.2) |
Net Other Comprehensive Income (Loss) | 5.9 | 5.7 | 15.1 | 13.6 |
Balance at End of Period | $ (380.9) | $ (516.4) | $ (380.9) | $ (516.4) |
Schedule of Components of Unrealized Gain (Loss) on Securities (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
|
Change in Components of Net Unrealized Gain on Securities | ||||
Change in Net Unrealized Gain on Securities | $ (1,925.8) | $ (260.8) | $ (7,500.7) | $ (1,048.0) |
Fixed Maturity Securities | ||||
Change in Components of Net Unrealized Gain on Securities | ||||
Beginning of Period Balance | (1,122.0) | 6,603.1 | 5,949.3 | 7,597.6 |
Change in Net Unrealized Gain on Securities | (2,446.6) | (329.8) | (9,517.9) | (1,324.3) |
End of Period Balance | (3,568.6) | 6,273.3 | (3,568.6) | 6,273.3 |
Deferred Acquisition Costs | ||||
Change in Components of Net Unrealized Gain on Securities | ||||
Beginning of Period Balance | (8.1) | (79.8) | (70.4) | (85.1) |
Change in Net Unrealized Gain on Securities | 21.6 | 6.8 | 83.9 | 12.1 |
End of Period Balance | 13.5 | (73.0) | 13.5 | (73.0) |
Reserve for Future Policy and Contract Benefits | ||||
Change in Components of Net Unrealized Gain on Securities | ||||
Beginning of Period Balance | (104.2) | (5,386.6) | (4,659.5) | (6,225.6) |
Change in Net Unrealized Gain on Securities | 868.5 | 242.7 | 5,423.8 | 1,081.7 |
End of Period Balance | 764.3 | (5,143.9) | 764.3 | (5,143.9) |
Reinsurance Recoverable | ||||
Change in Components of Net Unrealized Gain on Securities | ||||
Beginning of Period Balance | 19.7 | 152.8 | 132.1 | 200.2 |
Change in Net Unrealized Gain on Securities | (44.4) | (14.6) | (156.8) | (62.0) |
End of Period Balance | (24.7) | 138.2 | (24.7) | 138.2 |
Income Tax | ||||
Change in Components of Net Unrealized Gain on Securities | ||||
Beginning of Period Balance | 149.7 | (378.1) | (389.3) | (419.4) |
Change in Net Unrealized Gain on Securities | 336.5 | 19.5 | 875.5 | 60.8 |
End of Period Balance | 486.2 | (358.6) | 486.2 | (358.6) |
Net Unrealized Gain (Loss) on Securities | ||||
Change in Components of Net Unrealized Gain on Securities | ||||
Beginning of Period Balance | (1,064.9) | 911.4 | 962.2 | 1,067.7 |
Change in Net Unrealized Gain on Securities | (1,264.4) | (75.4) | (3,291.5) | (231.7) |
End of Period Balance | $ (2,329.3) | $ 836.0 | $ (2,329.3) | $ 836.0 |
Schedule of Reclassifications Out of Accumulated Other Comprehensive Income (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
|
Reclassification Adjustment out of Accumulated Other Comprehensive Income | ||||
Net Investment Gain (Loss) | $ (4.4) | $ (0.1) | $ (22.3) | $ 85.4 |
Credit Losses on Fixed Matruity Securities | 0.5 | 0.0 | 4.6 | 9.3 |
Benefits and Change in Reserves for Future Benefits | (1,579.3) | (1,753.9) | (5,181.3) | (5,659.2) |
Net Investment Income | 511.6 | 550.2 | 1,597.8 | 1,662.4 |
Other Expenses | (247.3) | (251.5) | (744.4) | (746.8) |
Income Tax Expense (Benefit) | 104.6 | 81.3 | 235.9 | 206.8 |
Net Income | (410.7) | (328.6) | (1,034.6) | (664.5) |
Reclassification out of Accumulated Other Comprehensive Income (Loss) | Net Unrealized Gain (Loss) on Securities | ||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income | ||||
Net Investment Gain (Loss) | (13.4) | (4.9) | (25.6) | 62.8 |
Credit Losses on Fixed Matruity Securities | (0.5) | 0.0 | (4.6) | (9.3) |
Benefits and Change in Reserves for Future Benefits | 0.0 | 0.0 | 0.0 | (133.1) |
Income Before Income Tax | (13.9) | (4.9) | (30.2) | (79.6) |
Income Tax Expense (Benefit) | (2.8) | (1.0) | (6.3) | (16.2) |
Net Income | (11.1) | (3.9) | (23.9) | (63.4) |
Reclassification out of Accumulated Other Comprehensive Income (Loss) | Net Gain on Hedges | ||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income | ||||
Income Before Income Tax | 12.6 | 15.1 | 39.5 | 49.5 |
Income Tax Expense (Benefit) | 2.7 | 3.2 | 8.3 | 10.4 |
Net Income | 9.9 | 11.9 | 31.2 | 39.1 |
Reclassification out of Accumulated Other Comprehensive Income (Loss) | Net Gain on Hedges | Interest Rate Swaps | ||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income | ||||
Net Investment Gain (Loss) | 0.0 | 0.2 | 0.0 | 2.0 |
Net Investment Income | 14.1 | 14.5 | 40.5 | 46.2 |
Reclassification out of Accumulated Other Comprehensive Income (Loss) | Net Gain on Hedges | Foreign Exchange Contracts | ||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income | ||||
Net Investment Gain (Loss) | 0.0 | 0.1 | 0.0 | 0.1 |
Net Investment Income | (1.5) | 0.3 | (1.0) | 1.2 |
Reclassification out of Accumulated Other Comprehensive Income (Loss) | Amortization of Net Actuarial Loss | ||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income | ||||
Other Expenses | (4.0) | (5.5) | (11.8) | (16.9) |
Reclassification out of Accumulated Other Comprehensive Income (Loss) | Prior Service Credit | ||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income | ||||
Other Expenses | 0.1 | 0.1 | 0.2 | 0.2 |
Reclassification out of Accumulated Other Comprehensive Income (Loss) | Unrecognized Pension and Postretirement Benefit Costs | ||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income | ||||
Income Before Income Tax | (3.9) | (5.4) | (11.6) | (16.7) |
Income Tax Expense (Benefit) | (0.8) | (1.1) | (2.4) | (3.5) |
Net Income | $ 3.1 | $ 4.3 | $ 9.2 | $ 13.2 |
Liability for Unpaid Claims and Claims Adjustment Expense (Detail) - USD ($) $ in Millions |
9 Months Ended | |
---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
|
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense | ||
Balance at January 1 | $ 23,664.7 | $ 24,180.2 |
Less Reinsurance Recoverable | 8,697.8 | 8,378.9 |
Net Balance at January 1 | 14,966.9 | 15,801.3 |
Incurred Related to | ||
Current Year | 5,130.1 | 5,471.1 |
Paid Related to | ||
Current Year | (2,118.6) | (2,225.3) |
Prior Years | (3,051.2) | (3,021.8) |
Total Paid | (5,169.8) | (5,247.1) |
Reserves Ceded Pursuant to Reinsurance Transaction | 0.0 | (990.0) |
Net Balance at September 30 | 14,398.0 | 14,914.7 |
Plus Reinsurance Recoverable | 8,401.4 | 8,854.8 |
Balance at September 30 | 22,799.4 | 23,769.5 |
Amount Related to Interest | ||
Incurred Related to | ||
Prior Years | 460.5 | 525.3 |
Incurred Claims | ||
Incurred Related to | ||
Prior Years | (601.4) | (613.3) |
Foreign Currency | ||
Incurred Related to | ||
Prior Years | (388.3) | (32.6) |
Operating Expense | ||
Incurred Related to | ||
Total Incurred | $ 4,600.9 | $ 5,350.5 |
Reconciliation of Policy and Contract Benefits and Reserves for Future Policy and Contract Benefits (Detail) - USD ($) $ in Millions |
Sep. 30, 2022 |
Dec. 31, 2021 |
Sep. 30, 2021 |
Dec. 31, 2020 |
---|---|---|---|---|
Insurance [Abstract] | ||||
Policy and Contract Benefits | $ 1,771.4 | $ 1,907.7 | $ 1,920.4 | |
Reserves for Future Policy and Contract Benefits | 42,108.7 | 48,007.5 | 48,475.7 | |
Total Policy and Contract Benefits and Reserves for Future Policy and Contract Benefits | 43,880.1 | 50,396.1 | ||
Life Reserves for Future Policy and Contract Benefits | 8,489.8 | 8,465.8 | ||
Accident and Health Active Life Reserves | 13,355.2 | 13,016.9 | ||
Adjustment Related to Unrealized Investment Gains and Losses | (764.3) | 5,143.9 | ||
Liability for Unpaid Claims and Claim Adjustment Expense | $ 22,799.4 | $ 23,664.7 | $ 23,769.5 | $ 24,180.2 |
Liability for Unpaid Claims and CAE - Additional Information (Details) - USD ($) $ in Millions |
9 Months Ended | ||||
---|---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Dec. 31, 2021 |
Mar. 31, 2021 |
Dec. 31, 2020 |
|
Liability for Unpaid Claims and CAE | |||||
Unum US Group Long-term Disability Reserve Reduction, Before Tax | $ (121.0) | $ (215.0) | |||
Unum US Group Life Reserve Reduction, Before Tax | (34.0) | ||||
Closed Block Long-term Care Reserve Increase | 2.1 | ||||
Closed Block Individual Disability Reserve Increase, Before Tax | 6.4 | ||||
Net Reduction in Unpaid Claims as a Result of Assumption Updates, Before Tax | (155.0) | (206.5) | |||
Reinsurance Recoverables, Incurred but Not Reported Claims | 8,401.4 | 8,854.8 | $ 8,697.8 | $ 8,378.9 | |
Phase 2 | Closed Block Individual Disability Reinsurance Transaction | |||||
Liability for Unpaid Claims and CAE | |||||
Reinsurance Recoverables, Incurred but Not Reported Claims | $ 990.0 | ||||
Increase in Benefits and Change in Reserves for Future Benefits | $ 133.1 | $ 133.1 |
Premium Income by Major Line of Business within Each Segment (Detail) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
|
Segment Reporting Information | ||||
Premium Income | $ 2,391.7 | $ 2,353.7 | $ 7,212.3 | $ 7,106.4 |
Operating Segments | ||||
Segment Reporting Information | ||||
Premium Income | 2,391.7 | 2,353.7 | 7,212.3 | 7,106.4 |
Operating Segments | Unum US | ||||
Segment Reporting Information | ||||
Premium Income | 1,559.6 | 1,500.8 | 4,676.8 | 4,548.7 |
Operating Segments | Unum US | Group Long-term Disability | ||||
Segment Reporting Information | ||||
Premium Income | 480.9 | 451.4 | 1,419.2 | 1,367.7 |
Operating Segments | Unum US | Group Short-term Disability | ||||
Segment Reporting Information | ||||
Premium Income | 232.2 | 212.4 | 685.9 | 641.2 |
Operating Segments | Unum US | Group Life | ||||
Segment Reporting Information | ||||
Premium Income | 417.7 | 404.2 | 1,249.9 | 1,228.8 |
Operating Segments | Unum US | Accidental Death & Dismemberment | ||||
Segment Reporting Information | ||||
Premium Income | 43.8 | 39.6 | 129.7 | 123.0 |
Operating Segments | Unum US | Voluntary Benefits | ||||
Segment Reporting Information | ||||
Premium Income | 199.0 | 209.6 | 635.2 | 640.4 |
Operating Segments | Unum US | Individual Disability | ||||
Segment Reporting Information | ||||
Premium Income | 118.9 | 115.7 | 350.3 | 345.0 |
Operating Segments | Unum US | Dental and Vision | ||||
Segment Reporting Information | ||||
Premium Income | 67.1 | 67.9 | 206.6 | 202.6 |
Operating Segments | Unum International | ||||
Segment Reporting Information | ||||
Premium Income | 173.3 | 181.6 | 540.5 | 539.5 |
Operating Segments | Unum International | Group Long-term Disability | ||||
Segment Reporting Information | ||||
Premium Income | 89.8 | 101.6 | 287.5 | 303.8 |
Operating Segments | Unum International | Group Life | ||||
Segment Reporting Information | ||||
Premium Income | 35.0 | 29.1 | 100.5 | 84.4 |
Operating Segments | Unum International | Supplemental | ||||
Segment Reporting Information | ||||
Premium Income | 27.4 | 28.3 | 85.8 | 84.2 |
Operating Segments | Unum International | Unum Poland | ||||
Segment Reporting Information | ||||
Premium Income | 21.1 | 22.6 | 66.7 | 67.1 |
Operating Segments | Colonial Life | ||||
Segment Reporting Information | ||||
Premium Income | 423.3 | 420.8 | 1,281.6 | 1,266.9 |
Operating Segments | Colonial Life | Accident, Sickness, and Disability | ||||
Segment Reporting Information | ||||
Premium Income | 236.1 | 238.0 | 714.0 | 715.1 |
Operating Segments | Colonial Life | Life Insurance | ||||
Segment Reporting Information | ||||
Premium Income | 100.2 | 94.6 | 303.2 | 287.3 |
Operating Segments | Colonial Life | Cancer and Critical Illness Colonial | ||||
Segment Reporting Information | ||||
Premium Income | 87.0 | 88.2 | 264.4 | 264.5 |
Operating Segments | Closed Block | ||||
Segment Reporting Information | ||||
Premium Income | 235.5 | 250.5 | 713.4 | 751.3 |
Operating Segments | Closed Block | Individual Disability | ||||
Segment Reporting Information | ||||
Premium Income | 59.5 | 72.3 | 185.3 | 216.8 |
Operating Segments | Closed Block | Long-term Care | ||||
Segment Reporting Information | ||||
Premium Income | 174.5 | 176.1 | 523.0 | 528.4 |
Operating Segments | Closed Block | Other Insurance Product Line | ||||
Segment Reporting Information | ||||
Premium Income | $ 1.5 | $ 2.1 | $ 5.1 | $ 6.1 |
Selected Operating Statement Data by Segment (Detail) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
|
Segment Reporting Information | ||||
Premium Income | $ 2,391.7 | $ 2,353.7 | $ 7,212.3 | $ 7,106.4 |
Net Investment Income | 511.6 | 550.2 | 1,597.8 | 1,662.4 |
Other Income | 63.0 | 65.9 | 197.5 | 180.5 |
Operating Segments | ||||
Segment Reporting Information | ||||
Premium Income | 2,391.7 | 2,353.7 | 7,212.3 | 7,106.4 |
Net Investment Income | 511.6 | 550.2 | 1,597.8 | 1,662.4 |
Other Income | 63.0 | 65.9 | 197.5 | 180.5 |
Adjusted Operating Revenue | 2,966.3 | 2,969.8 | 9,007.6 | 8,949.3 |
Adjusted Operating Income (Loss) | 379.9 | 260.4 | 1,186.3 | 896.5 |
Operating Segments | Unum US | ||||
Segment Reporting Information | ||||
Premium Income | 1,559.6 | 1,500.8 | 4,676.8 | 4,548.7 |
Net Investment Income | 170.6 | 176.2 | 509.4 | 539.5 |
Other Income | 49.0 | 43.5 | 146.8 | 125.2 |
Adjusted Operating Revenue | 1,779.2 | 1,720.5 | 5,333.0 | 5,213.4 |
Adjusted Operating Income (Loss) | 275.0 | 88.5 | 742.0 | 383.5 |
Operating Segments | Unum International | ||||
Segment Reporting Information | ||||
Premium Income | 173.3 | 181.6 | 540.5 | 539.5 |
Net Investment Income | 37.0 | 33.1 | 122.3 | 94.8 |
Other Income | 0.2 | 0.4 | 0.7 | 0.6 |
Adjusted Operating Revenue | 210.5 | 215.1 | 663.5 | 634.9 |
Adjusted Operating Income (Loss) | 29.9 | 27.4 | 82.0 | 78.6 |
Operating Segments | Colonial Life | ||||
Segment Reporting Information | ||||
Premium Income | 423.3 | 420.8 | 1,281.6 | 1,266.9 |
Net Investment Income | 38.6 | 51.8 | 115.4 | 131.1 |
Other Income | 0.3 | 0.3 | 0.8 | 0.8 |
Adjusted Operating Revenue | 462.2 | 472.9 | 1,397.8 | 1,398.8 |
Adjusted Operating Income (Loss) | 90.4 | 80.1 | 281.6 | 249.2 |
Operating Segments | Closed Block | ||||
Segment Reporting Information | ||||
Premium Income | 235.5 | 250.5 | 713.4 | 751.3 |
Net Investment Income | 251.4 | 284.6 | 817.7 | 876.5 |
Other Income | 13.1 | 19.3 | 45.6 | 49.8 |
Adjusted Operating Revenue | 500.0 | 554.4 | 1,576.7 | 1,677.6 |
Adjusted Operating Income (Loss) | 34.1 | 109.8 | 207.5 | 318.0 |
Operating Segments | Corporate | ||||
Segment Reporting Information | ||||
Premium Income | 0.0 | 0.0 | 0.0 | 0.0 |
Net Investment Income | 14.0 | 4.5 | 33.0 | 20.5 |
Other Income | 0.4 | 2.4 | 3.6 | 4.1 |
Adjusted Operating Revenue | 14.4 | 6.9 | 36.6 | 24.6 |
Adjusted Operating Income (Loss) | $ (49.5) | $ (45.4) | $ (126.8) | $ (132.8) |
Assets by Segment (Detail) - USD ($) $ in Millions |
Sep. 30, 2022 |
Dec. 31, 2021 |
---|---|---|
Segment Reporting Information | ||
Total Assets | $ 60,866.7 | $ 70,115.6 |
Operating Segments | Unum US | ||
Segment Reporting Information | ||
Total Assets | 16,183.0 | 18,696.3 |
Operating Segments | Unum International | ||
Segment Reporting Information | ||
Total Assets | 2,910.5 | 4,086.5 |
Operating Segments | Colonial Life | ||
Segment Reporting Information | ||
Total Assets | 4,412.5 | 4,895.9 |
Operating Segments | Closed Block | ||
Segment Reporting Information | ||
Total Assets | 33,876.8 | 38,287.9 |
Operating Segments | Corporate | ||
Segment Reporting Information | ||
Total Assets | $ 3,483.9 | $ 4,149.0 |
Reconciliation of Total Revenue and Income Before Income Tax to Operating Revenue and Operating Income (Detail) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
|
Segment Reporting, Revenue Reconciling Item | ||||
Total Revenue | $ 2,961.9 | $ 2,969.7 | $ 8,985.3 | $ 9,034.7 |
Net Investment Gain (Loss) | (4.4) | (0.1) | (22.3) | 85.4 |
Capitalized Computer Software, Impairments | 0.0 | 12.1 | 0.0 | 12.1 |
Operating Segments | ||||
Segment Reporting, Revenue Reconciling Item | ||||
Total Revenue | 2,961.9 | 2,969.7 | 8,985.3 | 9,034.7 |
Net Investment Gain (Loss) | (4.4) | (0.1) | (22.3) | 85.4 |
Adjusted Operating Revenue | 2,966.3 | 2,969.8 | 9,007.6 | 8,949.3 |
Income Before Income Tax | 515.3 | 409.9 | 1,270.5 | 871.3 |
Net Reserve Decrease Related to Reserve Assumption Updates, Before Tax | 155.0 | 181.4 | 155.0 | 181.4 |
Cost Related to Early Retirement of Debt | 0.0 | 0.0 | 0.0 | (67.3) |
Impairment Loss on ROU Asset | 0.0 | 0.0 | 0.0 | (13.9) |
Adjusted Operating Income | 379.9 | 260.4 | 1,186.3 | 896.5 |
Operating Segments | Closed Block Individual Disability Reinsurance Transaction | ||||
Segment Reporting, Revenue Reconciling Item | ||||
Net Investment Gain (Loss) | 0.0 | 0.0 | 0.0 | 67.6 |
Change in Benefit Reserves and Transaction Costs | 0.0 | 0.0 | 0.0 | (139.3) |
Amortization of the Cost of Reinsurance | (15.2) | (19.7) | (48.5) | (59.4) |
Operating Segments | Unrelated to Significant Transaction | ||||
Segment Reporting, Revenue Reconciling Item | ||||
Net Investment Gain (Loss) | $ (4.4) | $ (0.1) | $ (22.3) | $ 17.8 |
Segment Information Segments - Additional Information (Detail) |
9 Months Ended |
---|---|
Sep. 30, 2022
Integer
| |
Segment Reporting [Abstract] | |
Number of Operating Segments | 3 |
Employee Benefit Plans Net Periodic Benefit Cost (Detail) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
|
Pension Plan | UNITED STATES | ||||
Defined Benefit Plans and Other Postretirement Benefit Plans | ||||
Service Cost | $ 1.9 | $ 2.4 | $ 5.8 | $ 7.2 |
Interest Cost | 16.8 | 16.3 | 50.4 | 48.7 |
Expected Return on Plan Assets | (26.5) | (25.2) | (79.5) | (75.5) |
Amortization of Net Actuarial (Gain) Loss | 4.1 | 5.3 | 12.2 | 16.0 |
Amortization of Prior Service Credit | 0.0 | 0.0 | 0.0 | 0.0 |
Net Periodic Benefit Cost (Credit) | (3.7) | (1.2) | (11.1) | (3.6) |
Pension Plan | UNITED KINGDOM | ||||
Defined Benefit Plans and Other Postretirement Benefit Plans | ||||
Service Cost | 0.0 | 0.0 | 0.0 | 0.0 |
Interest Cost | 1.2 | 1.1 | 3.8 | 3.2 |
Expected Return on Plan Assets | (2.6) | (2.4) | (8.3) | (7.4) |
Amortization of Net Actuarial (Gain) Loss | 0.1 | 0.2 | 0.3 | 0.9 |
Amortization of Prior Service Credit | 0.0 | 0.0 | 0.0 | 0.0 |
Net Periodic Benefit Cost (Credit) | (1.3) | (1.1) | (4.2) | (3.3) |
Other Postretirement Benefit Plans | ||||
Defined Benefit Plans and Other Postretirement Benefit Plans | ||||
Service Cost | 0.0 | 0.0 | 0.0 | 0.0 |
Interest Cost | 0.8 | 0.8 | 2.3 | 2.3 |
Expected Return on Plan Assets | (0.2) | (0.1) | (0.4) | (0.4) |
Amortization of Net Actuarial (Gain) Loss | (0.2) | 0.0 | (0.7) | 0.0 |
Amortization of Prior Service Credit | (0.1) | (0.1) | (0.2) | (0.2) |
Net Periodic Benefit Cost (Credit) | $ 0.3 | $ 0.6 | $ 1.0 | $ 1.7 |
Basic and Diluted Earnings Per Share (Detail) - USD ($) $ / shares in Units, $ in Millions |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
|
Numerator | ||||
Net Income | $ 410.7 | $ 328.6 | $ 1,034.6 | $ 664.5 |
Denominator | ||||
Weighted Average Common Shares - Basic | 200,035,300 | 204,645,800 | 201,262,300 | 204,429,600 |
Dilution for Assumed Exercises of Stock Options and Nonvested Stock Awards | 1,614,900 | 496,500 | 1,256,700 | 623,300 |
Weighted Average Common Shares - Assuming Dilution | 201,650,200 | 205,142,300 | 202,519,000 | 205,052,900 |
Net Income Per Common Share | ||||
Basic | $ 2.05 | $ 1.61 | $ 5.14 | $ 3.25 |
Assuming Dilution | $ 2.04 | $ 1.60 | $ 5.11 | $ 3.24 |
Treasury Stock Transactions (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||||
---|---|---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
|||
Treasury Stock, Value [Abstract] | ||||||
Number of Treasury Shares Repurchased | 1,164,800 | 0 | 4,243,400 | 0 | ||
Cost of Shares Repurchased | [1] | $ 42.6 | $ 0.0 | $ 137.5 | $ 0.0 | |
Commissions Paid on Stock Repurchases | $ 0.1 | |||||
|
Stockholders' Equity and Earnings Per Common Share - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Millions |
3 Months Ended | 9 Months Ended | |||||
---|---|---|---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
Oct. 25, 2021 |
|||
Outstanding Restricted Stock and Stock Success Unit Grant Prices Lower Limit | $ 12.45 | $ 12.45 | |||||
Outstanding Restricted Stock and Stock Success Unit Grant Prices Upper Limit | $ 39.82 | $ 39.82 | |||||
Antidilutive Securities Excluded from Computation of Earnings Per Share | 1,300,000 | 100,000 | 1,100,000 | ||||
Authorized Amount of Treasury Share Repurchases Under Stock Repurchase Program | $ 250.0 | ||||||
Expiration Date of Share Repurchase Program Authorized in October 2021 | Dec. 31, 2022 | ||||||
Number of Treasury Shares Repurchased | 1,164,800 | 0 | 4,243,400 | 0 | |||
Cost of Shares Repurchased | [1] | $ 42.6 | $ 0.0 | $ 137.5 | $ 0.0 | ||
Remaining Amount of Treasury Share Repurchases Authorized Under Stock Repurchase Program | $ 62.5 | $ 62.5 | |||||
Authorized Shares of Preferred Stock | 25,000,000.0 | 25,000,000.0 | |||||
Par Value Per Share of Preferred Stock | $ 0.10 | $ 0.10 | |||||
Issued Shares of Preferred Stock | 0 | 0 | |||||
Accelerated Share Repurchase Agreement [Member] | |||||||
Number of Treasury Shares Repurchased | 1,700,000 | ||||||
Cost of Shares Repurchased | $ 50.0 | ||||||
Open Market Share Repurchases [Member] | |||||||
Number of Treasury Shares Repurchased | 1,200,000 | 2,500,000 | |||||
Cost of Shares Repurchased | $ 42.6 | $ 87.5 | |||||
|
Debt - Additional Information (Details) - USD ($) $ in Millions |
9 Months Ended | |
---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
|
Notes 4.500 Due 2025 | ||
Debt Additional Information | ||
Debt Instrument, Repurchased Face Amount | $ 500.0 | |
Cost Related to Early Retirement of Debt | 67.3 | |
4.000% Notes due 2024 | ||
Debt Additional Information | ||
Debt Instrument, Repurchased Face Amount | $ 350.0 | |
Cost Related to Early Retirement of Debt | 3.0 | |
7.405% junior subordinated debt securities due 2038 | ||
Debt Additional Information | ||
Debt Instrument, Repurchased Face Amount | 14.0 | |
Cost Related to Early Retirement of Debt | 1.2 | |
Senior Notes | 4.125% Senior Notes due 2051 | ||
Debt Additional Information | ||
Debt Instrument, Face Amount | $ 600.0 | |
Five-year Unsecured Revolving Credit Facility [Member] | ||
Debt Additional Information | ||
Line of Credit Facility, Maximum Borrowing Capacity | 500.0 | |
Line of Credit Facility, Additional Borrowing Capacity If Requested | 200.0 | |
Line of Credit Facility, Fair Value of Amount Outstanding | 0.0 | |
Letters of Credit Outstanding, Amount | 0.4 | |
Five-Year $350 million Term Loan Facility | ||
Debt Additional Information | ||
Line of Credit Facility, Maximum Borrowing Capacity | 350.0 | |
Line of Credit Facility, Fair Value of Amount Outstanding | $ 350.0 |
Income Tax - Additional Information (Details) $ in Millions |
9 Months Ended |
---|---|
Sep. 30, 2021
USD ($)
| |
Income Tax Disclosure [Abstract] | |
Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability | $ 24.2 |
Allowance for Expected Credit Losses on Premiums Receivable (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||||||
---|---|---|---|---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
Jun. 30, 2022 |
Dec. 31, 2021 |
Jun. 30, 2021 |
Dec. 31, 2020 |
|
Credit Loss [Abstract] | ||||||||
Premium Receivable, Allowance for Credit Loss | $ 31.4 | $ 32.6 | $ 31.4 | $ 32.6 | $ 34.3 | $ 34.2 | $ 31.0 | $ 38.8 |
Premiums Receivable, Gross | 561.1 | 575.8 | 561.1 | 575.8 | $ 593.4 | $ 530.7 | $ 576.3 | $ 525.8 |
Premium Receivable, Credit Loss Expense (Reversal) | $ (2.9) | $ 1.6 | $ (2.8) | $ (6.2) |
Impairment Loss on Internal-Use Software (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
|
Research and Development [Abstract] | ||||
Capitalized Computer Software, Impairments | $ 0.0 | $ 12.1 | $ 0.0 | $ 12.1 |
Reinsurance (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | |||||
---|---|---|---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
Dec. 31, 2021 |
Mar. 31, 2021 |
Dec. 31, 2020 |
|
Effects of Reinsurance | |||||||
Net Investment Gain (Loss) | $ (4.4) | $ (0.1) | $ (22.3) | $ 85.4 | |||
Other Expenses | 247.3 | 251.5 | 744.4 | 746.8 | |||
Reinsurance Recoverables, Incurred but Not Reported Claims | $ 8,401.4 | $ 8,854.8 | 8,401.4 | 8,854.8 | $ 8,697.8 | $ 8,378.9 | |
Closed Block Individual Disability Reinsurance Transaction | Phase 2 | |||||||
Effects of Reinsurance | |||||||
Negative Ceding Commission | $ (18.2) | ||||||
Net Investment Gain (Loss) | 67.6 | ||||||
Increase in Benefits and Change in Reserves for Future Benefits | $ 133.1 | 133.1 | |||||
Other Expenses | $ 6.2 | ||||||
Reinsurance Recoverables, Incurred but Not Reported Claims | 990.0 | ||||||
Prepaid Reinsurance Premiums | 43.1 | ||||||
Deposit Contracts, Assets | 5.0 | ||||||
Closed Block Individual Disability Reinsurance Transaction | Phases 1 and 2 | |||||||
Effects of Reinsurance | |||||||
Prepaid Reinsurance Premiums | 854.8 | ||||||
Deposit Contracts, Assets | $ 91.8 |
=+0WKSNAWC#0,T8N"NS#
M@3MTQTZ5EVDJ5C!3:J7WDA?9JJC0 T]YMF9/.3\Z!=(-"?P1L2;!C8Y=)Z/
M6+PVNP G?9D&MTS'3I1.'GA65BM9NP#^B367/^4@&=&S^M/N'C%E>R1.1M&^
M?S;#!!SL65FXA3EVTQR&4JX T.WZA\M4%-RJEQHR(AP96 \H+<#/-,GR\\&N*/:?Q^,\WM&4Y".^IYG\9,-%2@IY*[;C?"\H
M6>M%:3)&GA>.4\*RP>Q,/[L7LS-^*!*6T7L!\D.:$O%R01/^?#Z @U\/OK+M
MKE /QK.S/=G2%2T>]O="WHUK+6N6TBQG/ .";LX'<_AYX6.U0$O\R>ASWKH&
MRI1'SG^HF^OU^\X&FU
M6")(65;^)3\K1[062#WV!:A:@(X7^#T+<+5 >VY<(M-F+4E!9F>"/P.AI*4V
M=:%]HU=+:UBFMG%5"/DID^N*V>+NR^KNYGHY_W:Y!*MO\L_MY9=O*W!W!1;S
MU1_@ZN;N^PI\>/@R?UA>2YF/8 @>5DOPX;>/X#? ,G#+DD3N1WXV+B0 H"I6A=-EH"(3473$VR:F/Z#-VNBU+4J'9NX45NE710Z4(]QY^R\E%TO*K"8B] T6W]#>I-T)S2NHO"?F9F!08 "S3
MBO1/%51;%9/.CLT<'K.*"BZN>6=F**#V3__ 4/O7S:3WTE9QP%^[0#?I7WV15:AZRSF*;69
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M&5'EP@H5&R"FV$BV2JKM_
M97,NMXSZS+X&V1U^LJ>),G
M*FF//R4(+9AC ^:K\9T3?E3;DV R#(/Q<#R^8[Z)W?:$YYL
B))X]W]#/<80?P]ZC@Z94
M3S"V1IP0;_5' 9(==2ZZRZGA_@%7 7.&W3^_%,'7T >QC):K;'K#9CIG9S:W
MH%WJG" .)BR3M-G)Q/Z>N,,A^I@!.V 3;'=FGE\<>GR&QT=#\SR0.3XTAA['
M(+W(":NECBKX*G+EA,F_5X41++(AP70A134X3VE>2/^7?&\=M*+2R7I[EP4/
M1DB6,+-.7B^O8!P_="DUY/QG,&)8
M?&7F[-B4(LNA3$%Z0L-6\GM$L[G22_OB;G#CH(K/P7JCXWBF4L_9P$B';$GD
MFBTWHGT.UZO'Z\&B:5Q8V-6PXI;P2F?VH_R&+M+-1 YD5AG/IJ?7_6&E[KL,
M F_ MQ&'!T$]Y[>9[